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1.  Abstract 
   
  Ubiquitin is a highly conserved protein involved in several cellular processes like protein 
degradation, endocytosis, signal transduction and DNA repair. The discovery of ubiquitin-like 
proteins (UBL) and ubiquitin-like domains (ULD) increases the number of regulation pathways 
where the property of the ubiquitin-fold (Ub-fold) is profitable.  
 
  Autophagy  is  the  catabolic  pathway  used  in  cells  to  deliver  cytosolic  components  and 
dysfunctional  organelles  to  the  lysosome  for  degradation.  Light  chain  3  of  microtubule-
associated  protein  1  (MAP1LC3)  proteins  are  UBL  involved  in  the  expansion  of  the 
autophagosome,  which  sequesters  cytosolic  substrates.  Additionnaly,  this  protein  family, 
including  the  light  chain  3  proteins  (LC3-) a nd  the  γ-aminobutyric  acid  receptor-associated 
proteins  (GABARAP-)  subfamilies,  bind  to  autophagy  receptors  linked  to  polyubiquitinated 
proteins  aggregates.  For  this  project,  the  three  dimensional s tructure  of  a  protein  complex 
containing the autophagy effector GABARAPL-1 in the presence of the LC3- interacting region 
(LIR) of the autophagy receptor neighbor of BRAC1 gene 1 protein (NBR1) was determined by 
Nuclear Magnetic Resonance (NMR). The results confirmed that γ-aminobutyric acid receptor-
associated protein-like 1 (GABARAPL-1) belongs to the MAP1LC3 protein family, structurally 
characterized by an Ub-fold, consisting of a central β-sheet formed by four β-strands and two 
α-helices on one side of the β-sheet, preceded N-terminally by two α-helices, resulting in the 
formation of two hydrophobic pockets, hp1 and hp2. The autophagy receptor NBR1 interacts 
with  GABARAPL-1  through  these  pockets  with  its  LIR  motif  taking  an  extended  beta 
conformation  upon  binding,  forming  an  intermolecular  β-sheet  with  the  second  β-strand  of 
GABARAPL-1. This LIR motif consists of an  ΘxxΓ sequence preceded by negatively charged 
amino  acids,  where  Θ  and  Γ  are  represented  by  any  aromatic  and  hydrophobic  residues, 
respectively. Interaction studies of the LIR domains of different autophagy receptors (p62, Nix 
and NBR1) with different members of the MAP1LC3 protein family indicated that the presence 
of a tryptophan in the LIR motif increases the binding affinity. Substitution to other aromatic 
amino acids or increasing the number of negatively charged residues at the N-terminus of the 
LIR  motif  has,  however,  little  effect  on  the  binding  affinity  due  to  enthalpy-entropy 
compensation, suggesting that autophagy effector proteins can interact with a wide variety of 
different sequences with similar and moderate binding affinities. Abstract   
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  Additionally to be present in proteins dealing with protein folding and degradation, ULD 
were found in proteins involved in the regulation of signal transduction like TANK binding 
kinase 1 (TBK1), a serine/threonine kinase involved in the induction of the immune response. In 
this second project, based on the NMR chemical shifts of the domain of TBK1 including amino 
acids 302 and 383, secondary structure prediction programs (TALOS and CSI) confirmed the 
presence of an ULD in TBK1 by identifying one α-helix and four β-strands sequentially aligned 
as follows, ββαββ. This alignment corresponds to the secondary structure elements of ubiquitin 
and proved that TBK1_ULD belongs to the ubiquitin-like protein superfamily. The similarity to 
ubiquitin is even bigger by the presence in addition of a small β-strand and a short α-helix, 
which are observed in ubiquitin as the β5-strand and a 310-helix, respectively. The first attempts 
on the 3D structure determination confirmed the Ub-fold but due to the lack of assignment in 
TBK1_ULD, only a preliminary model was determined. Interaction studies of TBK1_ULD with 
the interferon assocaited domain-serine rich region (IAD-SRR) domain of interferon 3 (IRF3) 
showed that both sides of the molecule seem to be involved. Consequently, the TBK1/IRF3 
interaction is more complex than a one to one binding process. Unfortunately, the instability of 
TBK1_ULD associated to difficulties in IAD-SRR purification did not allow to further study this 
interaction more precisely. 
 
  Finally,  to  overcome  the  difficulty  encountered  in  NMR  experiments  because  of  low 
expression or poor solubility, an expression vector using the intrinsic properties of ubiquitin was 
designed. Fused to protein and peptide targets, this construct produced proteins and peptides in a 
larger amount than with traditional expression vectors. Using this construct, labeled peptides 
were also produced for NMR structural studies with a less cost than the chemical synthesis of 
pure labeled peptides. The presence of a hexa-histidine tag was useful for the isolation and the 
purification  of  the  constructs.  A  TEV  cleavage  site  was  included  to  keep  the  possibility  of 
releasing the ubiquitin moiety from the expressed protein or peptide. Moreover, the ubiquitin-tag 
could  also  still  be  attached  to  the  protein/peptide  of  interest  when  biophysical  methods  like 
NMR,  Isothermal  Titration  Calorimetry  (ITC)  or  Circular  Dichroism  (CD)  spectroscopy  are 
applied, providing the same results than for the protein/peptide moiety alone. 
   
 Zusammenfassung 
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2.  Zusammenfassung 
 
  Die Strukturbiologie von Proteinen ist ein wichtiges Forschungsfeld für Wissenschaftler, die 
die Funktion eines Proteins auf struktureller Sicht erläutern oder die Funktion in Abhängigkeit 
von der Struktur verstehen wollen. Die Bestimmung der Struktur eines Proteins, sowie die Art 
der Bindung an seinen Liganden sind bedeutungsvolle Erkenntnisse um biologische Systeme zu 
verstehen und neue Effektoren zu entwicklen, die von der pharmazeutischen Industrie verwendet 
werden könnten. In dieser Arbeit wurde kernmagnetische Resonanz (NMR) verwendet, nicht 
nur, um die Sekundärstruktur einer Proteindomäne, sondern auch die dreidimensionale Struktur 
eines  Proteins  mit  seinem  Liganden  zu  bestimmen.  Gekoppelt  mit  Isothermer  Titrations 
Kalorimetrie (ITC) wurde NMR auch zur Charakterisierung von Protein-Peptid-Interaktionen 
ausgeübt. 
  Ubiquitin  ist  ein  hoch  konserviertes  Protein,  das  in  verschiedene  zelluläre  Prozesse  wie 
Proteinabbau,  Endocytose,  Signaltransduktion  und  DNA-Reparatur  involviert  ist.  Die 
Entdeckung der Ubiquitin-ähnlichen Proteine (UBL) und Ubiquitin-ähnlichen Domänen (ULD) 
erhöht  die  Anzahl  der  Regulierungswege,  bei  denen  Erkenntnisse  über  das  Grundgerüst  der 
Ubiquitin-Faltung profitabel wären. 
  Zellen  verwenden  Autophagie  als  Abbauweg,  um  cytosolische  Komponenten  sowie 
dysfunktionale Organellen den Lysosomen zur Degradation zu liefern. MAP1LC3 Proteine sind 
UBL  Proteine,  die  bei  dem  Ausbau  eines  doppelten  Membransacks,  des  Autophagosoms, 
beteiligt sind. Dieser trennt die Substrate aus dem Cytosol und fusioniert mit dem Lysozym, 
wobei  Hydrolasen  die  im  Autophagosom  enthaltenen  Proteine  entfalten  und  lysieren.  Des 
Weiteren  binden  MAP1LC3  Proteine  (LC3-  und  GABARAP-  Unterfamilien)  auch 
Autophagie-Rezeptoren  in  Verbindung  mit  polyubiquitinierten  Proteineaggregaten. 
Polyubiquitinierung  ist  eine  prinzipielle  posttranslationale  Signalmodifikation,  die  für  die 
Markierung von Proteinen für deren Degradation verwendet wird. Mit der Charakterisierung des 
ersten Autophagie-Rezeptor p62 wurde ein wesentliches peptidisches Motiv für die Bindung an 
Autophagie  Effektoren  identifiziert.  Diese  LC3-Interaktions-Region  (LIR)  besteht  aus  einer 
WxxL  Sequenz  mit  vorangestellten  sauren  Aminosäureresten.  Mit  der  Entdeckung  weiterer 
Autophagie-Rezeptoren  mit  unterschiedlichen  LIR  Motiven,  mußte  die  Definition  des  LIR 
Sequenz überdacht werden. Anstelle von Tryptophan und Leucin werden jeweils aromatische 
und  hydrophobe  Aminosäuren  benötigt,  wobei  immer  noch  die  Anwesenheit  von  negativ 
geladenen  Aminosäuren  N-terminal  zu  diesem  Motiv  unabkömmlich  ist.  Die  MAP1LC3 Zusammenfassung   
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Proteinfamilie  ist  strukturell  durch  eine  Ubiquitin-Faltung  gekennzeichnet.  Diese  besteht  aus 
einem  zentralen  β-Faltblatt  aus  vier  β-Strängen  und  zwei α-Helices  auf  einer  Seite  des 
β-Faltblatt und desweiteren aus zwei N-terminalen α-Helices. Der Ubiquitin Kern, flankiert von 
den beiden zusätzlichen α-Helices, führt zur Bildung von zwei hydrophoben Taschen, hp1 und 
hp2. Vorherige Studien haben gezeigt, dass hp1 und hp2 an der Bindung des LIR Motivs durch 
die Interaktion mit der aromatischen und der hydrophoben Aminosäure von LIR beteiligt sind. 
  Für  dieses  Projekt  wurde  die  dreidimensionale  Struktur  des  Komplexes 
GABARAPL-1/NBR1-LIR mittels NMR bestimmt. Die Struktur bestätigte, dass GABARAPL-1 
die gleichen strukturellen Eigenschaften wie auch die anderen MAP1LC3 Proteine besitzt. Der 
autophagische Rezeptor NBR1 interagiert mit GABARAPL-1 mittels hp1 und hp2 durch den 
Tyrosin- und Isoleucin-Reste des LIR Motivs. Desweiteren besteht eine Interaktion zwischen 
den Lysinen in der N-terminalen α-Helices von GABARAPL-1 und den Glutaminsäuren und die 
Asparaginsäuren  N-terminal  des  LIR  Motivs.  Darüber  hinaus  nimmt  das  LIR  Motiv    eine 
erweiterte β-Konformation bei der Bindung ein und bildet so ein intermolekulares β-Faltblatt mit 
dem  zweiten  β-Strang  von  GABARAPL-1.  Interessanterweise  ist  der  aromatische  Rest  in 
NBR1-LIR ein Tyrosin, wohingegen sich es in den meisten der LIR Motiven um ein Tryptophan 
handelt. Bei einem genaueren Blick in die Struktur des GABARAPL-1/NBR1-LIR Komplexes 
konnte die Seitenkette von Tyrosin unterschiedliche Positionen in der hp1 Tasche einnehmen, 
die mit dem unterschiedlichen berechneten strukturellen Konformeren übereinstimmen. Diese 
mögliche  Flexibilität  des  NBR1-LIR  Motivs  ist  im  Einvernehmen  mit  den  Studien  zu 
Wechselwirkungen der LIR Domänen von unterschiedlichen Autophagie-Rezeptoren mit den 
verschiedenen Mitgliedern der MAP1LC3 Protein Familie. Allerdings erhöht die Anwesenheit 
von Tryptophan im LIR Motiv die Bindungsaffinität zu MAP1LC3 Proteinen, wie auch in p62, 
das somit ein besserer Interaktion Partner als NBR1 ist. ITC Experimente bestätigen, dass die 
Mutation von Tyrosin zu Tryptophan in NBR1-LIR zu einer stärkeren Interaktion im Vergleich 
zu  Wildtyp  mit  GABARAPL-1  führt.  Darüber  hinaus  zeigten  die  NMR-Titrationen  von 
NBR1-LIR Wildtyp und der Mutant unterschiedliche chemische Verschiebungen, langsam für 
die Tryptophan-Mutant und intermediär (nah zu langsam) für den Wildtyp, was die stärkere 
Interaktion in Anwesenheit eines Tryptophan anstelle eines Tyrosins in dem LIR Motiv bestätigt. 
Obwohl  die  beiden  LIR  Motive  im  Protein  Nix  einen  Tryptophan-Rest  besitzen,  interagiert 
dieser autophagische Rezeptor noch schwächer als NBR1 mit MAP1LC3 Proteinen. Folglich ist 
die  alleinige  Gegenwart  eines  Tryptophan  als  aromatischer  Rest  nicht  ausreichend,  um  eine 
starke Bindung zu erreichen. Des weiteren sind die Anwesenheit des hydrophoben Rests sowie Zusammenfassung 
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negativ  geladener  Aminosäuren  notwendig.  Wahrscheinlich  wirkt  der  erweiterte  hydrophobe 
Patch  in  NBR1-LIR  unterstützend,  um  die  Substitution  von  Tryptophan  durch  Tyrosin  zu 
kompensieren. Hinsichtlich der Bedeutung von negativ geladenen Resten im LIR Motiv für die 
Interaktion  mit  MAP1LC3  Proteinen  könnte  die  Anwesenheit  von  mehreren  Serinen  in  den 
verschiedenen  Autophagie-Rezeptor  Sequenzen  vermuten  lassen,  dass  posttranslationale 
Modifikationen  wie  Phosphorylierung  die  Interaktion  verbessern  könnten.  Im  Falle  von 
NBR1-LIR hatte die Erhöhung der Anzahl der negativ geladenen Reste am N-Terminus des LIR 
Motivs durch Enthalpie-Entropie Kompensation wenig Einfluss auf die Bindungsaffinität. Dieser 
Effekt wurde auch bei der Substitution von Tyrosin zu einer weiteren aromatischen Aminosäure, 
Phenylalanin, beobachtet. Diese Ergebnisse implizieren, dass die Autophagie Effektor-Proteine 
mit  einer  Vielzahl  von  verschiedenen  Sequenzen  mit  ähnlichen  und  moderaten 
Bindungsaffinitäten interagieren können. 
  Neben ihrer Funktion in Proteinfaltung und Degradation wurden ULDs in regulatorischen 
Proteinen der Signaltransduktion gefunden, wie auch in TANK-binding kinase 1 (TBK1), einer 
Serin/Threonin-Kinase,  die  an  der  Induktion  der  Immunantwort  beteiligt  ist.  NMR  wurde 
verwendet um nach zu weisen, dass die Domäne zwischen den Resten 302 und 383 in TBK1 
eine  Ubiquitin-ähnliche  Domäne  ist,  wie  bereits  in  silico  vorhergesagt  wurde.  Aufgrund 
Löslichkeits-  und  Stabilitätsprobleme  wurde  die  Strukturbestimmung  von  TBK1_ULD 
anspruchsvoller als zuvor angenommen. Dennoch konnte die Zuordnung des Peptid-Rückgrats 
von TBK1_ULD mit Hilfe selektiv markierter Proben zusätzlich zu den einheitlich markierten 
Proben durchgeführt werden. Die C
α, C
β und C
’ chemischen Verschiebungen von TBK1_ULD 
waren  notwendig,  um  die  sekundäre  Struktur  dieser  Domäne  mithilfe  von  TALOS  und  CSI 
Software  zu  berechnen.  Beide  Programme  bestätigen  das  Vorhandensein  einer 
Ubiquitin-ähnlichen Domäne in TBK1 durch die Ermittlung  einer α-Helix und vier β-Strängen 
in der Abfolge ββαββ. Diese Organisation entspricht genau der sekundären Strukturelemente 
von Ubiquitin und beweist, dass TBK1 zur ULD Protein-Superfamilie gehört. Die Ähnlichkeit 
mit Ubiquitin wurde noch deutlicher durch die Anwesenheit von einem zusätzlichen kleinen 
β-Strang  und  einer  kurzen  α-Helix,  die  dem  β5-Strang  und  der  310-Helix  in  Ubiquitin 
entsprechen. Die ersten Versuche die zur Bestimmung der 3D-Struktur führen sollten, bestätigen 
zwar die Ub-Faltung, aufgrund der fehlenden Zuordnung in TBK1_ULD konnte allerdings eine 
Struktur nur auf der Basis eines Ubiquitin Modells ermittelt werden. Es wurde bereits gezeigt, 
dass  TBK1_ULD  an  die  Interferon-assoziierte  Domän-serin-reiche  Region  (IAD-SRR)  von 
Interferon-regulatorischer  Faktor  3  (IRF3)  bindet  und  anschließend  diese  folglich  durch  die Zusammenfassung   
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TBK1_Kinase phosphoryliert wird, um in den Zellkern transportiert zu werden. Während der 
NMR Titration von IAD-SRR gegen TBK1_ULD zeigten beide chemischen Verschiebungen 
Störungen, welche nach neuen Signalen für Aminosäure Reste aussahen, die sich auf beiden 
Seiten des Moleküls befinden. Dies lässt darauf schließen, dass die TBK1_ULD/IRF3_IAD-SRR 
Interaktion komplexer als ein „eins zu eins“-Bindungsprozess ist. Leider hat die Instabilität von 
TBK1_ULD verbunden mit der Schwierigkeit bei der IAD-SRR Reinigung nicht erlaubt, weitere 
Studien dieser Interaktion genauer durchzuführen. 
  Die  beiden  ersten  Projekte  haben  die  Schwierigkeit  bei  der  Bestimmung  von 
Proteinstrukturen durch NMR aufgrund der Notwendigkeit der Herstellung einer hohen Menge 
an  löslichem  und  gleichzeitig  reinem  Protein  gezeigt.  Um  dieses  Problem  einer  niedrigen 
Expression  und/oder  schlechter  Löslichkeit  zu  bewältigen,  wurde  ein  Expressionsvektor  auf 
Basis von Ubiquitin hergestellt. Durch die inhärenten Eigenschaften von Ubiquitin wurde die 
Expression und Löslichkeit des fusionierten Proteins oder Peptids bereits weitgehend verbessert. 
Des  weiteren  war  die  Anwesenheit  eines  Hexahistidin-Tag  nützlich  für  die  Isolierung  und 
Reinigung der Konstrukte. Eine TEV-Spaltstelle bietet zudem die Möglichkeit der Abtrennung 
der Ubiquitin-Einheit von dem restlichen Protein oder Peptid. Dieser Expressionsvektor wurde 
verwendet um Proteine in einer größeren Menge als bei herkömmlichen Expressionsvektoren zu 
produzieren. Peptide wie NBR1-LIR (18 Aminosäuren) wurden ebenfalls auf dieser Weise mit 
geringeren Kosten als bei chemischen Synthesen von Peptiden hergestellt, insbesondere, wenn 
diese  für  die  NMR  Strukturuntersuchungen  markiert  werden  müssen.  Außerdem  könnte  der 
Ubiquitin-tag mit daran gebundenem Protein/Peptid bei biophysikalische Methoden wie NMR, 
ITC  oder  Circulardichroismus  (CD)  Spektroskopie  von  Interesse  sein. Im  Fall  der  NMR 
verstärkte die Präsenz des Ubiquitin-Einheit die Stabilität und die Löslichkeit von TBK1_ULD, 
welches zuvor zur Aggregation und Präzipitation neigte. Diese führten zu Schwierigkeiten bei 
der Durchführung von Langzeit-NMR-Experimenten. Aufgrund der Verwendung des Ubiquitin-
Vektors konnte eine hohe Ausbeute erzielt werden, wodurch NMR-Spektren für die Ubiquitin 
fusionierten Protein- oder Peptidproben aus Zelllysat aufgenommen werden konnten. Tatsächlich 
zeigte ein so aufgenommenes NMR Spektrum in Zelllysat das gleiche Signal-Muster und nahe 
zu eine gleich gute Qualität wie Spektren von gereinigten Protein. Gereinigte, Ub-fusionierte 
Peptide wurden für NMR-Experimente zur Titration verwendet und zeigten die gleichen Signale, 
jedoch mit kleinen Unterschieden zu dem synthetisierten Peptid. Diese Unterschiede basieren auf 
leichten  Veränderungen  im  Puffer.  Letztendlich  könnte  die  Produktion  von  Ub-fusionierten 
Peptide  für  Non-Uninominal  Sampling  (NUS)  NMR  mit  einer  starken  Verminderung  der 
benötigten  Spektroskopiezeit  verwendet  werden.  Gekoppelt  an  das  automatisierte Zusammenfassung 
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Zuordnungsprotokoll wurden Ub-fusionierten Peptide leichter, schneller und mit dem gleichen 
Ergebnis von unseren Kooperationspartnern zugeordnet. Wie schon für NMR wurden fusionierte 
Ub-Peptide auch für  ITC Experimente verwendet, um die thermodynamischen Parameter der 
Interaktion von MAP1LC3 Proteinen mit LIR Peptide zu bestimmen. Die gleichen Werte (Kd, 
ΔH,  ΔS  und  ΔG)  wurden  sowohl  für  p62  als  auch  für  Ub_p62  gegen  LC3B  erhalten.  Die 
Kontrollexperimente mit Ubiquitin, titriert gegen das Zielprotein, zeigten, dass Ubiquitin kaum 
Einfluss  auf  die  Bindung  hat.  Folglich  wurden  die  Studien  zu  Wechselwirkungen  von 
GABARAPL-1  mit  NBR1-LIR  sowie  von  NBR1-LIR_Y732W  mit  NBR1-LIR  fusioniert  an 
Ubiquitin durchgeführt. Hierbei wurden die Unterschiede durch die Substitution von Tyrosin 
durch Tryptophan durch ITC- und NMR- Experimente untersucht. Schließlich wurden bei der 
CD-Spektroskopie  ebenfalls  Ub-Fusionsproteine  eingesetzt.  Am  Beispiel  der  GABARAPL-1 
wurden CD-Kurven von Ub-GABARAPL-1, GABARAPL-1 allein und Ub allein aufgenommen: 
die  erhaltene  Kurve  für  Ub_GABARAPL-1  ist  die  Überlagerung  der  beiden  Kurven  aus 
GABARAPL-1 und Ubiquitin allein. Dies weist darauf hin, dass die Anwesenheit von Ubiquitin 
in dem fusionierten Konstrukt keine weiteren sekundären Strukturelemente als die bereits im 
Ubiquitin enthaltenen in das Zielprotein einfügt.    
-8-         Introduction 
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3.  Introduction  
   
  In his Elementary Treatise on Chemistry
1 published in 1789, the French chemist Lavoisier 
declared that nothing is created, nothing is destroyed, everything is only exchanged. Applied to 
living systems, this definition means that cells are not creating proteins, organelles and other 
components ab nihilo but use already existing nutrients to build them. In the case of protein 
metabolism, the pool of amino acids could be reused to build new proteins after degradation. 
Thus, protein recycling pathways are essential for cells to survive, to develop and to adapt to the 
different stimuli affecting them. Autophagy and the ubiquitin proteasome are two main catabolic 
pathways used in cells. Whereas the ubiquitin proteasome pathway, which is deeply involved in 
development  and  apoptosis  by  regulating  the  degradation  of  short-lived  proteins,  has  been 
extensively  reviewed,
2  the  studies  on  autophagy  since  the  last  decade  raised  a  lot  of  new 
questions. Surprisingly, these both pathways have more in common than it was first suspected. 
 
 
3.1. The ubiquitin system 
  Their successful studies on the ubiquitin proteasome pathway provided the Nobel Prize in 
Chemistry to Aaron  Ciechanover, Avram  Hershko and Irwin  Rose  in  2004.
3-5  Proteins,  after 
being tagged by a chain of several ubiquitin, are brought to the proteasome to be degraded for 
the regulation of their cell concentrations or because of misfolding. Ubiquitin is a 76 amino acid 
protein highly conserved from yeast to human and polyubiquitination occurs as a three steps 
conjugation  system.
2;  6;  7  First,  ubiquitin  is  activated  under  action  of  ATP  by  the  activating 
enzyme E1 with the formation of an intermediate ubiquitin adenylate, which binds through its 
C-terminal carbonyl group to the active site cysteine of E1 through a thioester bond. Second, 
ubiquitin is transferred to the active site cysteine of an ubiquitin-carrier protein E2 during the 
conjugation process. Third, ubiquitin is ligated through its C-terminal glycine to the ε-amino 
group of a lysine on the target protein via an amide bond under the action of an ubiquitin ligase 
E3 (Figure 1). By reproducing this process, a new ubiquitin molecule could bind to the previous 
one through a lysine to create a polyubiquitin chain. Usually the polyubiquitin chain is formed 
by linkage on the lysine at position 48 of each ubiquitin and the tagged protein is then degraded 
by the proteasome complex. Different linkages on the ubiquitin are also possible leading to other 
functions like endocytosis, signal transduction and DNA repair.
8-12 
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Figure  1:  The  ubiquitin  conjugation  system.  The  ubiquitination  of  target  protein  is  a  three-step 
enzymatic reaction with first an activation of ubiquitin via an E1 enzyme, then a transfer through an E2 enzyme and 
finally an E3 enzyme makes the ligation of ubiquitin to the target protein. 
 
 
 
3.2. Ubiquitin-like proteins  
  As  suggested  in  their  names,  ubiquitin-like  proteins  (UBL)  share  a  high  similarity  to 
ubiquitin.
13 Although not presenting obligatory a high sequence homology, UBL present the 
same structure than ubiquitin, the β-grasp fold.
14  
  UBL of type I, commonly named UBL, are conjugated to different targets and act as signal 
messengers  controlling  many  cellular  functions  like  cell  proliferation,  apoptosis,  proteolysis, 
endocytosis, transcription, DNA repair, signal transduction and autophagy.
12; 15 Several human 
diseases, including many types of tumors, are linked to the misregulation of UBL or proteins 
involved in their conjugation.
16 
  UBL  of  type  II,  also  named  ubiquitin-like  domain  (ULD),  define  proteins  possessing  a 
domain sharing the same 3D structure than ubiquitin whereas their primary sequences do not 
have obligatory a high similarity. At least, the hydrophobic patch around isoleucine at position 
44 in ubiquitin is conserved between the different ULD.
17 This domain could be also found along 
other domains of a protein. In opposition to ubiquitin and UBL, ULD are neither processed nor 
linked to other proteins to act as a post-translational modifier.
18   The  ubiquitin-fold  (Ub-fold) 
found in various proteins has a significant importance because it represents a common docking         Introduction 
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site for protein-protein interaction.
19 UBL and ULD are present in diverse proteins involved in 
the  cellular  machinery  or  in  the  folding  and  degradation  of  proteins  as  well  as  in  proteins 
regulating enzymatic activity and signal transduction.
18; 20 
 
 
3.3. Autophagy 
  Recent studies showed a possible link between ubiquitination and autophagy.
21 Autophagy is 
a  highly  conserved  catabolic  pathway  used  in  cells  to  conduct  cytosolic  components  to  the 
lysosome for degradation.
22 The term autophagy describes three types of processes:  
-  macroautophagy  defined  by  the  formation  of  a  double-membrane  sack,  the 
autophagosome, that is capable of fusing with the lysosome,
23 
-  microautophagy where the lysosome itself engulf cytosolic components,
24 
-  chaperone-mediated autophagy with proteins translocated through the membrane of the 
lysosomes.
25 
Macroautophagy,  being  the  main  autophagy  pathway,  will  be  described  hereafter  under  the 
generic term of autophagy. Autophagy was first considered to occur as a response against cell 
starvation
26  but  this  self-digestion  process  for  the  turnover  in  cells  is  also  involved  in  the 
removal of damaged organelles,
27 the degradation of long-lived proteins
28 and the containment 
of infectious agents or the antigen presentation.
29 
 
3.3.1.  Autophagosome 
  To avoid that cytosolic components are randomly engulfed during autophagy, a key step for 
selective autophagy is the recognition and the isolation of substrates, which entails surrounding 
of the substrates with the autophagosome that is capable of fusing with the lysosome.
30; 31 Under 
action  of  hydrolases,  the  different  components  brought  from  the  autophagosomes  to  the 
lysosomes are degraded until single elements are again available for the cell needs (Figure 2).
32 
The  origin  of  the  autophagosomes  is  still  subject  to  controversy.  In  yeast,  already  formed 
vesicles have been localized in the cytoplasm of cell forming the phagophore assembly site 
(PAS). At this site, a core of machinery proteins has been identified to be coupled to the PAS,
33 
which matures from a phagophore to an autophagosome.
34 Atg9 is a transmembrane protein 
present  as  well  in  the  Golgi  apparatus,  in  late  endosomes  as  in  the  PAS  and  initiates  the 
formation of the phagophore.
35 Atg9 is brought to the PAS by Atg23
36 and Atg27.
37 Atg9 is then 
released  from  the  PAS  by  the  Atg1  kinase  complex  associated  to  Atg2  and  Atg18.
36  The 
expansion of the phagophore is mediated by Atg8 coupled to phosphatidylethanolamine (PE) and Introduction   
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by Atg12 modified with the Atg5/Atg16 complex.
38 Whereas Atg12 is only present in the outer 
membrane  of  the  phagophore,
39  Atg8  conjugated  to  PE  is  found  in  the  inner  and  the  outer 
membrane.
40 
 
Figure 2: Autophagosome formation. The expansion of membrane in the cytosol results in the formation 
of a double membrane sack, the autophagosome, which entails its surrounding and fuses with a lysosome where 
hydrolases degrade its content.  
 
 
  In mammals, no PAS has been identified but an isolation membrane is induced to grow and to 
expand  under  the  action  of  ULK1,  homolog  of  Atg1,  coupled  to  the  phosphatidylinositol 
3-kinase (PI3K) complex and to mAtg9, homolog of yeast Atg9.
41 The further expansion and 
closing of the autophagosomes depends of the mammalian homologs of the Atg12/Atg5/Atg16 
complex  and  of  Atg8  represented  by  the  Atg16L  complex  and  by  the  light  chain  3  of 
microtubule-associated protein 1 (MAP1LC3) proteins, respectively.
42  
  However,  for  yeast  and  mammals,  the  question  about  the  origin  of  the  autophagosome 
membrane is still debated between four hypotheses:
43  
-  creation of the membrane de novo using lipids delivery, 
-  vesicular transport,  
-  a  cisternal  assembly  with  the  fusion  of  vesicles,  in  a  sleeping  state  in  the  cell  until 
induction, 
-  a membrane remodeling and extension from preexisting structures.  
  For this last theory, the endoplasmic reticulum (ER) was first supposed to be at the origin of 
the autophagosome membrane
44 as it was shown that PI3P, deeply involved in the formation of 
autophagosomes,  was  also  connected  to  ER.
45  In  the  meantime,  Atg5  and  Atg8/MAP1LC3         Introduction 
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proteins, key markers of autophagosomes, are present in the membrane of the ER but also of 
mitochondria
46  and  PE,  essential  for  the  insertion  of  Atg8  proteins  in  membrane,  is  mainly 
produced  by  mitochondria.
47  These  two  observations  develop  the  theory  of  a  mitochondrial 
origin  of  the  autophagosomal  membrane.  The  starting  point  of  the  autophagosomes  is  still 
unclear but it seems that the different structures enunciated previously are involved in their 
creation but at different time point and under different cell conditions. 
 
3.3.2.  Ubiquitin-like systems in autophagy 
  Based on genetic studies on Saccharomyces cerevisiae, 31 ATG genes have been identified 
with  more  than  the  half  involved  in  autophagosome  formation.
48  The  Atg  proteins  already 
introduced above could be functionally distinguished in five groups:  
-  the Atg1 kinase complex, 
-  the phosphatidylinositol 3-kinase complex,  
-  the integral membrane protein Atg9 and the Atg2-Atg18 complex, 
-  the Atg12 conjugation system,  
-  the Atg8 conjugation system.
49 
  A major role for the Atg8 conjugation system is its implication in the formation and in the 
maturation  of  the  autophagosome.
50;  51  The  Atg8  conjugation  system  is  highly  interesting 
because Atg8 is an UBL that follows the same conjugation procedure than ubiquitin. Unlike 
ubiquitin, which has a glycine in C-terminal position, Atg8 exhibits one only after cleavage of 
the arginine last residue by Atg4.
52 The presence of a glycine as last residue for Atg8 is essential 
for the following processes in the Atg8 conjugation pathway. Atg8 is first activated by one 
E1-like protein, Atg7.
53 Atg8 is then transferred to one E2-like protein, Atg3.
52 Finally, Atg8 is 
conjugated to PE through the free C-terminus of the glycine residue by an amine bond. PE can 
be later released from Atg8 under the cleaving action of Atg4.
51 No E3-like enzyme has been 
described  so  far  for  the  conjugation  step  but  knowing  the  fact  that  the  Atg12/Atg5/Atg16 
complex induces Atg8-PE formation, it is likely that these proteins act like an E3-like enzyme in 
the  Atg8  conjugation  system.
54  Conjugated  to  PE,  Atg8  binds  to  the  membrane  of  the 
autophagosome, already during its preformation but also all along the expansion process. Atg8 is 
thus used as an autophagosomal marker.
40 
 
3.3.3.  Autophagy effector proteins, the MAP1LC3 protein family 
  In  the  eukaryote  domain,  the  ATG  genes  are  highly  conserved  in  plants
55  and  in 
mammalians.
42; 56 Whereas only one Atg8 protein has been found in yeast, several mammalian Introduction   
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homologs  of  Atg8  have  already  been  identified,  which  form  the  MAP1LC3  protein  family 
consisting  of  two  subgroups,  the  light  chain  3  proteins  (LC3-)  and  the  γ-aminobutyric  acid 
receptor-associated proteins (GABARAP-) subfamily. These proteins are also named autophagy 
effectors. 
  The first mammalian homolog of Atg8 was discovered in rat and defined as the light chain 3 
of  the  microtubule-associated  protein,  LC3.
57  Depending  on  its  conjugation  state,  two 
denominations are used for LC3. LC3-I corresponds to a native integral form present in the 
cytoplasm  of  cells  and  LC3-II  is  the  PE  conjugated  form  associated  to  membranes.
58  The 
identification of three human homologs of the rat LC3 leads to the denomination of the LC3- 
subfamily  constituted  by  LC3A,  LC3B  and  LC3C.
59  These  proteins  share  a  high  sequence 
homology with the rat LC3 protein with 82%, 96% and 55% identity, respectively. Whereas 
LC3A and LC3C expose a glycine as last residue after their C-terminal proteolytic cleavage, no 
cleavage is observed for LC3B, which uses a lysine, also located in the C-terminal region, for 
further  conjugation.
59  Human  LC3-  proteins,  after  following  different  post-translational 
modifications  and  being  conjugated  to  PE,  are  also  tightly  bound  to  the  membrane  of  the 
autophagosome.
59    
  The GABARAP- subfamily consists of GABARAP, GABARAPL-1 (also known as glandular 
epithelial cell protein 1 (GEC1)), GABARAPL-2 (previously Golgi-associated ATPase enhancer 
of  16  kDa  (GATE-16))  and  GABARAPL-3.  GABARAP,  localized  in  all  tissues,  has  31% 
identity  in  the  primary  sequence  with  the  rat  LC3  protein,  indicating  the  possibility  of  a 
homologous  functions  for  this  protein.  Xin  et  al.
60  identified  three  paralogs  of  GABARAP, 
ubiquitously expressed. As for LC3- proteins, GABARAP- proteins are also converted in a form 
II conjugated to PE and localized into the membrane of autophagosomes.
61; 62 
  The  primary  sequences  of  Atg8  and  its  mammalian  homologs  LC3A,  LC3B,  LC3C 
GABARAP, GABARAPL-1 and GABARAPL-2 were analyzed with ClustalW.
63 Atg8 shares on 
average 55% and 35% sequence identity with GABARAP- and LC3- subfamily, respectively. 
Into the subfamilies, the sequence identity is always above 55% but is below 40% compared to 
each other (Table 1). All these proteins have similar size (117 to 147 amino acids). 
  GABARAP,  GABARAPL-2  and  LC3B  are  the  most  studied  proteins  in  the  human 
MAP1LC3 protein family. Due to their high sequence homology, the same general function is 
expected for these proteins. However, different specificities for LC3- and GABARAP- proteins 
are  hypothetical  depending  on  time  action  and  space  localization.
42;  64  Further  studies  have 
shown different functions in the autophagosome formation for LC3- and GABARAP- proteins,         Introduction 
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these  proteins  being  involved  in  the  elongation  of  the  phagophore  membrane  and  in  the 
maturation of the autophagosome,
64 respectively. 
 
Sequence 1  Size (aa)  Sequence 2  Size (aa)  Identity Score 
(%) 
Atg8  117  LC3A  121  35 
Atg8  117  LC3B  125  34 
Atg8  117  LC3C  147  38 
Atg8  117  GABARAP  117  54 
Atg8  117  GABARAPL-1  117  54 
Atg8  117  GABARAPL-2  117  55 
Atg8  117  GABARAPL-3  117  52 
LC3A  121  LC3B  125  81 
LC3A  121  LC3C  117  58 
LC3A  121  GABARAP  147  29 
LC3A  121  GABARAPL-1  117  33 
LC3A  121  GABARAPL-2  117  40 
LC3A  121  GABARAPL-3  117  31 
LC3B  125  LC3C  147  52 
LC3B  125  GABARAP  117  30 
LC3B  125  GABARAPL-1  117  31 
LC3B  125  GABARAPL-2  117  37 
LC3B  125  GABARAPL-3  117  29 
LC3C  147  GABARAP  117  37 
LC3C  147  GABARAPL-1  117  38 
LC3C  147  GABARAPL-2  117  41 
LC3C  147  GABARAPL-3  117  36 
GABARAP  117  GABARAPL-1  117  86 
GABARAP  117  GABARAPL-2  117  57 
GABARAP  117  GABARAPL-3  117  82 
GABARAPL-1  117  GABARAPL-2  117  60 
GABARAPL-1  117  GABARAPL-3  117  93 
GABARAPL-2  117  GABARAPL-3  117  57 
Table 1: Amino acid sequence identity among Atg8 proteins.  
The multiple alignment of protein sequences was performed by ClustalW2. All sequences are from human proteins 
except Atg8 from Saccharomyces cerevisiae. 
 
  The general mechanism proposed for the modification of the mammalian homologs of Atg8 is 
to be first processed by the cleavage of the C-terminus and the exposition of a glycine as last 
residue  under  the  action  of  autophagins  like  Apg4b,  homolog  of  yeast  Atg4.
65  MAP1LC3 
proteins are then activated by the mammalian homolog of Atg7 acting as E1-like protein and 
transferred to an E2-like protein, the mammalian homolog of Atg3, which conjugates MAP1LC3 
proteins to PE.
58;  66;  67 MAP1LC3 proteins could be later cleaved again by the autophagin in 
order to be released from the membrane and this cycle could be then repeated (Figure 3).
68 Introduction   
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Figure 3: The mammalian Atg8 conjugation system. GABARAP- and LC3- proteins are first cleaved  
at the C-terminus by hAtg4 to expose a glycine residue, then activated by hAtg7 (E1-like), transferred to hAtg3 
(E2-like) and finally ligated to lipids like PE.  
 
  Using  X-Ray  crystallography  as  well  as  nuclear  magnetic  resonance  (NMR),  the  three 
dimensional structure of Atg8,
69; 70 LC3,
71; 72 GABARAP
73-75 and GABARAPL-2
76 has already 
been  determined  (Figure  4).  All  MAP1LC3  proteins  share  an  Ub-fold  motif,
77  which  is 
N-terminally extended by two α-helices. The Ub-fold consists of a central β-sheet formed by 
four β-strands and two α-helices on one side of the β-sheet. The β-strands in the middle are 
parallel between them but antiparallel to the two other outer β-strands. The special characteristic 
of MAP1LC3 proteins is the presence of two α-helices at the N-terminus of the protein, specific 
of this protein family. Interestingly these helices have different ionic charges along the proteins 
of the family. Indeed, whereas α-helix 1 is basic and α-helix 2 acidic for LC3- proteins, α-helix 
1 is acidic and α-helix 2 is basic for GABARAP- proteins.
71 Nevertheless, most of the residues 
presenting ionic charges in these helices are conserved between the different homologs like K08, 
E14, R16, D/E19 and R24 on LC3B sequence (UniProt accession number Q9GZQ8). These 
residues are involved in stabilizing the protein structure by keeping these α-helices close to the 
Ub-fold through hydrogen bonds between the conserved residues E14 and E36, but also by salt 
bridges  between  the  conserved  residues  R16  and  D106  and  between  D19  and  K51.
78  One 
important point found in the case of GABARAP is the presence of two conformations in one 
crystal structure: a closed state with the α-helices at the N-terminus along the Ub-core and an 
open  state  where  α-helix  1  is  rotated  by  180°.
74  In  the  open  conformation,  α-helix  1  of 
GABARAP  interacts  with  the  C-terminus  of  another  GABARAP  molecule,  leading  to 
oligomerization in a head to tail manner. Until now, only GABARAP showed two conformations 
in X-ray crystallography and NMR depending on the conditions. LC3 and Atg8 showed instead 
only slight changes in the conformation of their N-terminal regions but after lipidation.
79 The 
structure of the other Atg8 homologs corresponds to GABARAP closed conformation, which 
will be mentioned as the common fold of Atg8 proteins hereafter. Thus, the overall structure         Introduction 
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consists  of  a  central  β-sheet  surrounded  by  two  α-helices  resulting  in  the  formation  of  two 
hydrophobic pockets, hp1 and hp2. Using the nomenclature of LC3B, hp1 is situated between 
α-helix 1, α-helix 2 and the β-sheet and is formed by the residues D19, I21, P30, I32, K51, L53 
and F108 and hp2 is situated between α-helix 3 and the β-sheet and is formed by the residues 
F52, V54, P55, V58, L63, I66 and I67.
80 These hydrophobic pockets are formed due to the 
presence of the α-helices specific of Atg8 proteins and are constituted by conserved amino acids 
along proteins of the family.  
 
Figure 4: Structure of Atg8 proteins. Overlay of the structure of Atg8 (cyan), LC3A (gray), LC3B in 
presence of p62 (magenta), GABARAP (yellow), GABARAPL-1 (green) and GABARAPL-2 (pink). Each protein 
possesses an Ub-fold preceded by two N-terminal α-helices, resulting in the formation of two hydrophobic pockets, 
hp1 and hp2. The similarity between these structures is reflected by an overal RMSD of 1.5 Å.  
 
3.3.4.  Autophagy receptor proteins 
  To regulate the degradation of protein aggregates, autophagy is also involved. Autophagy 
receptor proteins bind to a polyubiquitin chain linked to a protein, polyubiquitination being a 
common  modification  for  misfolded  proteins.
12;  81  These  receptors  are  also  localized  into 
autophagosomes after interacting with autophagy effectors.
82  
  The p62 protein is an adaptor protein capable of binding to a broad range of proteins through 
different  domains.  p62  is  thus  involved  in  several  pathways  of  cell  signaling.  The  protein 
contains a N-terminal Phox and Bem1p (PB1) domain responsible for its oligomerization and 
capable also to bind to the atypical protein kinase C (aPKC).
83;  84 Beside a zinc (Zn) finger 
domain,  p62  possesses  a  C-terminal  ubiquitin-associated  domain  (UBA),  which  binds  to 
ubiquitin or polyubiquitin signals (Figure 5).
85 Thus, one function of p62 is to act as transporter 
for ubiquitinated cargo. p62 is co-localized with ubiquitin inclusion bodies and found in LC3 
positive  structures  like  autophagosomes,  linking  the  ubiquitinated  substrates  that  should  be Introduction   
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degraded to the autophagy effector proteins in the membrane of the autophagosomes or, more 
generally, linking protein aggregation to autophagy.
86  
 
 
Figure 5: Autophagy receptor proteins and the LIR motif. The domain organization of autophagy 
receptors is shown in A. Autophagy receptors like p62 or NBR1 bind to polyubiquitinated cargo via their UBA 
domain whereas Nix is inserted into the membrane of mitochondria through its TM domain. In addition, p62 and 
NBR1  possess  a  PB1  domain  responsible  for  their  oligomerization  but  also  the  polymerization  of  p62.  The 
polymerization of NBR1 takes place through its coil-coil domain. The LIR sequence, involved in the interaction 
with autophagy effector proteins, is the common motif between the autophagy receptors. The amino acid sequence 
of  different  LIR  motifs  are  represented  in  B.  The  LIR  sequences  present  in  autophagy  receptors  and  enzymes 
modifying MAP1LC3 proteins as well as non-autophagy proteins are represented above and below the LIR motif, 
respectively. Aromatic residues corresponding to position 1 are marked in red, hydrophobic residues at position 4 in 
blue and negatively charged amino acids in green. All sequences are human except for Atg19 and Atg32, which are 
from Saccharomyces cerevisiae. 
 
  Moreover, p62 possesses a DDDWTHLS sequence motif that enables p62 to interact with 
MAP1LC3 proteins and therefore is called a LC3- interacting region (LIR).
87; 88 Originally, LIR 
sequences  were  defined  as  a  WxxL  motif.  Further  studies  on  proteins,  including  autophagy 
receptors,  interacting  with  MAP1LC3  proteins  showed  that  neither  the  tryptophan  nor  the 
leucine residues are strictly conserved. A more general definition of the LIR sequence should be 
xxΘxxΓ where Θ and Γ are aromatic and hydrophobic residues, respectively, with one or more 
acidic residues being required as well.
89 Hereafter, the annotation for the position of the residues         Introduction 
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in the LIR motif is used as follows: 1 for the aromatic residue Θ and 4 for the hydrophobic 
residue Γ; -1, -2 and -3 for residues located at the N-terminus of the aromatic residue Θ; 2 and 3 
for the residues between the aromatic residue Θ and the hydrophobic residue Γ; 5 for residues 
located at the C-terminus of the hydrophobic residue Γ (Figure 5).  
  Because knocked-out of p62 only reduces autophagy but does not inhibit it totally,
90; 91 other 
autophagy receptor proteins are also involved in autophagy. 
  Neighbor of breast cancer 1 gene 1 (NBR1) was initially characterized as potential gene of the 
ovarian cancer antigen CA125
92 but was also identified as an autophagy receptor that shares 
similar features with p62.
93;  94 Although NBR1 is more than twice as big as p62, the protein 
presents the same profile with the presence of a PB1 domain, a Zn finger, a UBA domain and a 
LIR domain. Unlike in p62, the PB1 domain of NBR1 does not lead into the oligomerization of 
NBR1, which takes place through the coil-coil domains situated between the Zn finger and the 
LIR domain.
95  This PB1 domain is involved in several interaction of whom p62 (Figure 5).
83  
Like p62, NBR1 can simultaneously bind to the ubiquitin cargo and to MAP1LC3 proteins.
93; 94 
Although the deletion of the LIR domain NBR1 as well as failure of autophagy lead to an 
accumulation  of  NBR1  in  cells,  NBR1  knocked-out  cells  are  still  presenting  an  autophagic 
activity even though reduced in regard to normal cells.
93 A major difference to p62 involves the 
LIR  domain.  While  most  LIR  sequences  show  a  tryptophan  at  position  1  and  a  leucine  at 
position 4, the LIR domain identified in NBR1 consists instead of a tyrosine and an isoleucine, 
respectively (Figure 5). These residues could be essential for the selectivity of the interaction 
with LC3 proteins. 
  Mitophagy  is  a  special  aspect  of  selective  autophagy  involving  mitochondria.  Damaged 
mitochondria for toxicity reasons and “normal” mitochondria depending of the cell turnover are 
degraded  in  a  similar  way  than  misfolded  protein.
96  The  characterization  of  mitochondrial 
proteins  acting  as  autophagy  receptors  explains  the  mechanism  of  mitophagy.
97-99  In  yeast, 
Atg32  is  an  outer  mitochondrial  membrane  (OMM)  protein  overexpressed  in  damaged 
mitochondria.
97;  98  Atg32  binds  directly  to  Atg8  present  in  the  PAS
40  or  indirectly  through 
Atg11.
100 This protein complex targets mitochondria into autophagosomes for degradation after 
fusion to lysosome. An interesting characteristic of Atg32 is the presence of a LIR domain 
represented  by  a  EEDWQAI  motif  necessary  for  direct  binding  to  Atg8  (Figure  5).
98  In 
mammals, although there is no homology with Atg32, the NIP3-like protein X (Nix) is also an 
OMM  protein  presenting  the  same  function  as  Atg32
101;  102  but  possessing  two  LIR  motifs 
(Figure 5). The first one is situated in the N-terminal region of the protein and its SSWVEL Introduction   
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sequence corresponds to the common LIR motif. Situated close to the BH3-like domain, the 
ADWVSDWSSR sequence of the second LIR motif consists of the juxtaposition of two LIR 
motifs. Although the sequence of the second LIR motif in Nix shows differences regarding the 
common LIR motif, it binds to all MAP1LC3 proteins (Figure 5).
99 Both LIR motifs allow the 
binding  of  Nix  to  MAP1LC3  proteins  but  mutations  in  the  first  LIR  abolish  totally  the 
interaction  whereas  mutations  in  the  second  LIR  only  decrease  this  interaction.
99  During 
erythropoiesis, mitochondria colocalized with MAP1LC3 proteins in autophagosomes via the 
overexpressed Nix protein. This removal of mitochondria is essential for the development of red 
blood cells.
99 
 
3.3.5.  Interaction between autophagy effectors and autophagy receptors 
  Binding  of  tryptophan-containing  LIR  domains  to  LC3-  and  GABARAP-  proteins  is 
structurally and functionally well characterized.
87;  88 In the structure of p62 in complex with 
LC3, the Θ and Γ residues of p62-LIR interact with the hydrophobic pockets hp1 and hp2 on the 
surface of the autophagy effector.
87; 103 The first hydrophobic pocket hp1, situated between the 
Ub-like fold core of MAP1LC3 proteins and the two N-terminal α-helices, interacts with the 
aromatic Θ residue. The hydrophobic Γ residue binds to the hydrophobic pocket hp2 located on 
the surface of the Ub-core domain. The LIR motif takes an extended beta conformation upon 
binding, forming an intermolecular β-sheet with the second β-strand of LC3.  
  The  consensus  LIR  motif  WxxL  undergoes  different  modifications  upon  the 
characterization of new binding partners to Atg8 and MAP1LC3 proteins, independently of their 
functions in autophagy or not. The Θ residue is more commonly a tryptophan but identification 
of NBR1 and Atg4b shows that it could be a tyrosine
93; 104 as well as a phenylalanine in the case 
of optineurin.
105 The Γ residue is preferentially a leucine but an isoleucine is present in the LIR 
motif  of  NBR1  or  calreticulin  and  it  has  been  suggested  that  valine  could  also  fit  at  this 
position.
93; 106 Finally, there is a lot of freedom for the residues at position -3, -2, -1, 2 and 3 but 
at least one negative charged residue, if not more, is always found at one of these positions 
(Figure  5).
89  No  structure  of  a  complex  or  detailed  interaction  study  of  autophagy  effector 
proteins with non-tryptophan LIR domains has been reported so far. The NBR1-LIR (YIIIL) has 
a much more hydrophobic nature in comparison to p62-LIR (WTHL), although they share the 
same functional features. This increase of hydrophobicity as well as other modifications in the 
motif could influence the interaction with autophagy effector proteins and might even lead to 
different or multiple orientations of the peptide sequence in the binding site.         Introduction 
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3.3.6.  Autophagy and diseases  
  By removing damaged organelles or misfolded proteins, presenting antigen and containing 
infection, autophagy preserves the integrity of the cells by avoiding the accumulation of toxic 
components.
107  Moreover,  autophagy  allows  cells  to  survive  by  adapting  their  conditions  to 
different  stimuli  like  starving  conditions.  Regarding  the  number  of  proteins  involved  in  the 
different steps necessary for autophagy, it is easily understandable that dysfunctions like absence 
of proteins or the incapability of binding to interaction partners have tremendous consequences. 
Dysregulation of autophagy pathways provides less tolerance to starvation conditions leading to 
several diseases.
107 Mice studies have shown that organelle aggregation and accumulation of 
ubiquitinated protein aggregates in different tissues due to defection of autophagy are the first 
steps in cell malignance before apoptosis, neurodegeneration, tumor formation or cell death.
108 
Several  human  diseases  like  inflammatory  diseases,  liver  injury,  diabetes,  neurodegenerative 
disorders  and  cancer  are  caused  by  mutations  in  proteins  involved  in  autophagy.
108  The 
following description of diseases involving proteins studied in this thesis is not exhaustive but 
shows the severe consequences faced in autophagy dysfunctions. The Paget disease, causing an 
abnormal and deforming bones growth,
109 is observed in patients presenting mutations in the 
UBA  domain  of  p62  leading  to  deficiencies  in  the  clearance  of  ubiquitinated  substrates.
110 
Alzheimer’s  and  Parkinson’s  diseases  are  characterized  by  cytoplasmic  inclusions  of  toxic 
proteins  in  the  brain.  p62  colocalizes  with  these  inclusions  bodies,  being  not  degraded  by 
autophagy.
111  Due  to  their  functional  similarities,  p62  and  NBR1  are  involved  in  similar 
diseases. Mallory bodies are inclusions found in liver cells of patients presenting alcoholic liver 
diseases  and  are  formed  due  to  the  presence  of  ubiquitinated  substrates  non-cleared  by  the 
p62/NBR1 cargo.
93 Failures in mitophagy result in tumorigenesis and abnormal cell death that 
are observed in Parkinson’s disease.
112 Knockout of or mutation in the Nix gene lead to tumor 
growth whereas the overexpression of Nix protects cells from the expansion of tumor cells.
113-115 
Moreover, Nix being directly involved in the erythroid maturation by clearance of mitochondria, 
anemia is observed in Nix deficient cells.
116 Until now, no disease has been directly correlated 
with mutations of MAP1LC3 proteins. Due to the high sequence and structure similarity of the 
different members of the family, it is likely that in case of mutations on one of the proteins, 
another protein of the family could substitute its function without the cells being affected as it 
was shown after GABARAP knock-out.
60;  117 Nevertheless, multiple knock-out of MAP1LC3 
proteins  blocks  autophagosome  formation.  Any  disruption  in  the  conjugation  of  MAP1LC3 
proteins to lipids or in the interaction with LIR domains leads to an accumulation of protein 
aggregates having the same consequences than describe above. Introduction   
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3.4. TBK1 and a putative ULD 
  TANK binding kinase 1 (TBK1) is an IκB kinase related kinase (IKK-related kinase) protein 
involved in the innate immune response. IKK-related kinases have a crucial role in the innate 
immune response by regulating the activity of the interferon regulatory factors and the NF-κB 
transcription factors.
118 Upon infections by bacteria and viruses, Toll-like receptors present on 
the membrane of macrophages, of fibroblasts as well as of dendritic, B- and T- cells activate 
TBK1 through the adaptor proteins TRAM and TRIF.
119 Bioinformatical analysis on the amino 
acid sequence of TBK1 showed that the protein could possess a ULD between residues 305 and 
385.
120  Another  feature  of  TBK1  is  the  presence  of  a  kinase  domain  responsible  for  the 
phosphorylation of the interferon regulatory factor 3 (IRF3). In its inactive conformation, the 
kinase and the potential ULD of TBK1 are distant to each other and can not interact. In the 
active form of TBK1, these two domains can interact. After activation, TBK1 recruits IRF3 upon 
the interaction of the expected ULD and the interferon associated domain (IAD) of IRF3.
120 The 
kinase  domain  of  TBK1  phosphorylates  IRF3  on  its  C-terminal  region  rich  in  serines  and 
threonines (SRR).
121 As an inactive form, IRF3 is located in the cytoplasm as a monomer. Upon 
phosphorylation,  IRF3  dimerizes  and  translocates  then  to  the  nucleus,  where  IFN  genes  are 
induced after interaction on the promoter region and engage the immune response to the bacterial 
and viral infections (Figure 6).
122 The putative ULD domain of TBK1 is thus essential for the 
activity of the protein. 
 
Figure 6: The TBK1 system. The activation 
of  TBK1  is  induced  by  LPS  or  poly  (I:C)  and 
TBK1 interacts then through its ULD domain with 
the IAD domain of IRF3. Upon its phosphorylation 
via the kinase domain of TBK1, IRF3 translocates 
into the nucleus and binds to the promoter region 
of  IFN-inducible  genes  in  order  to  start  the 
autoimmune response. 
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  The  sequence  similarities  given  by  the  sequence  alignment  software  ClustalW  between 
ubiquitin  and  TBK1305-385  is  low  with  only  9%  of  sequence  identity.  Nevertheless,  the 
hydrophobic  patch  around  isoleucine  at  position  44  (leucine-isoleucine-phenylalanine)  of 
ubiquitin  is  conserved  in  TBK1,  centered  on  isoleucine  at  position  353  (leucine-isoleucine-
tyrosine) (Figure 7). This hydrophobic patch is indispensable for the intramolecular interaction 
of  the  ULD  and  the  kinase  domain  of  TBK1  but  it  is  not  necessary  for  the  intermolecular 
interaction of TBK1_ULD with IRF3.
120 
 
Figure 7: Alignment of the primary sequences of ubiquitin and TBK1_ULD . TBK1_ULD and 
ubiquitin present a amino acid sequence identity of 9% Identical, conserved and semi-conserved amino acids are 
represented by (*), (:) and (.), respectively. The conserved isoleucine at position 44 in ubiquitin and at position 353 
in TBK1 is signaled with a bold character and an arrow. 
 
 
3.5. An ubiquitin-tag suitable for biophysical methods 
  NMR provides information on the structure and the dynamics of a protein,
123 the site(s) of 
interaction with binding partner
124 and to quantify this interaction.
125  Limiting parameters in the 
study of proteins by NMR have to be considered like: 
-  the size: up to 30 kDa to avoid overcrowded spectra and broadening peaks due to fast 
relaxation,  
-  the concentration: more than 3 mg of 
15N or 
15N/
13C isotopic labeled protein for a 15 kDa 
protein due to the low sensitivity of the technique,  
-  the purity: to avoid the presence of extra peaks due to contaminants,  
-  the stability: several days are needed to record one 3D-nuclear Overhauser enhancement 
spectroscopy (NOESY) experiment of the studied sample.  
  The first step is to optimize the best conditions of the sample to be suitable for further studies 
by NMR.
126 First have to be established the expression conditions to produce a sufficient protein 
yield and the purification methods, which are different for each protein. Once the protein sample 
is concentrated and does not seem to show any aggregation, the next step is to record a [
15N, 
1H] 
transverse  relaxation  optimized  spectroscopy  (TROSY)  -  hetero  single  quantum  correlation 
(HSQC)  experiment.
127  A  good  dispersion  and  a  small  line  broadening  of  the  peaks 
corresponding to each peptide bond of the protein are good signs for a “good behaving protein” 
for NMR. Further NMR experiments for 3D structure calculation or interactions studies could be 
performed.  To  face  the  different  problems  occurring  in  proteins  structural  biology,  diverse 
expression, solubility and purification tags like Glutathione S-Transferase (GST),
128 NusA,
129 Introduction   
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small ubiquitin-related modifier (SUMO),
130 maltose-binding protein (MBP),
128; 131 hexahistidine 
(His6) 
131 tags have been developed to increase the amount of protein produced. Nevertheless, 
removal  of  these  moieties  is  often  needed  for  biophysical  studies  necessitating  further 
purification steps leading to a loss of material. Thus the advantages gained due to favorable 
expression  and  solubility  is  not  obvious  anymore.  Using  the  high  expression  and  the  great 
solubility properties of ubiquitin, proteins and peptides could take advantage of being fused to 
ubiquitin for an enhanced expression.
132-134  
 
 
3.6. Goals of this study 
  Autophagy is the catabolic pathway used in cells to deliver cytosolic components and 
dysfunctional  organelles  to  the  lysosome  for  degradation  after  being  engulfed  in  the 
autophagosome. Selective autophagy is possible due to the presence of autophagy effectors, also 
named MAP1LC3 proteins by mammalian, which bind to the membrane of the autophagosome 
and of autophagy receptors, which interact with polyubiquitinated substrates and with autophagy 
effectors through a LIR motif. Binding of tryptophan-containing LIR domains to the MAP1LC3 
proteins is structurally and functionally well characterized.
87; 88; 94; 103; 104; 135-137 However, only a 
model of a complex of NSF
138 with GABARAP but no structure of a complex or a detailed 
interaction  study  of  autophagy  effector  proteins  with  non-tryptophan  LIR  domains  from 
autophagy  receptors  have  been  reported.  The  NBR1-LIR  domain  (YIIIL)  has  a  more 
hydrophobic nature than the p62-LIR domain (WTHLS). This increased hydrophobicity could 
influence the interaction with MAP1LC3 effector proteins and might even lead to different or 
multiple orientations of the peptide in the binding site. To address these questions, the interaction 
of the NBR1-LIR domain with mammalian Atg8 proteins was studied and compared to the LIR 
domains of p62 and of Nix, which was identified as a mammalian mitophagy receptor. Mutants 
of NBR1-LIR with tryptophan or phenylalanine in place of tyrosine were generated in order to 
understand the importance of position 1 for the binding mode. To answer a similar question, 
negatively  charged  amino  acids  located  at  the  N-terminus  of  the  core  LIR  domain  were 
additionally introduced. The results show a tighter interaction between Atg8 family proteins and 
LIRs in the presence of tryptophan as well as the importance of the surrounding residues. The 
NMR  structure  of  the  GABARAPL-1–NBR1-LIR  complex  was  determined  and  is  the  first 
example  of  the  structure  of  a  complex  involving  a  non-tryptophan  autophagy  receptor–LIR 
domain. The NMR structure confirmed that NBR1-LIR and GABARAPL-1 form intermolecular 
β-strands and that NBR1-LIR occupied both hydrophobic pockets of GABARAPL-1.         Introduction 
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  TBK1  is  deeply  involved  in  the  regulation  of  interferon  inducible  genes  for  the  immune 
response against bacterial and viral infections. Bioinformatics analysis determined the presence 
of an ULD in TBK1. Moreover, an intact ULD in TBK1 is essential because this domain was 
shown to interact with the kinase domain of TBK1 as well as with its substrate IRF3.
120 To 
confirm  the  ULD  in  TBK1,  the  determination  of  a  structured  Ub-fold  characterized  by  the 
presence  of  the  following  secondary  structure  elements  ββαββ  has  to  be  done.  The  same 
sequential arrangement and the same length as the corresponding structure elements in ubiquitin 
are a special feature of UBL and ULD. In addition, the structural characterization of TBK1_ULD 
interaction with IRF3 and with its kinase domain could better explain the mechanism of TBK1 
activation.  
 
  The  scientist  community  is  always  looking  forward  for  the  development  of  new 
biotechnological  tools  to  produce  efficiently  soluble  proteins  and  peptides  for  biochemical 
studies. Different expression vectors are already available and could provide enough material for 
biophysical studies. Nevertheless, several purification steps including cleavage of co-expressed 
tag lead often to a decrease of the final available amount of protein. The use of new expression 
vector including a modified ubiquitin could increase the production of proteins and peptides, 
which benefit from the presence of ubiquitin for a better expression in a soluble form. Moreover, 
due to the relative small size of ubiquitin, release of this expression tag should not be obligatory 
to use biophysical methods for the studies of proteins and peptides. The features of this new 
expression tool could provide a great advantage for the researchers in the biochemistry field.    
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4.  Materials 
4.1. Equipments 
 
Äkta purifier FPLC system                  GE Healthcare (Germany) 
Agarose gel running chamber                Peqlab (Germany) 
Autoclave                              Tecnomara AG (Switzerland),        
                                    Gettinge AB (Sweden)    
Balances                              Sartorius AG (Germany) 
Circular Dichroism Spectrometer              Jasco Inc. (USA) 
Centrifuges: 
  Biofuge RS 28                        Haereus Sepatech AG (Germany) 
  Centrifuge Sorvall RC 28S                Sorvall Instruments (Germany) 
  Centrifuge Sorvall RC 5B                 Sorvall Instruments (Germany) 
  Refrigerated centrifuge 5417R              Eppendorf (Germany) 
Columns: 
  GST, Superdex 75 16/60,                  GE Healthcare (Germany) 
  Q-sepharose, SP-sepharose, 
  NiNTA, HiTrap Desalting 16/60, 
  HiTrap SP FF 
Electrophoresis system: 
  electrophoresis apparatus                  Bio-Rad GmbH (Germany) 
  Power supply                         Bio-Rad GmbH (Germany) 
Freeze Dryer (Sublimator VaCo 10)            Zirbus GmbH (Germany) 
French Pressure Cell Press                  SLM Instruments (USA) 
Incubator                              Memmert (Germany) 
ITC (VP-ITC)                           MicroCal Inc (USA) 
Nanodrop 1000                          PeqLab (Germany) 
NMR spectometers (599 MHz,                Bruker Avance (Germany) 
600 MHz, 700 MHz, 800 MHz, 
900 MHz) 
PCR cycler                             Biometra AG and Eppendorf (Germany) 
pH-meter PHM 210                       Radiometer (Denmark) 
Pipettes and Tips                         Eppendorf (Germany) Materials   
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Rotors (GSA, GS3, ss-34, F28/50)               Sorvall Instruments (Germany) 
Shakers: 
  Incubating shakers                        Infors AG (Germany),           
                                      New Brunswick Scientific Inc. (USA) 
  Table shaker                            Heidolph Electro GmbH (Germany) 
Spectrophotometers  
  Cary 3 UV                             Varian (Australia) 
  Hitachi U-1100                          RD Analytik (Germany) 
Sonifier Labsonic                           B. Braun Biotech GmbH (Germany) 
Vortex mixer                              IKA (Stauffen, Germany) 
 
 
4.2. Molecular biology tools 
4.2.1.  Bacterial strains 
 
Strains  Description  Reference 
E. Coli DH5α  [F-,endA1, hsdR17 (rk-mk-), 
supE44, thi-1, recA1, gyrA (Nalr), 
relA1, Δ(lacZYA-argF)U169, 
φ80lacZΔM15] 
Hanahan 1983 
Woodcock 1989 
E. Coli BL21 (DE3)  fhuA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS λ DE3 = λ sBamHIo 
∆EcoRI-B int::(lacI::PlacUV5::T7 
gene1) i21 ∆nin5 
New England Biolabs 
 
E. Coli NEB T7 
Express 
fhuA2 lacZ::T7 gene1 [lon] ompT 
gal sulA11 R(mcr-73::miniTn10--
Tet
S)2 [dcm] R(zgb-210::Tn10--
Tet
S) endA1 Δ(mcrCmrr)114::IS10  
New England Biolabs 
E.Coli DL39  ilvE12 tyrB507 aspC13 rph-1 fnr-
25 LAM- 
LeMaster 1988 
 
Table 2: List of bacterial strains used 
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4.2.2.  Vectors 
4.2.2.1.  pGEX-4T1 
The pGEX-4T1 vector was purchased at GE Healthcare (Germany). 
 
Figure  8:  Properties  of  pGEX-4T1  with 
control regions.  
*Vector size (bp) 4969;  
*Glutathione S-transferase gene region: tac promoter: -10: 
205-211; -35: 183-188; lac operator:  217-237 ; Ribosome 
binding  site  for  GST:  244;  Start  codon  (ATG)  for  GST: 
258; Coding region for Thrombin cleavage: 918-935;  
*Multiple Cloning Site: 930-966;  
*b-lactamase gene region: Promoter: -10: 1330-1335; -35: 
1307-1312; Start codon (ATG): 1377; Stop codon (TAA): 
2235 ;  
*lacIq gene region: Start codon (GTG): 3318; Stop codon 
(TGA): 4398;                
*Plasmid  replication  region:  Site  of  replication  initiation: 
2995 ; Region necessary for replication: 2302-2998;  
 
4.2.2.2.  pETM-60 
The pETM-60 vector was provided by Stier at EMBL (Germany).  
 
Figure 9: Properties of pETM-60 with control 
region.  
*Vector size (bp): 7634;  
*NusA gene region: T7 promoter: 2633-2651; T7 terminator: 
1-129;  NusA  coding  sequence:  1068-2564  (substituted  by 
Ubiquitin  in  Ubiquitin  fused  constructs);  His-tag  coding 
sequence:  1050-1067;  TEV  cleavage  site  coding  sequence: 
1020-1040; lacI operator: 3038-4120;  
*Multiple cloning site: 158-208;  
*Plasmid replication region : pBR322 origin: 5535-6154; f1 
origin: 7300-7606; KanamycinR: 6260-7075. 
 
 
 
4.2.3.  Oligonucleotides 
All oligonucleotides were purchased from Eurofins MWG Operon (Germany). 
 
Cloning primers for TBK1_ULD_P3F5 
Forward: 5'-GATCTGGTTCCGCGTGGATCCGAGGAAGAAACCAGTGATGTGCTTCACCG-3' 
Reverse: 5'-CGGTGAAGCACATCACTGGTTTCTTCCTCGGATCCACGCGGAACCAGATC-3' 
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Cloning primers for TBK1_ULD_VL10AD 
Forward: 5'-GAATTCACCAGTGATGCGGATCACCGAATG-3' 
Reverse: 5'-CATTCGGTGATCCGCATCACTGGTGAATTC-3' 
 
Cloning primers for TBK1_ULD_V14D 
Forward: 5’-CTTCACCGAATGGATATCCATGTCTTC-3’ 
Reverse:  5’-GAAGACATGGATATCCATTCGGTGAAG-3’ 
 
Cloning primers for TBK1_ULD_F18D 
Forward: 5’-GTAATCCATGTCGATTCGCTACAACAC-3’ 
Reverse:  5’-GTGTTGTAGCGAATCGACATGGATTAC-3’ 
 
Cloning primers for TBK1_ULD_Y29D 
Forward: 5’-ACGGCGCATAAGATTGACATTCACAGC-3’ 
Reverse:  5’-GCTGTGAATGTCAATCTTATGCGCCGT-3’ 
 
Cloning primers for TBK1_ULD_I30D 
Forward: 5'-CGCATAAGATTTACGATCACAGCTATAAC-3' 
Reverse: 5'-GTTATAGCTGTGATCGTAAATCTTATGCG-3' 
 
Cloning primers for TBK1_ULD_Y33D 
Forward: 5'-GATTTACATTCACAGCGATAACACTGCTGC-3' 
Reverse: 5'-GCAGCAGTGTTATCGCTGTGAATGTAAATC-3' 
 
Cloning primers for TBK1_ULD_Y44D 
Forward: 5’-TTCCATGAACTGGTCGACAAACAAACCAAG-3’ 
Reverse:  5’-CTTGGTTTGTTTGTCGACCAGTTCATGGAA-3’ 
 
Cloning primers for TBK1_ULD_P91H92 
Forward: 5'-GTCACGAGCCTCGAGCGGGAGGAACGTGACTGACTGACGATCTGCC-3' 
Reverse: 5'-GGCAGATCGTCAGTCAGTCACGTTCCTCCCGCTCGAGGCTCGTGAC-3' 
 
Cloning primers for TBK1_ULD_L88R90R93 
Forward: 5'-CCTATCTTTGTCACGAGCCGCGAGCAGCCGCATGATGACTGACTGACG-3' 
Reverse: 5'-CGTCAGTCAGTCATCATGCGGCTGCTCGCGGCTCGTGACAAAGATAGG-3'         Materials 
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Cloning primers for Ub_NBR1-LIR_Y732W 
Forward: 5’-GCTCTGCTTCCTCAGAGGATTGGATCATCATCCTGCCGG-3’ 
Reverse: 5’-CCGGCAGGATGATGATCCAATCCTCTGAGGAAGCAGAGC-3’ 
 
Sequencing primers for N-terminal of GST-constructs 
Forward: 5’-GGGCTGGCAAGCCACGTTTGGTG-3’ 
Reverse: 5’-CACCAAACGTGGCTTGCCAGCCC-3’ 
 
Sequencing primers for C-terminal of GST-constructs 
Forward: 5’-CCGGGAGCTGCATGTGTCAGAGG-3’ 
Reverse: 5’-CCTCTGACACTTGCAGCTCCCGG-3’  
 
Sequencing primers for pETM-60 Upstream  
Forward: 5’-ATGCGTCCGGCGTAGA-3’ 
Reverse: 5’-TCTACGCCGGACGCAT-3’  
 
4.3. Buffers, equipments and solutions 
All chemicals were purchased from Roth (Germany) except when notified. 
All buffers and solutions were prepared with Milli Q water, filtred through 0.2 µm membrane 
and kept at +4°C if not stated otherwise. 
Heat stable glassware as well as temperature resistant solutions were autoclaved for 30 min at 
120°C and 2 bar.  
 
4.3.1.  Cloning 
Agarose 1%: 1% (w/v) agarose boiled in 0.5% TBE buffer. Store at RT. 
DNA-sample buffer: 50% (v/v) glycerin and 0.1% (w/v) bromophenol blue, dissolve in 100 mM 
Tris-HCl, pH 8.0. Store at RT. 
Ethidiumbromide stock solution: 10 mg ml
-1 ethidiumbromide stock solution 
Mini and Midi DNA preparation kits (Macherey-Nagel, Germany) 
Polymerases and polymerases buffer (New England Biolabs)  
Restriction enzymes (New England Biolabs) 
 
4.3.2.  Expression media 
Amino acid stocks (Sigma-Aldrich, Germany):  Materials   
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Antibiotics stock solutions (stored at -20°C) 
  Ampicillin: 150 mg ml
-1 Na
+-ampicillinsalt in 50% EtOH 
  Kanamycin: 75 mg ml
-1 kanamycin sulfate in H2O 
Glycerol cultures: Mix 60 µl of glycerin at 50% with 100 µl cell suspension and store at -80°C. 
IPTG stock solution: 1 M in H2O 
LB medium:   10 g tryptone, 5 g yeast extract, 10 g NaCl, for 1L  
M9 medium:  I: 290 mL H2O + 200 mL M9x5 + 10 mL 
15NH4Cl, 1 mL MgSO4   
          II: 490 mL H2O + 10 mL glucose (or 20 mL 
13C-glucose), 4 mL  glycerol  at  50%, 
          1 mL CaCl2, 300 µL thiamine 
          Mix I and II, add 1.0 mL TRACE-elements-I 
  Ammonium chloride (NH4Cl or labeled 
15NH4Cl): 1 g in 10 mL H2O at pH 7.0.    
  M9-salts (Maniatis) (5x): 44.5 g Na2HPO4, 2 H2O; 15 g KH2PO4; 2.5 g NaCl. pH 7.2 for 1L. 
  Calcium chloride (CaCl2): 1M in H2O 
  Glucose (
13C labeled and unlabeled): 2 g in 10 mL H2O 
  Magnesium sulfate (MgSO4) (Sigma-Aldrich, Germany): 1M in H2O 
  Thiamine: 20 mg ml
-1 stock solution in H2O. Store at -20°C 
  TRACE-elements-I: 2.50 g EDTA; 0.25 g FeCl3, 6 H2O; 0.025 g ZnO; 0.005 g  CuCl2, 2 H2O; 
0.005 g Co(NO3)2, 6 H2O; 0.005 g  (NH4)6Mo7O24, 4 H2O. pH 7.0 in 500 mL H2O. 
Protease  inhibitors  cocktail  (50x)  (home  made,  protease  inhibitors  from  Sigma-Aldrich, 
Germany): 59.88 mg AEBSF; 11.89 mg leupeptin; 7.71 mg bestatin; 4.88 mg aprotinin; 4.46 mg 
E-64; 1.71 mg pepstatin. In 50% MeOH.  
Selective labeling (for 1L of expression in minimal media, only half of the amount used when 
the amino acid is labeled):
 
-  alanine: 500 mg 
-  arginine: 400 mg 
-  aspartic acid: 400 mg 
-  asparagine: 650 mg 
-  cysteine: 50 mg 
-  glutamic acid: 650 mg 
-  glutamine: 400 mg 
-  glycine: 550 mg 
-  histidine:100 mg 
-  isoleucine: 230 mg 
-  leucine: 230 mg 
-  lysine: 420 mg 
-  methionine: 250 mg 
-  phenylalanine: 130 mg 
-  proline: 100 mg 
-  serine: 2100 mg 
-  threonine: 230 mg 
-  tryptophan: 56 mg 
-  tyrosine: 170 mg 
-  valine: 230 mg 
         Materials 
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SOC medium: 20.0 g tryptone; 5.0 g yeast extract; 0.5 g NaCl; 950 mL H2O. Shake it till totally 
dissolved. Add 10 mL of a 250 mM KCl solution (1.86 g KCl in 100 mL H2O). Adjust pH to 7.0. 
Adjust total volume to 1 L. Autoclave. Add 5 mL of a sterile 2 M MgCl2 solution (19 g MgCl2 in 
100 mL H2O). Add 20 mL of a sterile 1 M glucose solution (18 g glucose in 100 mL H2O, 
filtred). 
 
4.3.3.  Purification buffers 
Ammonium acetate buffer: 10 mM ammonium acetate at pH 7.3 
DNAse I from bovine pancreas (Sigma-Aldrich, Germany): 5 000 units in 20 mM Tris and 100 
mM MgSO4 (for 2 L of expression) 
DTT: 500 mM stock solution 
GST purification buffer:  
-  Loading buffer with 1xPBS at pH 7.5 
-  Elution buffer with 20 mM GSH in 1xPBS at pH 8.0 
IEC purification buffer:  
-  Loading buffer with 25 mM Na2HPO4, 2 H2O and 25 mM NaCl  
-  Elution buffer with 25 mM Na2HPO4, 2 H2O and 1 M NaCl  
pH adjusted depending on proteins pI. 
Lysis buffer: 50 mM Tris-HCl, 250 mM NaCl, 5% glycerol in H2O at pH 7.5 
Nickel-NTA purification buffer:  
-  Loading buffer with 250 mM NaCl, 50 mM Tris-HCl, 1% glycerol, 10 mM imidazole at 
pH 7.7  
-  Elution buffer with 250 mM NaCl, 50 mM Tris-HCl, 1% glycerol, 400 mM imidazole at 
pH 7.7  
PBS (10x): 1.37 M NaCl, 0.03 M KCl, 80 mM Na2HPO4 and 15 mM KH2PO4, pH 7.5. at RT. 
Sodium azide (NaN3) (Fluka Sigma-Aldrich, Germany): 0.3% (w/v) stock solution in H2O. 
 
4.3.4.  NMR buffers  
NMR buffer I: 25 mM Na2HPO4, 2 H2O, 100 mM NaCl, in H2O at pH 7.3 
NMR buffer II: 100 mM Na2HPO4, 2 H2O, 70 mM NaCl, 1.4 mM KCl and 0.9 mM KH2PO4 at 
pH 7.3 
NMR buffer III: 100 mM Na2HPO4 , 2H2O, 30 mM NaCl, 5 mM KCl at pH 7.3 
ULD buffer: 50 mM Tris in H2O at pH 7.2 
LC3- buffer: 50 mM Na2HPO4, 2 H2O, 100 mM NaCl at pH 7.0 Materials   
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4.3.5.  Gel chromatography buffers 
10xTGS: 30 g Tris, 144 g Glycerin, 10 g SDS at pH 8.6 for 1L   
Coomassie Staining solution: 50% (v/v) ethanol (96%), 10% acetic acid  (100%),  0.1%  G250 
coomassie brilliant blue, completed with water 
Destaining solution: 40% (v/v) MeOH (96%), 10% (v/v) acetic acid (100%), completed with 
water  
Polyacrilamide gels (for 2 gels): 
-  Running gel 12%: 2.5 mL H2O,  1.0 mL 1% SDS, 2.5 mL buffer A, 4.0 mL AcA-30, 50 
µL APS 10%, 5 µL TEMED Elution buffer with 250 mM NaCl, 50 mM Tris-HCl, 1% 
glycerol, 400 mM imidazole at pH 7.7   
-  Running gel 16.5%: 1.5 mL H2O, 1.0 mL 1% SDS, 2.5 mL buffer A, 5.0 mL AcA-30, 50 
µL APS 10%, 5 µL TEMED   
-  Running gel 18%: 0.5 mL H2O,  1.0 mL 1% SDS, 2.5 mL buffer A, 6.0 mL AcA-30, 50 
µL APS 10%, 5 µL TEMED 
-  Stacking gel 4%: 2.5 mL H2O, 0.5 mL 1% SDS, 1.3 mL buffer B, 0.7 mL AcA-30, 25 
µL APS 10%, 5 µL TEMED   
-  Buffer A: 1.5 M Tris at pH 8.8 
-  Buffer B: 0.5 M Tris-HCl at pH 6.8 
Protein  sample  buffer:  150  mM  Tris-HCl,  12%  (w/v)  SDS,  30%  (v/v)  glycerin,  6%  (v/v) 
β-mercaptoethanol, 0.05% coomassie blue at pH 7.0 
Tricine gels:   
-  Anode buffer: 100 mM Tris, 22.5 mM HCl (37%) at pH 8.9 
-  Cathode buffer: 100 mM Tris, 100mM Tricine, 0.1% (v/v) SDS at pH 8.25 
 
4.4. Software 
Adobe package 
Microsoft Office 
Nanodrop ND-1000 v.3.7.0 
Origin 6.1 
Sparky 3.115 
Topspin 
Unicorn 5.11 
Spectra Manager         Methods 
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5.  Methods 
 
5.1. Primary sequence analysis 
  ClustalW2 was used to align primary sequences of the different proteins and to calculate the 
percentage of homology between these sequences. 
  Physico-chemical  parameters  (amino  acid  and  atomic  compositions,  isoelectric  point, 
extinction  coefficient…)  based  on  the  protein  sequences  were  determined  by  the  ProtParam 
software from the ExPASy Proteomics Server. 
 
5.2. Cloning 
  Initial GST-fused constructs (TBK1_ULD, GABARAPL-1, GABARAPL-2, LC3A, LC3B) 
were provided from the Dikic group. 
 
5.2.1.  Substitution of GST to NusA 
  After  Polymerase  Chain  Reaction  (PCR),  pGEX_TBK1_ULD  was  digested  with  the 
restriction endonucleases NcoI and BamHI. The gene product of interest and the expression 
vector were then separated by agarose gel electrophoresis and extracted from the gel by using the 
QIAquick  gel  extraction  kit.  The  ligation  of  the  TBK1_ULD  PCR  product  with  the  open 
pETM-60 vector was performed overnight at 4°C according to the manufacturer’s instructions 
using the T4-DNA-ligase from NEB. 10 µl of the ligation product were transformed the next day 
into E. coli DH5α cells. After the cell growth in 3 ml LB of overnight culture, the plasmid DNA 
was then purified and the insertion of TBK1_ULD PCR product into pETM-60 vector backbone 
was analyzed by restriction digest. Positive clones were submitted for sequencing. 
 
5.2.2.  Substitution of NusA to ubiquitin 
  PCR  fragments  encoded  human  LC3  modifiers  (LC3A,  LC3B  and  GABARAPL-1)  were 
cloned into pETM-60 vector where the NusA leader was substituted with modified ubiquitin 
between NcoI and BamH1 sites. For the peptides (p62-LIR, Nix-LIR_W36, Nix-LIR_W140/144 
and NBR1-LIR), entire DNA fragments were ordered at MWG Bioscience and cloned at the 
same sites.  
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5.2.3.  Mutagenesis 
  To introduce single mutation on plasmid DNA, PCR based site-directed mutagenesis was 
used as follows: 
-  initialization for 60 seconds at 95°C 
-  denaturation for 30 seconds at 95°C 
-  annealing for 30 seconds at 60°C cycle  x 18 times                 
-  extension for 16 minutes at 68°C 
-  end at 4°C 
 
with a mixture composed of: 
-  10 ng plasmid DNA 
-  20 pmol 5’ primer oligonucleotide 
-  20 pmol 3’ primer oligonucleotide 
-  2.5 mmol dNTPs 
-  2.5 U polymerase 
-  5 µL 10 times Polymerase buffer 
-  4 mM MgSO4 (samples were also prepared in parallel without MgSO4) 
-  complete to 50 µL with sterile water 
 
  Once the PCR achieved, 1 µL dpNI were added to each probe and let at 1 hour for 37°C to 
cleave methylated DNA. Amplified DNA were analyzed on a 1% agarose gel.  
 
5.3. Isolation of plasmid-DNA and measurement of concentration 
  Positive cloning samples were purified on analytical scale with 3 mL overnight culture using 
the NucleoPlasmid PC Kit („Mini“) and on preparative scale with 100 mL overnight culture 
using the NucleoSpin Kit („Midi“) following manufacturer protocols (Macherey-Nagel, Düren). 
DNA pellets were resuspended in H2O. The measurement of plasmid-DNA concentration was 
performed by measuring the absorbance at 260 nm using the Nano-Drop Spectrometer. 
 
5.4. Transformation 
  Transformation of competent bacterial cells to take up plasmid DNA was based on the heat 
shot protocol.
139 Frozen competent cells were removed from the -80°C freezer and put on ice 
until melting. 50 ng DNA were added to the cells and kept on ice for 30 minutes then placed for         Methods 
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30 seconds at 42°C for heat-shock and again on ice for 2 minutes. Then 450 µL SOC medium 
were added and the tube placed at 37°C in the shaker. After 1 hour growth, 150 µL of the 
transformed cells were spread on an agar plate with the appropriate antibiotic and incubate at 
37°C overnight. 
  Plasmids encoded GST constructs and NusA or Ub-fused proteins/peptides were respectively 
transformed into E.Coli DH5α and E.Coli NEB T7 Express (equivalent to BL21) strains. 
 
5.5. Sequencing 
  After  analytical  expression  (cf.  below),  putative  “positive”  clones  were  sent  to  SeqLab 
(Göttingen) for sequencing using 600 to 900 ng of plasmid, 20 pmol of primer and completed 
with sterile water for a final volume of 7 µL. 
  
5.6. Cell growth and expression 
5.6.1.  Analytical expression 
  Single colonies were scratched from agar plate and resuspended in 3 mL LB medium with 1 
mM antibiotics. After reaching an optical density at 600 nm (OD600) ≈ 1, cells were induced with 
different concentration of isopropyl-β -D-thiogalactopyranosid (IPTG), 1mM, 0.5 mM, 0.25 mM 
and 0.1 mM at 37°C for 3 hours or at 20°C for 16 h.   
   
5.6.2.  Preparative expression 
  Preculture of transformed cells were grown in 50 mL LB overnight with the appropriate 
antibiotics. For DNA plasmid presenting ampicillin resistance, the preculture cells were spinned 
down the next morning, the supernatant was poured off and the cells resuspended in 1L medium. 
In case of kanamycin, cells were then directly inoculate into 1L medium.  
  Bacteria were grown in LB medium for expression of unlabeled proteins/peptides or in M9 
medium for expression of 
15N-labeled (1g/L 
15NH4Cl) and 
13C/
15N-labeled (1g/L 
15NH4Cl and 
2g/L 
13C-glucose)  proteins/peptides.  After  OD600  ≈1,  IPTG  at  final  concentration  1mM  was 
added  to  induce  gene  expression.  All  cells  were  expressed  for  3  hours  at  37°C,  except 
TBK1_ULD cells, which were expressed for 16h at 20°C.   
   
5.6.3.  Selective labeling 
  Selective labeled samples were produced only for TBK1_ULD. A sample selectively 
15N 
labeled for the lysine residues was produced by expression in BL21 bacteria. Samples selectively Methods   
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15N labeled for the phenyalanine, tyrosine, leucine or isoleucine residues were expressed in the 
auxotrophic strain DL39 following standard protocols. The amount of amino acids used for one 
liter of expression in minimal media is listed in the material section. 
 
5.7. Protein isolation and purification 
5.7.1.  Cell lysis 
  Resuspended pellets from cell cultures were either lysed by French Press under a 1200 psi 
pressure or using sonication with 50 pulses during 30 seconds with 1 minute rest, this cycle 
being repeated 8 times.  
  The  cell  lysate  was  harvested  at  18  000  rpm  for  30  min  at  4°C  to  remove  cell  debris. 
Resulting pellets were discarded whereas the supernatant was loaded on the appropriate affinity 
chromatography column for purification after after being filtrated through a 0.2 µm filter. 
   
5.7.2.  GST purification 
  The  supernatant  of  the  cell  lysate  was  loaded  with  an  external  pump  on  a  glutathione 
sepharose  4  Fast  Flow  (GE  Healthcare)  column.  The  column  was  washed  with  4  column 
volumes (CV) of 1xPBS buffer, pH 7.5 and GST-fused proteins were eluted with 1xPBS, 20 mM 
reduced glutathione, pH 7.9. Loading, washing and eluting steps were performed at a flow-rate 
of 2 mL min
-1. 
   
5.7.3.  NiNTA purification 
  The supernatant of the cell lysate was loaded onto the Ni-NTA column with an external 
pump. The column was previously equilibrated with the loading buffer (50 mM Tris, 250 mM 
NaCl, 1% glycerol and 10 mM imidazole, pH 7.7). After washing with 3 CV of loading buffer, 
the  NusA  constructs  as  well  as  the  Ub-fused  protein/peptides  constructs  containing  a 
hexahistidine tag were eluted with a linear gradient (10-400 mM) of imidazole with a flow rate 
of 2 mL min
-1. 
   
5.7.4.  Tag cleavage 
  GST-fusion  proteins  were  cleaved  with  thrombin  (1  unit  used  for  100  µg  proteins)  (GE 
Healthcare) directly in GST elution buffer overnight at 16°C.  
  NusA and ubiquitin were cleaved by tobacco etch virus (TEV) protease (produced in house) 
after adding 2 mM EDTA and 10 mM β-mercaptoethanol to NiNTA elution buffer overnight at 
16°C.           Methods 
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5.7.5.  Cation-exchange chromatography 
  A 20 mL sp-sepharose column was used with a flow rate of 2 mL min
-1 for the purification of 
cleaved Ub-constructs and a 5 mL HiTrap sp ff column to repurify samples after NMR and ITC 
experiments. The column was equilibrated with 3 CV of 25 mM sodium phosphate, 25 mM 
NaCl at pH 6.3. The sample was applied with an external loop and unbound proteins were 
removed by washing the column for 10 CV with 2 ml min
-1. The bound proteins were eluted 
with a linear gradient from 25 mM to 1M NaCl at 2 ml min
-1. 
 
5.7.6.  Buffer exchange 
  To exchange buffer conditions, samples with a volume below 5 mL were applied to HiPrep 
26/10 Desalting (GE Healthcare) column with a 4 mL min
-1 flow rate. For samples with a bigger 
volume, buffer exchange was achieved using 3 to 8 kDa cut-off dialysis membranes, stirred 
solutions of 500 times the sample volume at 4°C and two buffer changes within 24 h. 
    
5.7.7.  Size-exclusion chromatography 
  In order to purifiy proteins by size-exclusion chromatography, a Superdex 75 16/60 column 
was used. 5 mL of filtred solution through 0.2 µm filter were injected on the equilibrated column 
in final buffer conditions through an external loop with a 1 mL min
-1 flow rate. 3 mL elutions 
fraction collection were collected.  
 
  All affinity chromatography techniques were used on ÄKTA™ systems at 4°C. 
  Elution fractions were collected following protein absorbance at 280 nm and their purity was 
checked by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
 
5.8. Peptide preparation 
  p62-LIR  and  NBR1-LIR  peptides  were  purchased  from  Genecust  (Luxembourg). 
Nix-LIR_W36 and Nix-LIR_W140/144 were provided by AK Schwalbe. NBR1-LIR mutants 
(NBR1-LIR_Y732F, NBR1-LIR_S729E, NBR1-LIR_S728,729E) were purchased from Peptide 
Speciality Laboratories GmbH (Heidelberg, Germany). 
  The  solid-phase  synthesized  lyophilized  peptides  were  resuspended  in  50  mM  sodium 
phosphate, 100 mM NaCl at pH 7.0 to make stock solutions according to their molecular size. 
  Ub-fused peptides samples for structural determination by NMR (unlabeled, 
15N, 
13C and 
15N/
13C  labeled)  were  cleaved  with  TEV  protease  after  NiNTA  elution  and  purified  by 
size-exclusion chromatography in 10 mM ammonium acetate at pH 7.3. The resulting elution Methods   
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fractions were combined in a glass vial and frozen in liquid nitrogen. Once the refrigering unit 
reached -40°C and a pressure of 0.1 mbar, the sample was attached to the freezer dryer unit and 
let overnight under vacuum. After lyophilization, peptides were resuspended in 50 mM sodium 
phosphate, 100 mM NaCl at pH 7.0. 
 
5.9. Concentration samples 
  Centrifuge  concentrators  from  Millipore  with  a  cut-off  of  3  or  10  kDa  were  used  to 
concentrate protein solutions at 3 000 rpm until reaching the final wished concentration/volume.  
 
5.10.   Sample state  
5.10.1. Gel chromatographies 
  To identify the expression, the isolation, the purification and the stability efficiency of the 
target proteins, SDS-PAGE were performed. Depending on the size of the proteins of interest, 
different gel compositions were used (12%, 16.5% or 18% polyacrylamide or tricine gels). 
  Running gel was first poured and then sealed with water on the top. After polymerization, 
water was removed and replaced stacking gel. A comb with 10 or 15 slots were inserted to load 
samples.  Protein  samples  diluted  1:5  in  SDS  buffer  were  heated  up  for  5  minutes  at  95°C.  
Unstained protein marker from Fermentas (St. Leon-Rot) was used as reference. SDS-PAGE run 
for 15 minutes under 100 V and then 50 minutes under 200 V with 1xTGS buffer pH. Tricine 
gels run first for 20 minutes under 70 V followed with 45 minutes under 150 V cathode buffer 
was placed in the inside chamber and anode buffer outside. Gels were stained in Coomassie 
solution for 30 minutes and, after wash under water, destained in destaining solution for also 30 
minutes. 
 
5.10.2. Concentration determination 
  Based  on  their  extinction  coefficient,  pure  protein  concentration  was  calculated  from  the 
absorption at 280 nm using NanoDrop or Cary UV following the Beer-Lamber law: 
 
where A is the absorbance at 280 nM, ε the extinction coefficient of the protein, l the path length 
of the cuvette and C the concentration of the sample. 
 
5.11.   Circular Dichroism (CD) spectroscopy 
  CD  spectroscopy  uses  the  interaction  of  polarised  light  with  biological  molecules  like 
proteins, based on their chiral properties. Due to their structural asymmetry, chiral molecules 
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exhibit circular dichroism, meaning a differential absorbance of left-hand circularly polarised 
and right-hand circularly polarised light. 
  CD spectroscopy of Ub_GABARAPL-1, GABARAPL-1 and ubiquitin proteins was done in a 
10 mM  sodium  phosphate  buffer  at  pH  7.0  with  a  Jasco  J-810  spectropolarimeter  (Jasco 
Labortechnik, Gross-Umstadt, Germany) using a quartz cuvette with a path length of 0.1 cm. 
Assays were carried out at standard sensitivity with a band width of 1 nm and a response of 1 s. 
The data pitch was 0.1 nm and the scanning rate 50 nm per minute. The CD spectra were 
recorded from 300 to 190 nm. The presented data are the average of 20 scans. Melting curves for 
the same proteins in the same conditions were recorded monitoring ellipticity at 222 nm from 
4°C to 100°C with the rate of 1°C per minute. The temperature was controlled using a digitized 
water bath integrated with the instrument. The spectra were signal-averaged over at least three 
scans, baseline corrected by subtracting a buffer spectrum and smoothed by the mean value 
averaging.  
 
5.12.   Isothermal Titration Calorimetry (ITC)   
  ITC measures the gain or loss of heat appearing during reactants mixture. Applied to an 
interacting system, the amount of heat released or absorbed is directly connected the amount of 
binding  in this system. Reaction occurs in a sample cell containing the titrand and where a 
spinning  syringe  injects  regularly  precise  amount  of  titrant.  Compared  to  the  reference  cell 
maintained at a constant temperature, a feedback regulation as electrical power is applied to the 
sample  cell  to  respond  to  the  thermal  changes  due  to  the  interaction  and  to  reach  back  the 
equilibrium.  At  saturation,  the  heat  signal  decreases  and  only  background  heat  dilution  is 
observed, which need to be substracted from the heat interaction. 
  ITC  experiments  were  performed  at  25°C  using  a  VP-ITC  calorimeter  (MicroCal  Inc., 
Northampton, MA, USA) and analyzed with the ITC-Origin software (MicroCal Inc.) based on 
the assumption of one-site binding reactions. 
  For LC3A and LC3B experiments, 400 µM p62-LIR was titrated into 15 µM LC3B in 26 
steps  (10  µL  per  injection),  1.6  mM  Nix-LIR_W36  into  80  µM  LC3B,  2.0  mM 
Nix-LIR_W140/144 into 100 µM LC3B and 450 µM Ub_NBR1-LIR into 35 µM LC3B in 16 
steps (15 µL per injection).  
  For  GABARAPL-1  experiments,  350  µM  Ub_NBR1-LIR,  Ub_NBR1-LIR_Y211W, 
NBR1-LIR_Y732F,  NBR1-LIR_S729E  and  NBR1-LIR_S728,729E  were  titrated  into  25  µM 
GABARAPL-1 in 26 steps (10 µL per injection). Methods   
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  To measure the heat contribution due to the titrant alone after saturation of the interaction, 
heat dilution effect of the different peptides were analyzed by titrating the titrant against the 
buffer. These data were then substracted from the interaction data to only have the heat due to 
interaction involved in the thermodynamics data calculation. 
 
5.13.   Nuclear Magnetic Resonance (NMR) 
  Detailled  description  of  the  NMR  principle  is  exhaustively  available  in  the  litterature.  In 
short,  NMR  is  based  on  the  magnetic  properties  of  the  nuclei  of  each  atom.  Under  a  high 
magnetic field, the nuclei have spinning charges, which are all oriented in the same direction and 
precess about the magnetic field at the Larmour frequency. By applying a radio-frequence pulse, 
a  magnetic  resonance  occurs  when  the  spectrometer  frequency  matches  with  the  nuclear 
precessing frequency and produces thus a transverse magnetization for each spin. This transverse 
magnetization precesses differently for each spin due to the presence of the surrounding spins, 
which  create  additionnal  local  fields.  The  detection  of  the  resulting  precession  provides 
information of individual nuclei affected differently by their local environment, reflected by a 
chemical shift. A chemical shift is the difference between a resonance frequency and that of a 
reference substance. Thus, the total dispersion of the chemical shifts of a molecule is a specific 
picture corresponding to the different atoms (in 1D NMR) or to the relation between atoms (in 
2D or 3D NMR) of the molecule.
140 
 
5.13.1. Conditions 
  All NMR experiments were performed on Bruker Avance spectrometers operating at proton 
frequencies  between  600  and  900  MHz.  All  experiments  were  done  at  298K  except  when 
mentioned. The resulting spectra were processed by Topspin (Bruker) and analyzed by Sparky 
(UCSF) programs. 
  The list of the different NMR experiments used during this work as well as their common 
signification are listed in Table 3.  
 
 
 
 
 
 
         Methods 
-43- 
 
Purposes  NMR experiments 
Correlation  Common Use 
[
15N, 
1H] HSQC-TROSY 
15N and attached 
1H  Protein backbone fingerprint 
[
13C, 
1H] HSQC 
13C and attached 
1H  Protein backbone fingerprint 
[
1H, 
1H] TOCSY 
1H and attached 
1H  Backbone and side assignment 
[
15N, 
1H] TOCSY-TROSY  NH with 
1H along side chain 
1H side chain assignment 
[
1H, 
1H] NOESY 
1H-
1H distance  NOE constraints 
15N-separated NOESY-HSQC  NH and H using NOE 
1H side chain assignment 
15N-separated TOCSY-HSQC 
15N and attached 
1H  NHHN resonance pair 
assignment 
13C-separated NOESY-HSQC 
13C and attached 
1H  CHHC resonance pair 
assignment 
[
13C, 
15N] HNCO  NH with CO of preceding 
residue  Carbonyl assignment 
[
13C, 
15N] HN(CA)CO  NH with CO of own and 
preceding residue  Carbonyl assignment 
[
13C, 
15N] HNCA  NH with C
α of own and 
preceding residue 
C
α assignment 
[
13C, 
15N] HN(CO)CA  NH with C
α of preceding 
residue 
C
α assignment 
[
13C, 
15N] HNCACB  NH with C
α and C
β of own and 
preceding residue 
C
α and C
β assignment 
[
13C, 
15N] (H)CC(CO)NH-
TOCSY  NH with C of  preceding residue  C
α, C
β and C
side chain assignment 
[
13C, 
15N] TROSY-
H(CCCO)NH-TOCSY  NH with H of  preceding residue  H
α, H
β and H
side chain assignment 
13C H(C)CH-TOCSY  CH with attached H  H
α, H
β and H
side chain assignment 
Table 3: Typical NMR experiments used 
 
 
5.13.2. 1D NMR 
  Analysis of the 1D 
1H NMR spectrum of a protein gives information of the general state of 
folding of the protein depending of the dispersion of the protein signals but the spectrum is 
crowded with too many peaks in order to identify each residues. A simple 
1H NMR was recorded 
for each experiment to first check the well-fold of the protein and then to set-up parameters for 
2D experiments. 
 
5.13.3. 2D NMR: [
15N, 
1H] TROSY-HSQC and [
13C, 
1H] HSQC 
  Using 2D NMR like [
15N, 
1H] TROSY-HSQC,
127 the signals are dispersed between the two 
frequency axes and each cross peak corresponds to an amide bond of a residue of the protein, 
providing  a  fingerprint  specific  to  each  protein.  Because  the  resonance  of  each  cross  peak 
depends of its surrounding, modifications of the protein due to conformation states, internal 
mobility, denaturation, environment changes (buffer, pH, temperature…) and presence/absence 
of  a  ligand  are  reflected  in  the  different  NMR  spectra.  Performing  titration  experiments  by 
adding  gradually  a  non  labeled  ligand  against  a 
15N  labeled  protein  and  then  observing  the Methods   
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chemical shift perturbations (CSP) of the cross peaks provide information about the affected 
amino acids; the strongest CSP are observed for the peaks, which are the most modified by the 
new conditions, meaning the residues involved in the interaction. By plotting the CSP between 
the reference state (protein alone) and each titration point until the final state (protein saturated 
with ligand) against the protein concentration used, a titration curve is obtained from which the 
dissociation constant (Kd) could be calculated. 
 
5.13.4. Amide/proton exchange experiment 
  A [
15N, 
1H] TROSY-HSQC reference spectrum of LC3B was first recorded in NMR buffer 
conditions,  25  mM  sodium  phosphate,  100  mM  NaCl  at  pH  7.3.  The  sample  was  then 
lyophilized and later resolubilized in D2O. After a waiting time of 10 minutes, a new TROSY 
spectrum was recorded, then the next day and after several weeks, using the same acquisition 
parameters. 
 
5.13.5. Analysis of cell lysate samples from Ub-constructs 
  After 3 hours expression at 37°C, the expressed cells were harvested for 10 minutes at 6 000 
rpm. The pellet of the Ub-fused proteins was resuspended in 100 mM sodium phosphate and 2 
mM TCEP at pH 7.2. The cells were then lysed by sonication with 5 times 4 pulses. After 
undergoing N2 flow for 1 minute, the sample was centrifuged for 5 minutes at 14 000 rpm. The 
supernatant was finally filtred through a 0.2 µM filter before recording NMR spectra. 3 ml of the 
cell  cultures  were  enough  to  visualize  all  resonances  but  15  ml  were  necessary  for  3D 
experiments. 
 
5.13.6. Resonance assignment 
  Nevertheless, more information are needed to understand to which residue corresponds each 
cross peak. 3D NMR experiments allow to characterize the interaction between the spin systems 
of the protein like for example, the amide bond from a residue to the C
α and the C
β (for a 
HNCACB experiment) or to the CO (for HNCO) of the same residue and from the previous 
residue  of  the  primary  sequence.  Performing  a  sequential  assignment,  each  cross  peak 
corresponding to the backbone atoms of the protein could be then identified. To complete the 
information about the protein, the same type of experiments has to be performed in order to 
assign the side chains of the amino acids constituing the protein of interest. Added to total 
correlation spectroscopy (TOCSY) experiments where the cross peaks are observed upon bond 
relation  up  to  three  covalent  bonds  and  others  available  experiments,  an  assignment  of  all         Methods 
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protons  of  the  protein  is  possible.  Assignment  of  the  protein  is  not  enough  for  structure 
determination  where  each  atoms  of  the  protein  has  to  be  located  in  the  space.  Nuclear 
Overhauser effect spectroscopy (NOESY) experiments are the widely used NMR experiments to 
determine  the  structure  of  protein.  The  nuclear  Overhauser  effect  (NOE)  is  based  on  the 
magnetization transfer between two nuclear spins via cross-relaxation, the two nuclear spins 
being  close  enough  in  space.  NOESY  experiments  provide  information  on  intramolecular 
distances illustrated by cross peaks between two protons which are distanced by less than 5 Å in 
space.  This  proton-proton  interaction  could  be  directly  related  to  the  protein  structure,  the 
NOESY intensity signal being inversely related to the proton-proton distance. Additionnaly in 
the study of a complex between two proteins, intermolecular NOEs are an important parameter 
that could also be observed, illustrating the close interaction between these proteins.  
  For  the  assignment  of  TBK1_ULD,  HNCA,  HNCACB, 
15N-separated  3D-NOESY, 
15N-separated 3D-TOCSY, as well as homonuclear 2D-TOCSY and 2D-NOESY spectra were 
recorded as well as [
15N, 
1H] TROSY-HSQC for the selective labeled samples. 
  HN, NH, C
α and C
β resonances for LC3B and GABARAPL-1 proteins were obtained from 
individual HNCACB experiments with minor guidance of reported resonances assignment from 
BMRB entries 5958 and 5058 for LC3B and GABARAPL-1, respectively. Backbone and side 
chain resonances for GABARAPL-1 in complex with NBR1-LIR peptide were assigned with the 
standard  set  of  the  3D  experiments:  HNCA,  HNCACB,  HNCO,  HN(CA)CO, 
(H)CC(CO)NH-TOCSY,  TROSY-H(CCCO)NH-TOCSY.  The  assignment  was  proven  and 
completed  with 
15N-edited  and 
13C-edited  (for  aliphatic  and  aromatic  regions)  NOESY 
experiments. For the resonance assignment of NBR1-LIR in complex with GABARAPL-1, the 
same set of NMR experiments was used with additional 3D H(C)CH-TOCSY experiment. 
 
5.13.7. Secondary structure determination 
  Based on the analysis of the 
1H and 
13C chemical shifts, CSI
141 and TALOS
142 programs 
identified secondary structure elements of TBK1_ULD. Torsion angles constraints determined 
by  TALOS  based  on  chemical  shift  perturbations  were  added  to  CYANA  for  3D  structure 
calculation. 
 
5.13.8. Tertiary structure calculation 
  A first step of the calculation of protein 3D structure is the assignment on all NOEs signals 
and that is automated by the CANDID module of the CYANA software. Based on distance 
restraints obtained from the NOEs and torsion angle restraints provided by TALOS, a first cycle Methods   
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of structure calculation is started by CYANA, followed by new cycles where new restraints 
acquired from the previous cycle are added until unique assignment for each 
1H-
1H pair and 
elimination of the non-assigned. An ensemble of 20 conformers presenting the smallest target 
function, the best agreement between the obtained structure and the different restraints used, is 
selected and submitted to refinement based on simulated annealing, an alternance of high and 
low  temperature  phases  to  obtain  the  best  energy  minimization.  The  final  precision  of  the 
structure is determined by the root-mean-square deviation (RMSD) showing the deviation of the 
mean structure to the average structure. 
 
5.13.8.1. TBK1_ULD structure determination 
  CANDID module of CYANA 1.0.5 program
143 was implemented to calculate the structure of 
TBK1_ULD and to assign NOE signals in 3D 
15N- and 
1H-NOESY spectra. 32 hydrogen bonds 
observed in Ubiquitin structure
144 were transposed to TBK1_ULD sequence and were added to 
the intial calculations. In total, 1781 signals (866 from [
15N, 
1H] TBK1_ULD and 915 from [
1H, 
1H] TBK1_ULD) together with 91 torsion angles restraints (aco) predicted by TALOS
142 and 26 
upper limits renstraints (upl) describing α–helical hydrogen bonds (as consensus of TALOS and 
CSI
141 programs) were used in the initial CYANA run. 702 meaningful distance restraints, 91 
torsion angle restraints and 58 upper distance limits restraints for hydrogens bonds provided by 
the initial calculations were used to calculate the final 20 (from 100) CYANA conformers with 
CYANA  3.0  (Table  in  Appendix  9.5).  The  final  20  (from  100)  CYANA  structures  have  a 
backbone RMSD 0.65 Å within a structured part (residues 14 to 88); 80 % NOE signals were 
assigned. 
 
5.13.8.2. GABARAPL-1/NBR1-LIR structure determination 
  CANDID module of CYANA 1.0.5 program
143 was implemented to calculate structure of 
GABARAPL-1/NBR1-LIR complex and to assign NOE signals in 3D 
15N- and 
13C- NOESY 
spectra. In total, 4732 signals (4140 from [
13C, 
15N] labeled GABARAPL-1 and 592 from [
13C, 
15N] labeled NBR1-LIR) together with 203 torsion angles constraints from TALOS
142 and 46 
upper limits constraints for α-helical hydrogen bonds (identified as consensus of the TALOS and 
CSI
141  programs)  were  used  in  the  initial  CYANA  calculations.  According  to  CYANA 
algorithm,  the  complex  was  simulated  by  connection  of  the  GABARAPL-1  and  NBR1-LIR 
polypeptides with imaginary linker of 82 L5 pseudogroups. 1364 meaningful distance restraints, 
203  torsions  angles  restraints  and  84  upper  distance  limits  restraints  for  hydrogens  bonds 
provided by the initial calculations were used to calculate the final 20 (from 100) CYANA         Methods 
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conformers  with  CYANA  3.0  (Table  in  Appendix  9.5).  These  20  final  conformers  with  the 
lowest target function values were subjected to restrained energy minimization in explicit solvent 
against  the  AMBER  force  field
145  using  the  program  OPALp.
146  The  final  20  (from  100) 
CYANA  structures  have  backbone  RMSD  0.65  Å  within  a  structured  part  (GABARAPL-1 
residues 12-114 and NBR1-LIR residues 729-737); near 85 % of the NOE signals were assigned.  
 
5.13.9. Interaction studies by NMR 
5.13.9.1. TBK1_ULD project 
  The  titration  of  IAD-SRR  against 
15N_TBK1_ULD  was  done  by  co-concentrating  both 
proteins, purified by size-exclusion chromatography, until reaching a molar ratio of 1/2:1, 1:1 
and  2:1.  For  the  titration  of  GST_IAD-SRR  against 
15N_TBK1_ULD,  proteins  were 
co-concentrated until molar ratio 1:1 and 2:1.  
  [
15N, 
1H] TROSY-HSQC spectra were recorded at each step.  
 
5.13.9.2. Autophagy project 
  Titration of p62-LIR, Nix-LIR_W36 and Nix-LIR_W140/144 against 
15N-labeled proteins 
(~100µM) was performed at 25°C by gradually adding stock solutions of unlabeled peptides 
until reaching a molar ratio 1:10 (protein to peptide). 
  Unlabeled Ub_NBR1-LIR was added on an eight step titration to a 120 µM
 15N-labeled LC3B 
solution until reaching five molar excess. 
15N-labeled GABARAPL-1 was concentrated to 100 
µM. Titration experiments were performed by adding gradually unlabeled Ub_NBR1-LIR and 
Ub_NBR1-LIR_Y211W to obtain a final 1:3 molar ratio. [
15N, 
1H] TROSY-HSQC spectra were 
recorded at each step. 
  Titration  experiments  were  performed  by  adding  gradually  unlabeled  GABARAPL-1  to 
15N-labeled  NBR1-LIR  and 
13C-labeled  NBR1-LIR  (1  mM  concentration)  until  reaching  1:1 
molar ratio. After each addition of GABARAPL-1, [
15N, 
1H] TROSY-HSQC or [
13C, 
1H] HSQC 
spectra were recorded for 
15N_NBR1-LIR and 
13C_NBR1-LIR, respectively. 
 
5.13.9.3. Analysis of titration data 
  For each individual amid group, the chemical shift differences, Δδ, at each titration step were 
calculated using the following formula:
147 
€ 
Δδ = ΔδHN
2 + (ΔδNH /6.5)
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with ΔδHN and ΔδNH representing the chemical shift differences for the amide proton and the 
amide nitrogen of one residue, respectively. 
  For the interactions where a fast exhange mode was observed and a “one binding site” mode 
was assumed, Kd was calculated using the least-square method. The following equation for the 
Kd calculations was used:
148; 149 
€ 
Δδ =
Δδmax
2C
(C + C* MR+ Kd)− (C* MR+ C + Kd)
2 − 4* MR*C
2  
with Δδ the current chemical shift difference value (Y-axis value), Δδmax the maximal chemical 
shift  difference  upon  the  titration, C   the  protein  concentration  in  the  NMR  tube,  Kd  the 
dissociation constant and MR the molar ratio where the Δδ was observed (X-axis value). The 
global fitting over all individual titration curves was done using a global minimization algorithm 
(MatLab 6.5 software package).           Results 
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6.  Results 
6.1. TBK1_ULD project 
6.1.1.  Expression and purification of TBK1_ULD 
  To confirm by NMR the presence of the ubiquitin motif in TBK1 predicted in silico, two 
TBK1 constructs were provided by Dr. Fumiyo Ikeda to check which one could be the most 
preferable for NMR experiments. The first construct TBK1_ULDs (residues 302-383) contains 
only the predicted ULD domain whereas the second construct TBK1_ULDl (residues 282-403) is 
larger. The TBK1_ULD constructs were first analytically expressed to screen the best conditions 
of expression. The first expression try showed that both TBK1_ULD constructs expressed as 
soluble proteins at 37°C but with a low expression yield. The expression at 25°C overnight 
increased  the  amount  of  GST_TBK1_ULD  produced.  Therefore,  this  protocol  was  used  for 
protein expression in a preparative scale (Figure 10). The expression of the protein of interest 
was induced by addition of IPTG. Different concentrations were used for the induction at 25°C 
(200 µM, 500 µM and 1 mM final concentration). The best expression yield was obtained for 1 
mM IPTG. 
 
Figure 10: Analytical expression of GST_TBK1_ULDs and GST_TBK1_ULDl. The results of 
the analytical expression was analyzed by SDS-PAGE. The first line represents the non-induced GST_TBK1_ULDs 
after reaching OD600≈1.0. For each construct, a sample was used after 1 to 6 hours (lines 1 to 6) induction with 1 
mM IPTG at 25°C. 
 
  After the cell lysis, the TBK1_ULD constructs presenting a GST tag were purified by affinity 
chromatography on a glutathione sepharose column (Figure 11A). The collected elution fraction 
was cleaved by thrombin protease. A cleavage screening was performed to adapt the amount of 
thrombin needed, the temperature, the duration of cleavage and the buffer conditions. Even by 
applying the best found conditions (3 units enzyme for 100 µg protein in GST elution buffer at 
pH 7.7 overnight at 18°C), the cleavage rate was not really efficient with the remaining presence 
of non-cleaved product in solution. More thrombin protease was needed than the advice of the 
manufacturers (Figure 11B).  Results   
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Figure  11:  Isolation  and  purification  GST_TBK1_ULDs  and  GST_TBK1__ULDl.  The 
isolation of both constructs on a glutathione sepharose column is represented in A and the their analytical cleavage 
in B. In A, line 1 represents the cell lysate fraction, the line 2 the flow-through, the line 3 the washing step and the 
lines 4 and 5 the elution fractions. In B, the bracket 1 represents the control without any thrombin, the bracket 2 with 
thrombin for 1h, in the bracket 3 for 3 hours and in the bracket 4 overnight. Thrombin cleavage was performed 
under different pH conditions: pH = 6 in lines a, pH = 6.8 in lines b and pH = 7.7 in lines c. 
 
  The  cleaved  TBK1_ULDs  was  separated  from  the  GST  tag  using  size-exclusion 
chromatography. Monitoring the absorbance at 280 nm on a Superdex S75 column, one small 
monodispersed  peak  eluted  at  approximately  90  mL,  corresponding  to  a  molecular  mass  of 
around  10  kDa  following  the  calibration  measurements,  which  matches  with  the  size  of 
TBK1_ULDs.  A  broad  peak  eluting  close  to  the  dead  volume  contained  uncleaved 
GST_TBK1_ULDs as well as cleaved GST (Figure 12A). 
 
 
Figure 12: Purification of GST_TBK1_ULDs. The elution profile of GST_ULDs purification by size 
exclusion chromatography with a Superdex S75 after thrombin cleavage is represented in A. The void volume elutes 
around 45 mL and corresponds to elution fractions 1 to 5. The cleaved GST is a dimer in solution with a molecular 
size of around 56 kDa eluting at 60 mL. The peak 18 corresponds to an elution around 90 mL, which is correlated to 
a  molecular  size  of  10  kDa.  The  SDS-PAGE  profile  of  the  elution  peaks  in  A  is  illustrated  in  B.  The  line  1 
represents the first elution fraction corresponding to the void volume. The lines 2 to 5 and the lines 6 to 10 represent 
the elution fractions corresponding to the peaks eluting from 45 to 60 mL and around 80 mL, respectively. 
           Results 
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  SDS-PAGE confirmed that each peak eluting as the expected molecular mass corresponds to 
GST_TBK1_ULDs, GST or TBK1_ULDs. The examination of the fraction elutions containing 
TBK1_ULDs did not reveal the presence of any contaminants (Figure 12B). Pure samples were 
then concentrated to a volume of 300 µL for NMR measurements. During the concentration 
steps, some precipitation was already observed using 1.5x gel filtration buffer (GFB) II buffer at 
pH  8.6.  TBK1_ULDs  was  concentrated  in  different  buffer  compositions  and  with  different 
additives (arginine/glutamic acid, NaCl, MgCl2, CHAPS, glycerol, pH and phosphate) to reduce 
the appearance of aggregates in the samples. By comparing the amount of soluble TBK1_ULDs 
present to the total amount of protein signal in a SDS-PAGE, the best conditions potentially 
suitable for NMR for TBK1_ULDs were found to be 50 mM Tris, 50 mM arginine/glutamic acid 
at  pH  7.2.  The  presence  of  other  additives  did  not  show  any  improvements  in  the  final 
concentration of the protein (Figure 13). 
 
Figure 13: Optimization of buffer conditions for 
ULDs. The line 1 is the reference conditions in 1.5x GFB II 
buffer at pH 8.6. In A, the pellet was resuspended with 50 mM 
Tris and 0.1% SDS, in B with 50 mM Tris, in C with 50 mM 
Tris and 50 mM arginine/glutamic acid, in D with 50 mM Tris 
and 500 mM NaCl, in E with 50 mM Tris and 10 mM MgSO4 
and  in  F  with  PBS  buffer  at  pH  7.5.  t  represents  the  total 
fraction and the s the soluble fraction. 
 
 
  In parallel, mutations have been introduced in TBK1_ULDs. None of these new constructs 
where residues from N- and C- terminal region were substituted (PF3,5EE; VL10,11AD; V14D; 
F18D; P H91,92EE; L RR88,90,93RQD)  as  well  as  residues  close  to  the  hydrophobic  patch 
(Y29D; I30D; Y33D) improved the protein solubility. Precipitations after cleavage were even 
worse than for the wild type, some mutants did not let the GST-tag to be cleaved by the thrombin 
protease and some of the constructs did not even express. 
  TBK1_ULDs was also expressed under NusA expression vector but, even if an increase of the 
expression level was observed, NusA_TBK1_ULD was present almost exclusively in inclusion 
bodies. Extraction and resolubilisation tries did not allow to isolate and purifythe target protein 
(results not shown). 
  Even  though  less  than  1  mg  of  pure  TBK1_ULDs  under  GST  expression  per  liter  of 
expression were obtained, the yield provided enough material to perform NMR experiments. 
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6.1.2.  Secondary structure determination 
6.1.2.1.  Optimization of NMR conditions 
  After  the  first  expression  and  purification  tries,  a  proton  NMR  (
1H  NMR)  spectrum  of 
TBK1_ULD was recorded in 1.5x GFB II buffer at pH 8.6 at 298K. Peaks in the low and high 
field  regions  were  sharp  and  showed  a  good  chemical  shift  dispersion  indicating  for  a 
well-folded protein (Figure 14). 
 
Figure 14: 
1H NMR spectra of TBK1_ULD. The good dispersion from the protons signals, both for 
amino (A) and methyl groups (B) of TBK1_ULD, is an indication for a well-folded protein. 
 
  A first [
15N, 
1H] TROSY-HSQC was recorded under the same conditions. 76 well-dispersed 
peaks on an expected total of 94 were observed but with line broadening, several centers and 
different line-shape (Figure 15). Even though the protein is folded in these conditions, the shape 
of the peaks was not ideal to perform further NMR experiments. According to the screening 
conditions of TBK1_ULD purification, the amount, the shape and the dispersion of TBK1_ULD 
resonances in [
15N, 
1H] TROSY-HSQC spectra were monitored under these different conditions.  
 
 
Figure  15:  [
15N, 
1H]  TROSY-HSQC  of  TBK1_ULD.  The  first  NMR  spectrum  recorded  for 
TBK1_ULD revealed a nice peak dispersion illustrating a well-folded protein but the presence of broad peaks with 
several centers  (F84 in the zoomed box) reveals some dynamics in TBK1_ULD.           Results 
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  By adding salt (up to 400 mM NaCl) in the sample, ten more signals were then observable 
and some of the peaks presenting several centers disappeared but the peaks were still broad. 
Adding progressively CHAPS to the reference spectrum of TBK1_ULD, although some peaks 
became sharper and a diminution of double peaks could be noticed, no real improvement was 
detectable (results not shown). 
 
 
Figure 16: [
1H, 
1H] NOESY spectrum of TBK1_ULD. The 
presence  of  several  NOESY  cross-peaks  confirmed  that  TBK1_ULD  in 
these conditions was a well-folded and globular protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  After several attempts, the best conditions for TBK1_ULD were established as 50 mM Tris, 
50 mM arginine/glutamic acid at pH 7.2. The [
15N, 
1H] TROSY-HSQC spectrum of the isolated 
domain (amino acids 302 to 383) showed a chemical shift dispersion that is indicative of a 
well-folded and globular domain and the rich NOESY spectrum confirmed the folding of the 
protein  (Figure  16).  Unfortunately,  no  good  “structural  NMR”  samples  with  at  least  a 
concentration of 0.5 mM and stable for more than 3 days could be produced. Due to these 
conditions,  the  secondary  structure  of  the  potential  ULD  domain  of  TBK1  has  been  later 
determined  only  with  calculations  based  on  the  assignment  of  the  chemical  shift  values  of 
TBK1302-383.   
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6.1.2.2.  Assignment 
  For the sequential assignment, HNCA, HNCACB, 
15N-separated 3D-NOESY, 
15N-separated 
3D-TOCSY as well as homonuclear 2D-TOCSY and 2D-NOESY spectra were measured on 
Bruker Avance spectrometers operating at proton frequencies between 500 and 800 MHz. Using 
this standard approach, good peak connectivities were observed for sequential assignment but 
only around 40% of the resonances could be assigned at this point. 
  To  complete  the  assignment,  selective  labeling  was  used.  Different  samples  with  labeled 
lysine, leucine, isoleucine or phenylalanine were prepared. For each selectively labeled amino 
acid, the expected number of peaks corresponding to the number of residues of this type in 
TBK1_ULD was present in the [
15N, 
1H] TROSY-HSQC spectrum except for one leucine. These 
cross-peaks overlayed with the cross-peaks present in the fully labeled sample (Figure 17A). 
With the help of selective labeling, most of the backbone assignment (90%) was achieved with 
this method (Figure 17B). 
 
Figure  17:  Assignment  of  TBK1_ULD.  The  overlay  of  the  representive  region  of  [
15N, 
1H] 
TROSY-HSQC  spectra  of  TBK1_ULD  using  selective  labeling  with  lysine  (blue),  leucine  (green),  isoleucine 
(yellow) and phenylalanine (purple) is shown in A. The representation of [
15N, 
1H] TROSY-HSQC spectrum of 
TBK1_ULD with the full assignment of the amide resonances of TBK1_ULD is represented in B. 
 
6.1.2.3.  Secondary structure calculation 
  Analysis of the secondary structure elements with the programs TALOS
142 and CSI,
141 based 
on the 
13C
α, 
13C
β, 
13CO and 
1H
α chemical shifts, identified one long α-helix and five β-strands. 
As a consensus between the two predictions, the α-helix contains the residues A332 to Q342, the 
first β-strand the residues M309 to S315, the second β-strand the residues M319 to I326, the 
third β-strand the residues E351 to Y354, the fourth β-strand the residues R358 to R361 and 
finally the fifth β-strand the residues P378 to L384. In addition to these main structural features, 
the chemical shifts indicated, only for TALOS prediction, a short helical segment between amino           Results 
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acids A367 and H369 that corresponds to the 310-helix of ubiquitin (Figure 18A). The secondary 
structure elements of TBK1_ULD have the same sequential arrangement (ββαββαβ) and the 
same length as the corresponding secondary structure elements in ubiquitin proving that TBK1 
belongs to the ULD superfamily. Despite these structural similarities between the ULD and 
ubiquitin, differences exist in their dynamic behavior. Interestingly, the whole β-sheet and in 
particular  the  two  β-strands  in  TBK1_ULD  corresponding  to  β-strand  1  and  β-strand  3  in 
ubiquitin  exhibit  broad  resonances  with  several  maxima,  which  is  characteristic  for 
conformational exchange processes. Being plotted on the ubiquitin three-dimensional structure, 
these residues form a well-defined surface (Figure 18B).  
 
 
Figure 18: Secondary structure of TBK1_ULD. The alignment of the secondary structure prediction 
from TALOS and CSI softwares (A) confirmed the ULD fold in TBK1 with the presence of the secondary structure 
motif  ββαββ  followed  by  one  short  α-helix  and  one  β-strand.  The  residues  of  TBK1_ULD  presenting  broad 
resonances in NMR spectra are plotted on the structure of ubiquitin depending of their intensity (peaks with several 
maxima in red, normal peak in green). 
 
 
6.1.3.  Tertiary structure determination 
  The low solubility and the tendency to aggregate (highest reachable concentration around 0.2 
mM with only a stability of approximately 2 days) for all tested fragments did not allow to 
perform a complete assignment nor to calculate a high-quality 3D structure for TBK1_ULD. 
Nevertheless,  using  proton  assignments  from  the  3D 
15N-NOESY  and  the  2D 
1H-NOESY 
spectra, some side chains resonances were also assigned with the help of the topology similarity 
between ubiquitin and TBK1_ULD. It was thus possible to calculate a preliminary structural Results   
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model of TBK1_ULD with the use of the hydrogen bonds observed in the X-ray structure of 
ubiquitin (PDB: 1UBQ)
144 transposed to the sequence of TBK1_ULD. 
 
 
Figure 19: NMR Structure of TBK1_ULD. Left: overlay of the backbone atoms of the 20 energy-refined 
conformers of TBK1_ULD. Loops are shown in gray, α-helices in green and cyan and β-strands in magenta. Right: 
the mean structure of the complex is presented as a ribbon diagram with annotation of the secondary structure 
elements. 
 
  The 3D structure of TBK1_ULD confirmed the secondary structure elements predicted by 
CSI and TALOS: ULD of TBK1 adopts an ubiquitin like (β-grasp) fold. In the ββαββ core, the 
four β-strands form a mixed β-sheet ordered β2-β1-β5-β3 where β1 (M309 to S315) and β5 
(N377 to S383) are parallel but anti-parallel to β2 (M319 to I326) and β3 (E351 to Y354). The 
first  α-helix  contains  the  residues  from  A332  to  Q342  and  connects  β2  and  β3  to  form  a 
right-handed β-α-β unit. The second α-helix, longer than the one predicted by TALOS and CSI, 
starting from L363 and finishing with H369 is present outside of the ubiquitin core (Figure 19 
and structural statistics in Appendix 9.5). Finally, around I353 is concentrated several residues 
with hydrophobic side groups forming a large hydrophobic patch on the surface of TBK1_ULD 
(Figure 20). 
 
Figure  20:  NMR  structure  of 
TBK1_ULD and ubiquitin. The surface 
representation  shows  TBK1_ULD  (left)  and 
ubiquitin  in  (right).  Hydrophobic  residues 
(leucine, isoleucine, valine, phenylalanine and 
tyrosine) are in black, other residues in wheat. 
I353  in  TBK1_ULD  and  I44  in  ubiquitin, 
center  of  the  hydrophobic  patch  in  both 
proteins are colored in yellow. 
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  The superposition of TBK1_ULD structure with the structure of ubiquitin showed strong 
similarities with a global RMSD of 3 Å, reduced to 1.5 Å when only the structured region 
(α-helices and β-strands) are taken in account. Some differences are still observed like the fourth 
β-strand predicted (R358 to R361), which is not structured like it is in the case of ubiquitin 
(Figure 21). 
 
Figure  21:  Overlay  of  the  NMR  structures  of  TBK1_ULD  and  ubiquitin.  TBK1_ULD  is 
represented in the same colors than in Fig. 18, ubiquitin is in gold. Left: Overlay of the full structures. Right: Zoom 
on β-strand 4 of TBK1_ULD, equivalent to β-strand 5 in ubiquitin in (top) and on α-helix 2 in (bottom). 
 
6.1.4.  Expression and purification of IRF3 
  Three different constructs under the GST expression system were provided by Dr. Fumiyo 
Ikeda to confirm by NMR the interaction of the interferon regulatory factor association domain 
(IAD) of interferon regulatory factor 3 (IRF3) with TBK1_ULD by NMR. The first construct, 
GST_IAD,  contained  strictly  the  IAD  domain  (residues  190  to  384).  The  second  construct, 
GST_IAD-SRR, is an extension of IAD until the C-terminal of IRF3 (residues 190 to 427) 
including the serine rich region (SRR). The last construct, GST_IRF3, is the full IRF3 (residues 
1 to 427). First attempts were performed on GST_IAD, which showed nice expression after 3 
hours  induction  at  37°C  with  1  mM  IPTG.  A  fast  degradation  was  already  observed  by 
SDS-PAGE  with  the  appearance  of  multiple  smaller  bands  in  the  cell  lysate  fraction  in 
comparison to the expression fraction. No protein were detected in the elution fraction from the 
GST purification (Figure 22). 
  The second tries were done with the GST_IAD-SRR construct. Here, the expression yield was 
still good even though lower than for GST_IAD under the same conditions. In this case, it was 
possible  to  detect  GST_IAD-SRR  in  the  elution  fractions  (Figure  22).  To  remove  the  GST 
moiety,  analytical  cleavage  of  GST_IAD-SRR  with  thrombin  protease  was  performed.  The 
cleavage rate was very low even by increasing amounts of thrombin protease, changing the 
temperature or increasing the time of incubation. Moreover, because of the similar size of GST 
and IAD-SRR (≈ 26 kDa), cleaved IAD-SRR was not distinguishable from the GST moiety by Results   
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SDS-PAGE. GST is a dimer in solution so size-exclusion chromatography should separate the 
cleaved IAD-SRR from the GST moeity was loaded. Gel filtration results were not clear but the 
elution fractions that should correspond to pure IAD-SRR were collected and concentrated for 
NMR titration experiments (results not shown). 
 
Figure  22:  Isolation  of  GST_IAD  and  GST_IAD-SRR.  For  the  isolation  of  GST_IAD  on  a 
glutathione sepharose column (left), the line 2 represents the non-induced GST_IAD, the line 3 the final expressed 
protein, the line 4 the cell lysate, the line 5 the flow-through and the lines 6 and 7 the elution fractions (The line 1 
represents tetra ubiquitin, not related to GST_IAD purification). For the isolation of GST_IAD-SRR (right), the line 
1 represents the non-induced GST_IAD-SRR, the line 2 the final expressed protein, the line 3 the cell lysate, the line 
4 the flow-through, line 5 the washing step and the lines 6 and 7 the elution fractions. 
 
  To overcome the problem of separating GST from IAD-SRR, a NusA expression vector was 
used. The expression yield was sufficient at 37°C for 3 hours with 1 mM IPTG but isolation on 
Ni-NTA column showed that half of NusA_IAD-SRR did not bind to the nickel matrix and was 
found  in  the  flow-through.  Cleavage  with  TEV  protease  of  both  elution  and  flow-through 
fractions  from  the  Ni-NTA  purification  provided  IAD-SRR  products.  After  purification  by 
size-exclusion chromatography, IAD-SRR was found in the void volume and no protein was 
found at the elution time expected for a protein of around 25 kDa (Figure 23). The attempts to 
concentrate anyway the eluted IAD-SRR failed with the fast appearance of precipitation. 
  Because of the unsuccessfull purification with the two previous contructs, GST_IRF3 was 
also used even though the size of IRF3 could be problematic for NMR titration experiments. 
Using the same expression protocol as for GST_IAD-SRR, GST_IRF3 expression yield was 
lower and some proteolytic cleavage was already observable during the first purification steps 
(results not shown). These results were not favorable to continue with this construct in addition 
to the size of IRF3, which could be a disadvantage for further studies by NMR.           Results 
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Figure  23:  Isolation  and p urification  of  NusA_IAD-SRR.  NusA_IAD-SRR  was  isolated  on  a 
Ni-NTA column. Line 1 represents the non-induced NusA_IAD-SRR, the line 2 the final expressed protein, the line 
3 the cell lysate, the line 4 the flow-through, and the line 5 the elution fractions. After cleavage by TEV protease, the 
protein was purified by size-exclusion chromatography. The line 6 represents the void volume, the line 7 the fraction 
eluting at 42 mL (75 kDa) and the line 8 the fraction eluting at 80 mL (25 kDa). 
 
  Finally, in order to get some complementary information on TBK1_ULD interaction with 
IRF3, an uncleaved GST_IAD-SRR sample was purified for further experiments. Even though 
the purity was not total, the sample was used anyway for primary information. 
 
6.1.5.  Interaction studies of TBK1_ULD/IRF3_IAD-SRR 
  First NMR titration experiments were performed using uniformly 
15N labeled TBK1_ULD 
and unlabeled IAD-SRR. Due to purification issues and fast degradation of IAD-SRR, it was 
only possible to study this interaction with few titration steps. After addition of IAD-SRR to 
15N_TBK1_ULD at molar ratio of 1:1/2, 1:1 and 1:2 (TBK1_ULD:IAD-SRR), two main effects 
were  observed  upon  the  titration.  First  effect,  several  residues  were  strongly  affected  by 
chemical  shift  perturbations  (CSP)  indicating  intermolecular  interactions  in  a  fast  exchange 
mode.  This  effect  was  well  observed  for  residues  L352  and  Y354  that  are  present  in  the 
hydrophobic  patch  of  TBK1_ULD  but  also  for  residues  L352  and  F380.  Second  effect,  the 
appearance of new peaks in the spectra caused by the possible formation of a tight complex 
between the two proteins. No experiments for the assignment of TBK1_ULD in presence of 
IAD-SRR  were  done,  so  it  was  impossible  to  know  to  which  residues  correspond  the  new 
resonances.  Nevertheless,  resonances  corresponding  to  residues  K331  and  I353  showed  a 
decreased of the intensity. In the meantime, new peaks appeared but not close to the peaks 
disappearing during titration. The number of appearing peaks being higher than the disappearing 
ones, it seems that several TBK1_ULD residues are present in solution in two states, free and 
bound to IAD-SRR (Figure 24).  Results   
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Figure 24: Interaction of TBK1_ULD with IRF3_IAD-SRR. The overlay of representative regions 
of [
15N, 
1H] TROSY-HSQC spectra from TBK1_ULD in presence of IRF3_IAD-SRR with different molar ratio, 1:0 
(red), 1:1/2 (yellow), 1:1 (green) and 1:2 (blue) is shown. While in (A) the full spectrum is illustrated, (B) and (C) 
represent different regions where CSP as well as disappearance/reappearance of peaks are observed. 
 
  Being plotted on the TBK1_ULD molecule, those perturbations appeared on both side of the 
molecule. Even though the residues affected the strongest are more preferentially situated on the 
TBK1_ULD side where the β-strands are localized, several residues from the α-helices present 
also  strong  CSP  upon  titration  with  IAD-SRR  of  IRF3  (Figure  25).  The  TBK1_ULD/IRF3 
interaction seems therefore to be a more complex process than a 1 to 1 binding model. 
 
 
Figure  25:  Interaction  surface  of  IAD-SRR  on  TBK1_ULD.  The  residues  of  TBK1_ULD  are 
represented under differents colors depending on the strength of their perturbation due to the presence of IAD-SRR. 
In red are represented the residues presenting two-states or strong chemical shift perturbations, in yellow residues 
with small perturbations and in grey residues not affected by the presence of IAD-SRR. 
 
  To  monitor  this  interaction,  a  second  experiment  was  performed  by  titrating  uncleaved 
GST_IAD-SRR against TBK1_ULD in order to overcome the issue of IAD-SRR purification. 
Almost every peak disappeared or decreased significantly during the titration due to the slow           Results 
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tumbling effect of the big complex formed by GST_IAD-SRR/TBK1_ULD. V310 and D390, 
present at the N- and C-terminal regions of TBK1_ULD, were the only visible residues at the 
end of the titration, because they could have a faster tumbling effect than the rest of the complex 
(Figure 26). 
 
 
Figure 26: NMR titration of GST_IAD-SRR against TBK1_ULD.  The  reference  spectrum  of 
TBK1_ULD (red) shows a nice peak dispersion for all residues of the protein. In presence of GST_IAD-SRR at a 
molar ratio 1:1 (green), most of the resonance peaks are still present but with a decrease of intensity coupled to 
small chemical shift perturbations. At a molar 1:2, most of the peaks disappeared. Only V310 and D390 are still 
visible. 
 
 
6.2. Autophagy project 
6.2.1.  Expression and purification of MAP1LC3 proteins 
 
Figure  27:  Expression  and  purification  of  GST_MAP1LC3  proteins.  The  expression  of  the 
different  MAP1LC3  proteins  fused  to  GST  are  represented  in  (A).  The  (-)  and  (+)  symbols  represent  the 
non-induced and the final expression state for each protein, respectively. The lines A, B, 1 and 2 corrrespond to 
LC3A,  LC3B,  GABARAPL-1  and  GABARAPL-2  proteins,  respectively.  The  expression  and  the  purification 
profiles of GST_GABARAPL-1 are shown in (B). The line 1 represents the non induced protein, the line 2 the final 
expression, the line 3 the pellet of the cell lysate, the line 4 the cell lysate, the line 5 the flow-through of the 
glutathione sepharose column, the line 6 the elution fraction, the line 7 the elution fraction with thrombin protease 
after 16 hours and the line 8 after 64 hours. After 64 hours cleavage action of the thrombin protease, the elution 
fraction was purified by size-exclusion chromatography on a Superdex 75 column. The line 9 represents the elution 
corresponding to the void volume, the line 10 the elution fraction after 55 mL and the line 11 the elution fraction 
after 75 mL. 
 
  The  different  sequences  provided  by  Dr.  Vladimir  Kirkin  and  Dr.  David  McEwan  were 
cloned into pGEX-4T1 expression vectors with a deletion of the C-terminus including the last Results   
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glycine  residue  to  avoid  any  possible  conjugation  (sequences  listed  in  Appendix  9.1).  All 
constructs (GST-GABARAPL-1, GST-GABARAPL-2, GST-LC3A and GST-LC3B) could be 
expressed nicely upon screening conditions where the best temperature, the IPTG concentration 
and  the  duration  of  expression  were  tested.  The  ideal  conditions  found  were  3  hours  of 
expression  at  37°C  with  1  mM  IPTG  (Figure  27A).  GST-fusion  proteins  were  isolated  by 
glutathione  affinity  chromatography,  cleaved  by  thrombin  protease  and  purified  through 
size-exclusion chromatography following the same protocols as described for the TBK1_ULD 
project. Even though the cleavage was more successful than for the previous project, a large 
amount of uncleaved protein was still present in solution. The use of more thrombin protease for 
proteins expressed on a large scale was not the best economic solution (Figure 27B).  
  DNA fragments coding for the different MAP1LC3 proteins were cloned into the expression 
vector  pETM-60.  This  vector  presents  the  NusA  protein  to  enhance  the  expression  of  the 
His6-tagged recombinant proteins fused to the C-terminus of NusA through a TEV protease 
cleavage site recognition sequence. The analytical expression of these new constructs presented 
higher expression yield than for the GST constructs under the same conditions, 3 hours at 37°C 
with 1 mM IPTG (Figure 28). After expression, cells were harvested and the resuspended pellet 
was lysed. The cell lysate was then loaded onto a Ni-NTA affinity column where the NusA 
constructs bind through the His6-tag prior to the TEV cleavage site. The flow-through did not 
contain any of the proteins of interest. The elution fractions were collected and cleaved by TEV 
protease  using  standard  protocols.  Cleavage  rate  with  TEV  protease  was  maximal  and  pure 
proteins  in  a  high  yield  were  more  easily  obtained  than  in  case  of  GST  based  constructs. 
MAP1LC3  proteins  were  then  separated  from  the  NusA  tag  and  the  uncleaved  protein  by 
ion-exchange chromatography followed by size-exclusion chromatography (Figure 28). Each 
MAP1LC3  protein  was  eluted  monodispersly  around  80  mL  on  a  Superdex  S75  column 
corresponding to a molecular size of approximately 14 kDa, the average molecular size of these 
proteins.  MAP1LC3  proteins  were  also  obtained  from  Ub-constructs  with  the  procedure 
described in chapter 6.3.2.  
 
Figure  28:  Expression  and  purification  of 
NusA_LC3B. The line 1 represents the non induced protein, the 
line 2 the final expression, the line 3 the cell lysate, the line 4 the 
flow-through  of  the  NiNTA  purification,  the  line  5  the  elution 
fraction, the line 6 the elution fraction after action of TEV protease, 
the lines 7, 8 and 9 the flow-through of the IEC after action of TEV 
protease and the line 10 the elution of the IEC. 
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  Based on the protocols used by different groups to determine the structures of some Atg8 and 
MAP1LC3 proteins by NMR, a 25 mM sodium phosphate and 100 mM NaCl buffer solution at 
pH 7.3 was first used. The purity of the size-exclusion chromatography elution fractions was 
checked upon SDS-PAGE and samples could be concentrated for NMR and ITC applications 
until  1  mM  (40  mg  for  1L  expression  of  protein  fused  to  NusA)  without  noticing  any 
precipitation. The  first  NMR  samples  showed  nicely  shaped  resonance  peaks  in a  [
15N, 
1H] 
TROSY-HSQC spectrum and a similar dispersion pattern compared to the [
15N, 
1H] TROSY-
HSQC spectra published in the biological magnetic resonance bank (BMRB) database for the 
corresponding proteins. By performing some slight adjustments in the buffer conditions (50 mM 
sodium phosphate and 100 mM NaCl at pH 7.0), the broadening of the peaks was reduced. These 
new conditions were chosen as a reference buffer for NMR and ITC. 
 
6.2.2.  Expression and purification of peptides containing LIR motifs 
 
Figure  29:  Expression  and  isolation  of  NBR1-LIR  constructs.  The  analytical  expression  of 
NBR1-LIR is shown in (A). Both constructs were expressed under a GST expression vector for 3 hours at 37°C after 
induction with 1 mM IPTG. The isolation profile of GST_NBR1l is shown in (B). The line 1 represents the cell 
lysate, the line 2 the flow-through and the line 3 the elution fraction of GST_NBR1l on a glutathione sepharose 
column. The cleavage of GST_NBR1l is shown in (C). The line 1 represents the elution fraction of GST_NBR1l on a 
glutathione sepharose  column and the line 2 this elution fraction after cleavage with thrombin protease. 
 
  Plasmids coding for peptides containing LIR motifs were cloned under pGEX-4T1 expression 
vectors.  Dr. Vladimir Kirkin provided generously constructs containing the coding sequence of 
NBR1-LIR  protein  with  different  lengths  varying  from  46  to  276  amino  acids  (NBR1short 
(residues  718-763),  NBR1long  (residues  718-802),  NBR1874  (residues  691-874)  and  NBR1966 
(residues 691-966)). The two shorter versions of NBR1, GST_NBR1short and GST_NBR1long, 
expressed nicely in a soluble form as well at 37°C as at 22°C (Figure 29). After purification by 
glutathione affinity chromatography, first attempts showed a good cleavage rate by thrombin 
protease but only the GST moiety was observable and no peptide. Because of their small sizes, 
NBR1short  and  NBR1long  peptides  were  not  seen  on  SDS-PAGE  (Figure  29)  even  with a  Results   
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SDS-PAGE  containing  18%  polyacrylamide.  Even  passed  through  size-exclusion 
chromatography, no reasonable peaks were detected at 280 nm. The bigger constructs, NBR1874 
and NBR1966, expressed also nicely under the same conditions but the cleavage was not total and 
proteins were not easily detectable (results not shown). Nevertheless, the uncleaved constructs 
were very stable in solution. GST_NBR1874 and GST_NBR1966 being potentially too big for 
further NMR interaction studies, these constructs were purified for Dr. Vladimir Kirkin for his 
first interaction tries using Surface Plasmon Resonance. 
  In the meantime, the project using ubiquitin as an expression vector was initiated. Using 
peptides containing LIR motif were a good target for a proof of concept. Thus NBR1-LIR wild 
type and NBR1-LIR_Y732W peptides produced from Ub constructs were also used for structural 
and interaction studies. These expression and purification protocols are precisely described in 
chapter 6.3.3. 
  Finally for the last titration experiments, mutated NBR1-LIR peptides (NBR1-LIR_Y732F, 
NBR1-LIR_S729E and NBR1-LIR_S728,729E) were used as chemically synthesized peptides 
for time reason (peptidic sequences are listed in the Appendix 9.2). 
 
6.2.3.  Interaction Atg8/LIR 
6.2.3.1.  LC3B vs. LIRs 
6.2.3.1.1.  LC3B vs. p62-LIR 
LC3B vs LIR 
ΔH 
kcal mol
-1 
ΔS 
cal mol
-1 K
-1 
ΔG 
kcal mol
-1 
Kd 
µM 
p62  -10.5  -8.7  -8.0  1.5 
Nix_W36  -2.7  +9.4  -5.5  91 
Nix_W140/144  -2.8  +5.0  -4.3  670 
NBR1  -4.4  +10.7  -7.6  2.9 
Table 4: Thermodynamic parameters obtained by ITC for the interaction of LC3B with 
different LIR domains.  
All experiments were performed at 25°C. ΔH, ΔS and Kd values were measured with the assumption of a one site 
model.  Statistical  errors  for  all  calculations  were  quite  small  (below  3%)  and  the  uncertainty  of  the  sample 
concentrations was approximately 5% (or more in case of peptides containing no tryptophan or tyrosine residues). 
Therefore, a total error of 10% for all parameters could be expected. 
 
  The interaction of LC3B with p62-LIR was already well characterized on a structural level in 
the  literature  showing  a  strong  binding
87;  103  and  was  consequently  used  in  this  project  as 
reference for the interactions of MAP1LC3 proteins with the LIR motifs of autophagy receptors.           Results 
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  ITC experiments revealed a strong binding affinity for the LC3B/p62-LIR interaction with a 
Kd of 1.5 µM. Whereas the strong negative enthalpy (ΔH = -10.5 kcal mol
-1) plays in favor of 
binding, the contribution of negative entropy (ΔS = -8.7 cal mol
-1 K
-1) is unfavorable, resulting in 
a free energy ΔG of -7.9 kcal mol
-1 (Table 4 and raw data in 9.3). 
 
  By NMR, p62-LIR titration against LC3B revealed a typical strong interaction in a slow 
exchange mode, where the two peaks corresponding to the “free” and “bound” states could be 
observed for each HN resonance of LC3B residues affected by the presence of p62-LIR. The 
intensity of each peak is proportional to the population of free LC3B and LC3B bound to the 
p62-LIR peptide in solution (Figure 30).  
 
 
Figure 30: LC3B interaction with p62-LIR. The overlay of representative regions (left for F52, middle 
for  K51  and  V58  and  right  for  V54)  in  [
15N, 
1H]  TROSY-HSQC  spectra  of  LC3B  in  presence  of  p62-LIR  is 
represented. Contours are presented in different colors corresponding to individual titration points (red as reference 
with LC3B alone and in presence of p62-LIR at different molar ratio: orange 1:1/8, yellow at 1:1/4, coral at 1:1/2, 
pink at 1:3/4, gray at 1:1, cyan at 1:2, magenta at 1:5 and purple at 1:10). 
 
  Although  almost  every  peak  is  affected  in  this  two-state  transition,  the  CSP  are  more 
important (up to 0.6 ppm) concerning residues involved in the formation of hp1 for L53, of hp2 
for V58 and L63 or close to these pockets for R24, Q26, H27, V33, F52, V54 and N59 (Figure 
31A). Because of this two-state transition for almost all resonances, no dissociation constant 
could  be  calculated  based  on  the  chemical  shift  dispersion.  Nevertheless,  due  to  the  slow 
exchange  mode  characterized  during  this  interaction,  a  dissociation  constant  in  the  low 
micromolar  range  is  expected.  Being  mapped  on  the  LC3B  structure,  the  resonances  with 
meaningful CSP form not a localized surface but the whole volume of the molecule, indicating 
specific  differences  in  structural  or  mobility  properties  between  free  LC3B  and  LC3B  in 
complex with p62-LIR (Figure 31B). Results   
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Figure 31: Interaction of LC3B with p62-LIR. The CSP of LC3B in presence of p62-LIR are shown in 
(A) and are plotted on the structure of LC3B (PDB: 2K6Q) in (B). The residues presenting a double-state transition 
are colored in red and the residues, which did not show CSP or very small ones are in grey.  
 
 
6.2.3.1.2.  LC3B vs. Nix-LIRs 
   
Figure 32: LC3B interaction with Nix-LIRs. The overlay of representative regions (left for F52, middle 
for  K51  and  V58  and  right  for  V54)  in  [
15N, 
1H]  TROSY-HSQC  spectra  of  LC3B  in  presence  of  different 
Nix-LIR_W36 ( A)  and  Nix-LIR_W140/144  (B)  is  represented.  Contours  are  presented  in  different  colors 
corresponding to individual titration points (red as reference with LC3B alone and in presence of LIRs at different 
molar ratio: orange 1:1/8, yellow at 1:1/4, coral at 1:1/2, pink at 1:3/4, gray at 1:1, cyan 1:2, magenta at 1:5 and 
purple at 1:10). For Nix-LIR_W140/144 against LC3B, only the experiments representing the molar ratio 1:0, 1:1/2, 
1:1, 1:2 and 1:10 were performed and for NBR1-LIR, the last titration point is at molar ratio 1:5.  
 
  In Nix, two potential LIR domains have been identified, around W36 and around W140/144. 
Both Nix-LIR domains have a significantly weaker interaction  with LC3B than p62-LIR (Kd of 
91 µM for Nix-LIR_W36 and around 700µM for Nix-LIR_W140/144). This weaker interaction 
is also reflected by a less negative binding enthalpy (ΔH = -2.7 kcal mol
-1 for Nix-LIR_W36 and 
ΔH = -2.8 kcal mol
-1 for Nix-LIR_W140/144) but the positive entropy (ΔS = 9.4 cal mol
-1.K
-1 for 
Nix-LIR_W36 and ΔS = 5.0 cal mol
-1 K
-1 for Nix-LIR_W140/144) contributes to the binding.           Results 
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The free energy for both interactions is similar (ΔG =-5.5 kcal mol
-1 for Nix-LIR_W36 and ΔG = 
-4.3 kcal mol
-1 for Nix-LIR_W140/144) but less negative than for LC3B/p62 (Table 4 and raw 
data in Appendix 9.3).  
  The NMR titration of LC3B with the Nix-LIR_W140/144 peptide showed an interaction in a 
fast  exchange  mode.  For  each  titration  step,  sharp  peaks  were  observed  for  each  residue 
resonance, shifted from its previous position with almost no decrease of the peak intensity until 
reaching almost a complete saturation. The overall CSP in this case are smaller, indicating a 
weaker binding of this peptide to LC3B. The residues from LC3B that are the most affected are 
the ones present in α-helix 2 (R24, Q26 and H27), in β–strand 1 (I35), in β–strand 2 (K51, F52, 
L53 and V54) and in α-helix 3 (I67) (Figure 32A). 
  The  NMR  titration  of  LC3B  with  Nix-LIR_W36  peptide  represented  a  fast  (close  to 
intermediate) exchange mode. Here the affected peaks are shifted with a decrease of the peak 
intensity  at  the  initial  stages  of  the  titration  and  a  following  increase  near  the  complete 
saturation. The residues showing the strongest CSP are localized in the structured region of 
LC3B like I34 and R37 from β–strand 1, R69 and R70 from α-helix 3, L82 and G85 from 
β-strand 3 or I95 and E97 from α-helix 4. For some of the peaks, after decrease of the peak 
intensity, no reappearance of the peaks was noticed in the neighborhood even for a ten times 
molar excess of the peptide in molar ratio. This effect was seen for the residues belonging to 
α-helix 2 (R24, E25, Q26, H27 and T29), to β-strand 1 (V33 and I35), to β-strand 2 (T50, K51, 
F52, L53 and V54) and to α-helix 3 (L63, I64, I66, I67 and L71), which were also the residues 
the most affected in the titration of Nix-LIR_W140/144 against LC3B (Figure 32B). The values 
of the CSP are in between the ones for Nix-LIR_W140/144 and p62-LIR titration, however, the 
affected residues are generally the same. 
  Similar  to  the  LC3B/p62-LIR  interaction,  the  CSP  induced  by  both  Nix-LIR_W36  and 
Nix-LIR_W140/144 peptides envelop the whole LC3B molecule. LC3B residues participating in 
the  formation  of  the  intermolecular  β-structure  in  the  LC3B/LIR  complex  (K51,  L53)  and 
directly in contact with the two hydrophobic moieties of the LIR motif (I23, I34, K51, F52 and 
L53  for  W340;  V33,  I35,  L63,  I67  and  R70  for  L343)  are  strongly  affected.  Additionally, 
residues forming the barrier between the two hydrophobic pockets (those interacting with T341 
and H342 in p62-LIR) show strong CSP (H27, K49, R69 and R70). However, there are some 
residues shown to be in very close contacts with the hydrophobic motif of LIR but presenting 
rather small or not meaningful CSP values (D19, V20, I66 and F108). From the other hand, the 
biggest CSP values were observed for residues, which are not in direct contact with the LIR Results   
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moiety. Certain structural elements of LC3B out of hp1 and hp2, like L22, R24, E25 and Q26 in 
the α2-helix; V58 and N59 in the loop between strand β2 and α3; residues 83-87 (β3-β4 strands 
and loop in-between); residues 90-96 (beginning of α4 and loop prior it), can rather adopt a new 
conformation for a more efficient interaction with the LIR motif (Figure 33A).  
 
Figure  33:  Interaction  of  LC3B  with  Nix-LIR_W36  and  Nix-LIR_W140/144.  The  CSP  of 
LC3B in presence of Nix-LIRs are shown in (A). Individual Kd, which have been calculated from three residues 
selected to represent areas in proximity to hp1 (I34), hp2 (R70) and distant from both (G85) are represented in (B). 
The CSP are plotted on the structure of LC3B (PDB: 2K6Q) in (C). The residues are represented in different colors 
following the strength of the CSP: below 0.04 ppm in grey, between 0.04 and 0.08 ppm in yellow and above 0.08 
ppm in red. The left pictures concern the interaction of LC3B with Nix-LIR_W36 and the right ones the interaction 
of LC3B with Nix-LIR_W140/144. 
 
  An average dissociation constant of the interaction was calculated for the residues showing 
prominent deviation of their chemical shifts during the NMR titration experiments according to 
an one-site binding model. The CSP of three different LC3B residues localized either in one 
hydrophobic pocket (I34 belonging to hp1) or close to one (R70 involved in α-helix 3 and close 
to hp2) and out of it (G85 in the loop between β-strand 3 and α-helix 4) were used as an average 
representant of the different LC3B resonances. Kd values calculated from the CSP of LC3B upon           Results 
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titrations  with  Nix-LIR_W36  (100  µM)  and  Nix-LIR_W140/144  peptides  (375  µM)  are 
consistent to the ITC-derived values (Figure 33B).  
  The LC3B residues affected during these interactions with Nix-LIRs as well as with p62-LIR 
were plotted on the structure of LC3B/p62 (PBD 2K6Q)
87 following the intensity of the CSP 
(Figure  33C).  The  structure  mapping  of  LC3B  in  presence  of  p62-LIR,  Nix-LIR_W36  or 
Nix-LIR_W140/144 revealed many similarities in the residues and the regions affected by the 
interaction  of  these  peptides  with  LC3B  but  showed  differences  in  the  strength  of  the 
perturbation. 
 
6.2.3.1.3.  LC3B vs. NBR1-LIR 
  Monitoring the LC3B/NBR1-LIR interaction by ITC, a dissociation constant Kd of 2.9 µM 
with a negative enthalpy (ΔH = -4.4 kcal mol
-1) and a positive entropy (ΔS = +10.7 cal mol
-1 K
-1) 
were calculated resulting to a free energy ΔG of -7.6 kcal mol
-1 close to the one for LC3/p62 
interaction (Table 4 and raw data in Appendix 9.3).  
 
 
Figure 34: LC3B interaction with NBR1-LIR.  The  overlay  of  representative  regions  (left  for  F52, 
middle for K51 and V58 and right for V54) in [
15N, 
1H] TROSY-HSQC spectra of LC3B in presence of NBR1-LIR 
is  represented.  Contours  are  presented  in  different  colors  corresponding  to  individual  titration  points  (red  as 
reference with LC3B alone and in presence of LIRs at different molar ratio: orange at 1:1/8, yellow at 1:1/4, coral at 
1:1/2, pink at 1:3/4, gray at 1:1, cyan at 1:2, magenta at 1:5 and purple at 1:10). 
 
  The Kd obtained by ITC showed that NBR1-LIR binds stronger than both Nix-LIR to LC3B 
but still weaker than p62-LIR. NMR titration experiments of NBR1-LIR against LC3B also 
showed this tendency. In one hand, a binding pattern similar to p62-LIR interaction with a slow 
exchange mode was observed where the free and bound states are present for some residues 
(Q15 and L22 from α-helix 2, I31 and I34 from β-strand 1, K49 from β-strand 2, E62 and R69 
from α-helix 3, Y99 and S101 from α-helix 4 and L44, L47 or V58 from the loop regions). In 
the other hand, a faster exchange mode like for Nix-LIR_W36 was observed, leading to the 
disappearance of the majority of the resonances upon titration (E25 from α-helix 2, E36 and Results   
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M37 from β-strand 1, D48, F52 and D56 from β-strand 2, R69 and L71 from α-helix 3, V83 
from β-strand 3, I95, S96 and E100 from α-helix 4 and K39, H57, N59, A78, N84, H86, S97 and 
M88 from the loop region) whereas these peaks were still present at the same molar ratio for 
p62-LIR  (Figure  34).  The  co-presence  of  these  two  situations  brings  the  idea  that  LC3B 
interacts strongly with NBR1 but in an intermediate (close to slow) exchange mode. Moreover, 
these examples showed again that not only one region but also the whole of LC3B molecule is 
perturbed by the presence of a LIR domain, here from NBR1. 
 
6.2.3.2.  Other MAP1LC3 proteins vs. LIRs 
6.2.3.2.1.  LC3A vs. Nix-LIRs 
  LC3A interacts with both Nix-LIRs with dissociation constants of 28 µM and 130 µM for 
Nix-LIR_W36 and Nix-LIR_W140/144, respectively. LC3A interaction with both Nix-LIRs is 
entropy driven with a high positive entropy (ΔS = 17.9 cal mol
-1 K
-1 for Nix-LIR_W36 and ΔS = 
15.0 cal mol
-1 K
-1 for Nix-LIR_W140/144) and a reduced contribution of enthalpy (ΔH = -1.0 
kcal mol
-1 for Nix-LIR_W36 and ΔH = -0.8 kcal mol
-1 for Nix-LIR_W140/144). As for LC3B, 
the free energy of the interaction is similar for both Nix peptides (ΔG = -6.3 kcal mol
-1 for 
Nix-LIR_W36 and ΔG = -5.3 kcal mol
-1 for Nix-LIR_W140/144) and less negative than for p62 
and NBR1 peptides (raw data in Appendix 9.3).  
  By  NMR  titration,  a  fast  exchange  mode  for  LC3A  against  Nix-LIR_W140/144  and  an 
intermediate (close to fast exchange) mode for LC3A against Nix-LIR_W36 were observed as 
for LC3B. In the presence of Nix-LIR_W36, LC3A peaks are shifted up to 0.6 ppm. R24 from 
α-helix 2, T50 from β-strand 2, V58 from the hp2 and N59 and N74, both at the limit of α-helix 
3, are the residues the most affected by presence of Nix-LIR_W36. Peaks corresponding to the 
residues K51, F52 and L53, which are at the barrier of hp1 and hp2, disappeared upon titration 
(Figure 35A). Concerning Nix-LIR_W140/144 titration, the most affected peaks are T50, F52, 
V54 from β-strand 2 and part of hp2, the residues N59 and Q85 and the C-terminus of β-strand 4 
with  a  maximum  CSP  up  to  0.35  ppm.  Only  L53  disappeared  after  addition  of 
Nix-LIR_W140/144 (Figure 35B). Using the same corresponding residues than for LC3B (I34, 
R70 and Q85), dissociation constants of the interaction of LC3A with Nix-LIRs were calculated: 
Kd of 43 µM for LC3A/Nix-LIR_W36 and of 192 µM for LC3A/Nix-LIR_W140/144 (Figure 
35). 
           Results 
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Figure 35: Interaction of LC3A with Nix-LIRs. The overlay of representative regions (left for I34, 
middle for R70 and right for Q85) in [
15N, 
1H] TROSY-HSQC spectra of LC3A in presence of Nix-LIR_W36 (A) 
and  Nix-LIR_W140/144  (B),  associated  to  the  individual  dissociation  constant  calculated  for  these  residues  is 
represented. Contours are presented in different colors corresponding to individual titration points (red as reference 
with LC3A alone and in presence of Nix-LIR at different molar ratio: orange at 1:1/8, yellow at 1:1/4, coral at 1:1/2, 
pink at 1:3/4, gray at 1:1, purple at 1:1.5, cyan at 1:2, magenta at 1:5 and blue at 1:10). Three residues were selected 
to represent areas in proximity to hp1 (I34), hp2 (R70) and distant to both (Q85) in order to determine Kd of the 
interaction. 
 
6.2.3.2.2.  GABARAPL-1 vs. Nix-LIR_W36 
  In this case, only few titrations points were done, starting from molar ratio 1:1 to a five-times 
molar excess of Nix-LIR_W36. After adding Nix-LIR_W36, most of the residues located in hp1, 
hp2 or in close neighborhood presented the strongest CSP (I68, R69 and I72) or disappeared 
(M32 to V35, K50 to S57, F64, L67 and F108). The residues situated far away from these 
hydrophobic  pockets  showed  smaller  CSP  without  modification  in  the  peak  intensities  upon 
titration.  This  observation  supports  an  intermediate  (close  to  fast)  exchange  mode  for  the 
interaction of GABARAPL-1 with Nix-LIR_W36 (Figure 36). 
 
 
Figure 36: Interaction of GABARAPL-1 with Nix-LIR_W36. The overlay of representative regions 
(left for R69 and right for I68) in [
15N, 
1H] TROSY-HSQC spectra of GABARAPL-1 in presence of Nix-LIR_W36 
is  represented.  Contours  are  presented  in  different  colors  corresponding  to  individual  titration  points  (red  as 
reference  with  GABARAPL-1  alone  and  in  presence  of  Nix-LIR_W36  at  different  molar  ratio:  orange  at  1:1, 
magenta at 1:2, green at 1:3 and blue at 1:5).   
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6.2.3.3.  Specificity of NBR1-LIR 
6.2.3.3.1.  GABARAPL-1 vs. NBR1-LIR by NMR  
  The NMR spectra of a complex of LC3B with the NBR1-LIR domain revealed significant 
line-broadening  of  both  peptide  and  protein  resonances,  making  a  detailed  structural  NMR 
analysis impossible. Therefore, investigations were done to see if the interaction of NBR1-LIR 
with other MAP1LC3 proteins would result in the formation of a protein complex and to see then 
which member of the protein family provide the most favorable spectral characteristics. While 
all  of  the  investigated  family  members  (LC3A,  LC3B,  GABARAPL-1  and  GABARAPL-2) 
exhibited broad lines due to exchange-broadening, the spectra of NBR1-LIR in complex with 
GABARAPL-1  showed  the  most  favorable  spectral  characteristics  to  further  investigate  this 
interaction by NMR. 
  The  previously  described  studies  of  LC3B  interaction  with  three  different  LIR  domains 
showed three different kinetic exchange modes observable by NMR, representing three different 
interaction strengths. Interestingly in the case of GABARAPL-1 interaction with NBR1-LIR, 
almost all residues were perturbed but in the three different ways: i) CSP for residues interacting 
weakly in a fast exchange mode concerning residues not directly involved in the interaction with 
NBR1-LIR like in the loop regions or in α-helix 4 (Q97, L98, Y99 or E100); ii) presence of two 
peaks  corresponding  to  the  free  and  bound  states  for  the  residues  showing  the  strongest 
interaction in a slow exchange mode represented by the residues situated in α-helix 3 closing the 
hp2 (L67, I68, R70 or R71); iii) interaction in an intermediate exchange mode with a decrease of 
the peak intensity then an increase at an other position and finally reaching a full peak intensity 
approaching to the saturation. A majority of the GABARAPL-1 residues and more precisely the 
ones situated in the hp1 (L54) and hp2 (Y53 and L59), in α-helix 2 (E16, K24 and K28) or in the 
close neighborhood (V37 or T60) are from the type iii) in presence of NBR1-LIR, meaning that 
these residues are the ones the most probably involved in the interaction. The saturation of the 
interaction  being  only  approached  during  this  experiment,  the  intensity  of  the  peaks 
corresponding to the bond form of GABARAPL-1 is often weaker than the one corresponding to 
the free form. The presence of a broad peak overlapping free and bound state peaks (Q63, F83, 
A93) or the presence of a peak between these two states (G22, L59, Y65, I72) indicates also an 
intermediate  (close  to  fast)  kinetic  exchange  between  these  two  states  leading  to  a  weaker 
interaction than for LC3B. Some peaks were also not observable anymore or difficult to assign 
like  residues  I25  and  K52  from  hp1  and  V55  and  F64  from  hp2  after  adding  NBR1-LIR, 
confirming this intermediate exchange (Figure 37).           Results 
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Figure 37: GABARAPL-1 interaction with NBR1-LIR. The overlay of representative regions (left for 
Y49  and  right  for  L55)  of  [
15N, 
1H]  TROSY-HSQC  spectra  of  GABARAPL-1  in  presence  of  NBR1-LIR  is 
represented. Contours are presented in different colors corresponding to individual titration points (red as reference 
with GABARAPL-1 alone and in presence of LIR domains at different molar ratio: magenta at 1:1/8, orange at 
1:1/4, yellow at 1:1/2, gray at 1:3/4, green at 1:1, purple at 1:1.5, brown at 1:2 and blue at 1:3).  
 
  Detailed  structural  analysis  of  the  GABARAPL-1/NBR1-LIR  complex  also  required  the 
observation  of  NMR  signals  of  NBR1-LIR  in  the  presence  of  GABARAPL-1.  In  titration 
experiments  of 
15N-labeled  NBR1-LIR  with  GABARAPL-1,  the  amide  resonances 
corresponding to amino acids D731, Y732, I733, I734, I735 and L736 disappeared, all belonging 
to the core of the LIR motif. At the same time, the resonances of the amino acids surrounding 
NBR1-LIR motif did not disappear but showed only more or less strong CSP depending of their 
distance to the core motif (Figure 38A). In the presence of a large excess of GABARAPL-1 
(molar ratio 1:10), some of the peaks reappeared but the sample was too unstable for further 
NMR  experiments  due  to  the  appearance  of  precipitation  (results  not  shown).  However,  by 
performing titration experiments with 
13C-labeled NBR1-LIR, CH signals for all residues of the 
LIR  domain  were  observable  at  lower  molar  ratios.  Focusing  on  the  spectral  region 
corresponding to the δ-methyl groups of isoleucine, three overlapping peaks were present in the 
reference spectrum of the free peptide, which shifted significantly upon titration to three well 
distinguishable resonance positions (Figure 38B). Based on the good quality of these spectra, 
multi-dimensional NOESY experiments, where intra- and intermolecular NOEs were observed, 
were recorded for the structure determination of the complex.    Results   
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Figure 38: NBR1-LIR interaction with GABARAPL-1. The overlay of the [
15N, 
1H] TROSY-HSQC 
spectra of NBR1-LIR in presence of  GABARAPL-1 at 1:0 (red), 1:1/4 (yellow), 1:1/2 (coral) and 1:1 (blue) molar 
ratio in (A) and of the representative region of isoleucine CHδ in [
13C, 
1H] HSQC for NBR1-LIR (red as reference) 
and in presence of GABARAPL-1 (blue at molar ratio 1:1) in (B) is represented. 
 
  To investigate the role of the aromatic residue in position 1, a mutant form of NBR1-LIR was 
created in which the tyrosine residue was mutated to tryptophan, the aromatic amino acid the 
most observed at this position in LIR domains. Upon NMR titration of NBR1-LIR_Y732W 
against GABARAPL-1, almost every residue was also perturbed but in majority presenting only 
two states, free and bound, like residues L50 and Y49, L55, L63 and I64 constituing hp1 and 
hp2, respectively, suggesting a tighter interaction with NBR1-LIR mutant. Moreover, whereas 
some  GABARAPL-1  peaks  did  not  reappear  after  addition  of  NBR1-LIR  even  close  to 
saturation, this effect was not seen in the case of NBR1-LIR_Y732W, confirming the formation 
of a tighter complex for GABARAPL-1 with the tryptophan mutant form of NBR1-LIR than in 
case of the wild type. NMR titration experiments of the 
15N-labeled GABARAPL-1 both with 
NBR1-LIR and the NBR1-LIR_Y732W mutant showed that the exchange-broadening of the 
tryptophan  mutant  was  reduced  compared  to  the  wild  type  peptide,  indicating  stronger 
interaction in a slower exchange mode between the bound and the free form (Figure 39).           Results 
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Figure 39:  GABARAPL-1  interaction  with  NBR1-LIR_Y732W.  The  overlay  of  representative 
regions (left for Y49 and right for L55) of [
15N, 
1H] TROSY-HSQC spectra of GABARAPL-1 in presence of 
NBR1-LIR_Y732W is represented. Contours are presented in different colors corresponding to individual titration 
points (red as reference with GABARAPL-1 alone and in presence of NBR1-LIR_Y732W at different molar ratio: 
magenta at 1:1/8, orange at 1:1/4, yellow at 1:1/2, gray at 1:3/4, green at 1:1, purple at 1:1.5, brown at 1:2 and blue 
at 1:3). 
 
6.2.3.3.2.  GABARAPL-1 vs. NBR1-LIR by ITC 
  To understand thermodynamically the involvement of different residues in the LIR motif of 
NBR1  in  the  interaction  with  GABARAPL-1,  ITC  experiments  were  performed  in  which 
NBR1-LIR  and  several  of  its  mutants  were  titrated  against  GABARAPL-1.  Titration  of 
NBR1-LIR against GABARAPL-1 showed a strong binding (Kd = 1.3 µM) equivalently driven 
by the contributions of the enthalpy and entropy of binding (ΔH =  -4.1 kcal mol
-1 and ΔS = 11.6 
cal mol
-1 K
-1) leading to a free energy ΔG of -7.6 kcal mol
-1 equivalent of the interaction of 
LC3B with NBR1-LIR (Table 5 and raw data in Appendix 9.3). 
  The measurement of the binding affinity of GABARAPL-1 to NBR1-LIR_Y732W by ITC 
showed a stronger binding indicated by a reduction of the dissociation constant to 0.4 µM. The 
tighter binding of NBR1-LIR_Y732W is also reflected in a more negative binding enthalpy 
contribution (ΔH = -5.7 kcal mol
-1). As in presence of the wild type, the binding entropy for 
GABARAPL-1/NBR1-LIR_Y732W interaction is large and positive (ΔS = 10.3 cal mol
-1 K
-1) 
but the free energy is slightly more negative (ΔG = -8.8 kcal mol
-1) (Table 5 and raw data in 
Appendix 9.3). 
  To further investigate the importance of the nature of the aromatic residue of LIR in position 
1  in  the  interaction,  the  tyrosine  residue  in  NBR1-LIR  was  mutated  to  phenylalanine  and 
NBR1-LIR_Y732F was titrated against GABARAPL-1. A strong interaction (Kd = 2.9 µM) with 
a very low binding entropy (ΔS = 2.6 cal mol
-1 K
-1) was revealed suggesting a tighter interaction 
that was reflected also by a more negative binding enthalpy (ΔH = -6.8 kcal mol
-1) relative to Results   
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that of the wild type peptide but with the same free energy (ΔG = -7.6 kcal mol
-1) than for 
NBR1-LIR wild type (Table 5 and raw data in Appendix 9.3). 
 
GABARAPL-1 
vs NBR1-LIR 
ΔH 
kcal mol
-1 
ΔS 
cal mol
-1 K
-1 
ΔG 
kcal mol
-1 
Kd 
µM 
NBR1  -4.1  +11.6  -7.6  3 
NBR1_Y732W  -5.7  +10.3  -8.8  0.4 
NBR1_Y732F  -6.8  +2.6  -7.6  2.9 
Table  5:  Thermodynamic  parameters  obtained  by  ITC  for  the  interactions  of 
GABARAPL-1 with NBR1-LIR wild type and mutants at position 1.  
All experiments were performed at 25°C. ΔH, ΔS and Kd values were measured with the assumption of a one site 
model. Although statistical errors for all calculations were quite small (below 3%), the uncertainty of the sample 
concentrations was approximately 5% (or more in case of peptides containing no tryptophan or tyrosine residues). 
Therefore, a total error of 10% for all parameters could be expected. 
  
  In order to investigate if the addition of negatively charged residues preceding the tyrosine in 
NBR1-LIR could increase the affinity to GABARAPL-1, glutamate mutants were created. The 
mutation S729E resulted in a slightly increased affinity to GABARAPL-1 characterized by a 
more negative binding enthalpy (ΔH = -4.8 kcal mol
-1) and a decrease of the binding entropy (ΔS 
=  9.5  cal  mol
-1 K
-1).  These  effects  were  further  enhanced  with  the  double  mutant 
NBR1-LIR_S728,729E  (ΔH  =  -5.5  kcal  mol
-1  and  ΔS  =  7.2  cal  mol
-1 K
-1).  In  both  cases, 
however, the overall effect was however rather small owing to a remarkable compensation of 
enthalpic and entropic effects, resulting in very similar dissociation constant and free energy 
values that are not significantly different from the wild type peptide (Kd of 2.7 and 2.4 µM and 
ΔG of -7.6 and -7.7 kcal mol
-1, for the single and double mutant, respectively) (Table 6 and raw 
data in Appendix 9.3). 
 
GABARAPL-1 vs 
NBR1-LIR 
ΔH 
kcal mol
-1 
ΔS 
cal mol
-1 K
-1 
ΔG 
kcal mol
-1 
Kd 
µM 
NBR1  -4.1  +11.6  -7.6  3 
NBR1_S729E  -4.8  +9.5  -7.6  2.7 
NBR1_S728,729E  -5.5  +7.2  -7.7  2.4 
Table  6:  Thermodynamic  parameters  obtained  by  ITC  for  the  interactions  of 
GABARAPL-1 with NBR1-LIR wild type and mutants at position -1 and -2.  
All experiments were performed at 25°C. ΔH, ΔS and Kd values were measured with the assumption of a one site 
model. Although statistical errors for all calculations were quite small (below 3%), the uncertainty of the sample 
concentrations was approximately 5% (or more in case of peptides containing no tryptophan or tyrosine residues). 
Therefore, a total error of 10% for all parameters could be expected.           Results 
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6.2.4.  Flexibility of Atg8 proteins 
6.2.4.1.  LC3B 
 
Figure 40: Flexibility of LC3B. Amide proton exchange experiments of LC3B are shown in (A). The left 
spectrum is the [
15N, 
1H] TROSY-HSQC reference spectrum for LC3B. The middle and the right spectra show the 
replacing of amide protons of LC3B by deuterons after placing the lyophilized sample into D2O for 10 minutes and 
1 hour, respectively. The relative intensity (decrease of intensity regarding to the intensity of reference peaks) of 
LC3B residues after amide protons exchange is shown in (B) and is plotted on the structure of LC3B in (C). The 
residues disappearing before 10 minutes, before 1 hour and still present after 1 hour are represented in green, yellow 
and red, respectively. 
 
  To monitor the flexibility of LC3B, amide/proton exchange experiments were performed by 
NMR. After measuring a [
15N, 
1H] TROSY-HSQC reference sprectrum for LC3B, the sample 
was  lyophilized  and  then  resuspended  into  D2O. A fter  10  minutes,  a  new  [
15N, 
1H] 
TROSY-HSQC spectrum for the sample was recorded and some amide protons were already 
completely replaced with deuterons and only 51 residues peaks were present against 96 for the 
reference sample. All resonances of amino acids belonging to the first α-helix, to the N-terminus 
of the second α-helix, to the loop between β-strands 1 and 2, to the N-terminus of β-strand 2, to 
the loop between α-helix 3 and β-strand 3 and to the loop between β-strand 3 and α-helix 3 were 
the first to disappear on the [
15N, 
1H] TROSY-HSQC spectrum. Over the next hour, remaining of 
the amide protons present in α-helix 2, in β-strand 2, in α-helix 4 and at the C-terminus of LC3B 
exchanged completely and were not observable anymore in the next [
15N, 
1H] TROSY-HSQC 
spectrum (Figure 40A). However, some amide protons (24 residues peaks) participating in the 
central antiparallel sheet of LC3B were still present in the TROSY spectrum after some months 
like for residues belonging to β-strand 1, to the central part of α-helix 3, to β-strand 3, to a part Results   
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of the loop between α-helix 4 and β-strand 4 and to β-strand 4 (Figure 40B). Plotted on the 
surface of LC3B, the fast exchange appears for amide groups exposed to the solvent whereas 
those buried in the core of LC3B should present a slower exchange rate (Figure 40C). 
 
6.2.4.2.  GABARAPL-1   
  Residues Q8 to D12 constituting α-helix 1 but also F15, R18 and I25 from α-helix 2 were 
hardly seen in each recorded [
15N, 
1H] TROSY-HSQC spectrum of GABARAPL-1. Although 
the  absence  of  these  residues  could  be  due  to  proteolytic  cleavage,  the  NMR  signals 
corresponding to these residues were present in [
13C, 
1H] HSQC and 
13C-edited NOESY. The 
flexibility  of  the  two  N-terminal  α-helices  of  GABARAPL-1,  occuring  in  a  slow  process 
regarding to NMR time-scale, could probably explain the disappearance of the amide proton 
peaks during the [
15N, 
1H] TROSY-HSQC experiment. Similarly, broad or double peaks were 
observed for residues, R18 and E23 as well as K19 and K24, which belongs to α-helix 2. This 
observation  confirmed  that  the  N-terminal  region  of  GABARAPL-1  is  subjected  to  some 
dynamics (results not shown).  
 
6.2.5.  3D structure of GABARAPL-1/NBR1-LIR 
  NMR titration experiments showed that a ~1.5-2.0 molar excess of one interaction partner 
was  required  to  saturate  the  binding  site.  To  obtain  structural  constraints  for  both  partners, 
NOESY spectra of complexes in which either GABARAPL-1 or the NBR1-LIR domain was 
13C/
15N labeled in the presence of a 1.5 molar excess of the unlabeled interaction partner were 
recorded. Under these conditions, almost all (backbone and side chain) resonances in the spectra 
were  assigned  (except  for  the  N-terminal  part  of  GABARAPL-1  near  and  along  the  small 
α-helix 1). Due to dynamic contributions and protein concentration limitations (aggregation at 
~1.5 mM concentration) intermolecular 3D J-resolved NOESY spectra did not provide reliable 
intermolecular resonances. However, in the 3D NOESY spectra of NBR1-LIR in presence of 
GABARAPL-1,  and  vice  versa,  eight  NOE  cross-peaks  could  be  unambiguously  manually 
assigned as intermolecular NOEs but two of them could not be manually assigned for which 
intermolecular NOEs. Using CYANA for peak picking and automatic assignment, a total of 69 
intermolecular NOEs were unambiguously assigned (Figure 41). The different intermolecular 
NOEs are listed in the Appendix 9.4. Based on the backbone and the side-chains assignment of 
GABARAPL-1 and NBR1-LIR and the selection of all NOE signals in 3D 
15N and 
13C NOESY 
spectra,  the  CANDID  module  of  CYANA
143  assigned  these  NOESY  cross  peaks.  With  the           Results 
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additional  torsion  angles  and  upper  distance  limit  restraints  provided  by  the  TALOS
142  and 
CSI
141 programs, 20 final conformers were calculated with CYANA. 
 
Figure 41: GABARAPL-1/NBR1-LIR interaction proved by intermolecular NOEs. A partial 
strip corresponding to I734 Hγ12 and I734 Hγ13 (of NBR1) is shown in (A). In addition to intramolecular NOEs to 
I734 CH3δ1, I734 Hγ12, I734 Hγ13 and I734 Hβ, an intermolecular NOE at 0.045 ppm corresponding to L50 CH3δ1 
could be unambiguously manually assigned. In (B), the strip of I733 CH3γ2 shows a peak at 5.078 ppm, which could 
be unambiguously manually assigned as an intermolecular NOE corresponding to Y49 Hα. NOE cross peaks for 
I735 CH3δ1 are shown in (C) with the resonances at -0.141 ppm and 0.232 ppm assigned to intermolecular NOEs 
corresponding to I64 CH3δ1 and V51 CH3γ1, respectively. 
 
  As  expected,  the  three  dimensional  structure  of  GABARAPL-1  in  the  presence  of  the 
NBR1-LIR domain is similar to the structure of other MAP1LC3 proteins. The typical ubiquitin 
core ββαβαβ is preceded by two α-helices 1 and 2. These two N-terminal α-helices (α1, Q4 to 
D8; α2, F11 to K24) are the result of the position of a proline (P10) in the middle of a longer α-
helix by creating a kink. The β-sheet domain is composed of four β-strands, two being parallel 
(β1, R28 to K35; β4, L105 to S110) and the other two are attached antiparallel (β2, K48 to P52; 
β3, F77 to V80). The two N-terminal α-helices close hp1 formed by the convex side of the 
β-sheet. The other hydrophobic pocket, hp2, including the concave side is covered by α-helices 
α3 (V57 to R67) and α4 (M91 to D97) (Figure 42 and structural statistics in Appendix 9.5). The 
hydrophobic pocket hp1 is formed by the residues E17, I21, P30, I32, K48, L54 and F99 while 
Y49,  V51,  P52,  L55,  F60,  L63  and  I64  are  constituting  the  hydrophobic  pocket  hp2.  The 
structure of GABARAPL-1 in complex with the NBR1-LIR domain shows only small changes 
relative to the non-complexed crystal structure (PDB entry 2R2Q reference) with a backbone 
RMSD of 1.78 Å over the structured part (Q4 to S110). Results   
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Figure  42:  NMR  structure  of  the  GABARAPL-1/NBR1-LIR  complex.  The  overlay  of  the 
backbone atoms of the 20 energy-refined conformers of GABARAPL-1 in complex with NBR1-LIR is shown in 
(A). Loops are shown in gray, α-helices in cyan, β-strands in magenta and NBR1-LIR is colored in red. Residues 1 
to 7 of GABARAPL-1 are disordered and were therefore excluded. Only the structured region of NBR1 (S728 to 
E738) is shown. The mean structure of the complex is presented as a ribbon diagram in two orientations (the view 
on the right corresponds to a 45° rotation) in (B). 
 
 
  In the complex, the LIR motif of the NBR1 peptide adopts an extended conformation and 
adds a β-strand to the central β-sheet of GABARAPL-1. The side chain of Y732 (Θ NBR1-LIR 
aromatic residue, position 1) binds deep into hp1 and makes close contact with E17, I21, P30, 
K48, L50 and F104 with distances less than 4 Å (Figure 43). hp2 interacts with the side chain of 
I735 (Γ NBR1-LIR hydrophobic residue, position 4), with short distances to amino acids Y49, 
V51, P52 and L55 on one side of the pocket and L63, I64 and R67 on the other side (Figure 43).  
           Results 
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Figure 43: LIR binding sites of GABARAPL-1 in presence of the NBR1-LIR domain. The 
position of Y732 and I735 (red) within NBR1-LIR and their interaction with the hp1 (orange) and hp2 (green) on 
GABARAPL-1 (grey) are shown. 
 
  The other two hydrophobic amino acids, I733 and I734 at position 2 and 3, are in contact with 
the surface of GABARAPL-1 (along β-strand 2). L736, the last hydrophobic residue at position 
5, is in close proximity to hp2 but its side chain is oriented in a different direction and makes 
contact  instead  with  V51  and  P52.  Finally  the  two  acidic  amino  acids  E730  and  D731  at 
positions -2 and -1 interact with the positively charged α-helix 2 (closer residues are E17, K20 
and I21) (Figure 44). 
 
Figure  44:  Interaction  of  the  acidic 
residues  of  NBR1-LIR  with  positively 
charged amino acids of GABARAPL-1. 
E730 and D731, located at the N-terminus of Y732 
in NBR1-LIR, make close contacts with positively 
charged  residues  of  GABARAPL-1,  especially 
with residues in α-helix 2 (K16, K20 and K24). 
 
 
 
 
  Careful analysis of the aromatic region of the NMR spectra revealed that the ε-protons of 
Y732 show two different peaks in the complex with GABARAPL-1, probably representing a 
major and a minor conformation (Figure 45A). Unfortunately, the quality of the sample was not 
sufficient  to  observe  specific  NOEs  for  both  conformations  but  only  for  the  more  intense 
resonance. However, during the structure calculation two different populations of the peptide 
with different positions of the tyrosine side chain in the hydrophobic pocket were consistent with 
the restraints, suggesting that potentially more than one conformation of the tyrosine side chain 
might exist (Figure 45B). Results   
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Figure 45: Flexibility in the interaction of NBR1-LIR with GABARAPL-1. The regions from a 
[
13C, 
1H] HSQC spectrum showing different signals corresponding to the tyrosine resonance positions CHε (left) 
and CHδ (right) of the NBR1-LIR in presence of GABARAPL-1 at a molar ratio 1:8 are illustrated in (A). The 
potential positions of the tyrosine residue of NBR1-LIR in the hp1 (orange) of GABARAPL-1 are represented in 
(B). Both conformers are compatible with all NMR restraints and were observed in the structure calculation of the 
GABARAPL-1/NBR1-LIR complex. 
 
 
6.3. Ubiquitin project 
6.3.1.  Design of ubiquitin tag constructs 
  Cloned into the pETM-60 vector, the target proteins were fused to the C-terminus of ubiquitin 
presenting  a  TEV  protease  cleavage  site  preceded  by  a  His6-tag.  The  first  Ub-fused  protein 
constructs involving TBK1_ULD showed already degradation products after only few hours of 
expression (results not shown). To overcome the degradation issue, the ubiquitin used in the next 
construct was slightly modified with the two last glycines substituted to S75 and A76. Compared 
to the constructs containing ubiquitin wild type, the modifications within ubiquitin increased the 
internal stability without any cleavage products appearing upon expression and the solubility of 
the expressed fusion constructs (Figure 46). 
 
Figure  46:  Expression  of  Ub-fused  constructs.  The 
expressed  proteins  from  1  to  7  are  optineurin-LIR,  TBK1_ULD, 
p62-LIR,  NBR1-LIR_long,  LC3A,  LC3B  and  Nix-LIR_W140/144, 
respectively.  Each  final  expression  was  obtained  after  3  hours  of 
expression at 37°C with 1 mM IPTG. 
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6.3.2.  Expression and purification of pure proteins/peptides 
  First experiments showed that mammalian Atg8 proteins used for the “autophagy project” 
(chapter 6.2.1) could be expressed in a very large amount (100  mg mL
-1) in less than 3 hours 
expression at 37°C with 1 mM IPTG without any degradation products. Screening the expression 
conditions  by  changing  the  amount  of  IPTG,  the  temperature,  the  degree  and  the  time  of 
expression did not improve significantly the expression yield (Figure 46). 
  Proteins and peptides expressed with the designed ubiquitin expression tag were purified by 
immobilized metal ion affinity chromatography (IMAC) using a Ni-NTA column due to the 
presence of the His6-tag. After the cell lysis using a French Press and after the removal of the 
cell debris by centrifugation, the cell lysate was loaded onto a Ni-NTA column. Flow-through, 
washing and elution fractions were analyzed by SDS-PAGE and showed that ubiquitin fused 
proteins were nicely isolated. The presence of a TEV cleavage site between the C-terminus of 
ubiquitin and the target protein gave the possibility to produce pure protein by removing the 
ubiquitin moiety. The collected elution fractions were cleaved by TEV protease using standard 
protocols. The cleavage rate was very efficient and no uncleaved product was detectable by 
SDS-PAGE (results not shown).  
  Because the molecular size of the target protein was often close to the one of ubiquitin, 
size-exclusion  chromatography  did  not  always  separate  both  proteins  efficiently.  A  second 
purification  step  by  ion  exchange  chromatography  with  an  sp-sepharose  column  was 
successfully used for Ub_GABARAPL-1 but, for Ub_LC3B, the target protein was still present 
in the flow-through where only ubiquitin should have been found. Performing a new Ni-NTA 
purification of the cleaved elution fraction after dialysis appeared to separate successfully the 
target protein in the flow-through from ubiquitin, which bound to the matrix because of the 
remaining His6-tag. Then a last purification step using size-exclusion chromatography was done 
to remove the remaining contaminants and obtain a pure final sample. Moreover, the target 
protein was eluted at the retention volume corresponding to its expected molecular size and was 
subjected  to b uffer  exchange  at  the  same  time  (results  not  shown).  LC3A,  LC3B  and 
GABARAPL-1 were easily purified from Ub-constructs, providing an average expression yield 
of  30  mg  L
-1.  With  this  amount,  the  proteins  could  be  further  used  for  NMR  and  ITC 
experiments.  Results   
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Figure  47:  Purification  of  cleaved  Ub_NBR1-LIR.  After  the  action  of  TEV  protease,  cleaved 
Ub_NBR1-LIR was purified by size-exclusion chromatography. The elution profile is illustrated in (A) and the 
SDS-PAGE  with  the  corresponding  collected  fractions  is  shown  in  (B).  The  [
15N, 
1H]  TROSY-HSQC  spectra 
corresponding to fractions #12-14, #15-17 and #18-20 are represented in (C) from the left to the right, respectively.  
 
  The methods used for protein purification could not exactly be applied for peptides owing 
their small size. Indeed concentration steps had to be avoided because of the risk of peptide loss 
through the concentrating membrane, which have a 3 kDa cut-off when most of the peptide used 
in this study have a lower molecular size. Thus, slight modifications in the purification protocol 
were  applied  to  successfully  purify  peptides  from  the  Ub-construct.  The  first  attempts  on 
peptides  purification  expressed  from  an  Ub-fused  construct  were  performed  with 
Ub_NBR1-LIR.  After  TEV  cleavage  of  the  Ni-NTA  elution  product,  size-exclusion 
chromatography  in  ammonium  chloride  buffer  was  performed  to  separate  the  peptide  from 
ubiquitin. Unfortunately, elution peaks of ubiquitin and target peptides were not always perfectly 
separated (Figure 47A). Nevertheless, after checking the fraction purity with SDS-PAGE, some 
elution fractions presenting absorbance at 280 nm were free of ubiquitin (Figure 47B). These 
fractions  were  then  lyophilized  and  resuspended  in  the  final  NMR  buffer  (50  mM  sodium 
phosphate, 100 mM NaCl at pH 7.0). Because of the small size of the NBR1-LIR peptide, no 
band corresponding to the protein was observed by SDS-PAGE but the UV absorbance at 280 
nm, which could be related to the presence of the tyrosine residue in NBR1-LIR, confirmed the 
purification of the target peptide. The first [
15N, 
1H] TROSY-HSQC spectrum showed a nice 
dispersion of all expected peaks, 12 peaks corresponding to the LIR motif plus 3 peaks from 
cloning artifacts. P737 as well as the two first residues of the construct belonging to the cloning           Results 
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site were not seen in the spectrum. The presence of ubiquitin in the background was very subtile 
and did not interfere with NBR1-LIR resonances (Figure 47C). The [
15N, 
1H] TROSY-HSQC 
spectrum of NBR1-LIR was a proof that pure labeled NBR1-LIR was correctly isolated. Thus 
the same protocol was used to purify the unlabeled NBR1-LIR necessary as interaction partner 
of GABARAPL-1 for the structure determination of the protein complex. Because no direct 
biochemical detections of the unlabeled NBR1-LIR was possible, it was assumed that the UV 
detection of the protein absorbance associated with no SDS-PAGE signal was a proof of the 
good purification of unlabeled NBR1-LIR. At the end, 10 to 20 mg of pure peptide was obtained 
per liter of expression. 
 
6.3.3.  Expression and purification of ubiquitin fused proteins/peptides 
  As  shown  above,  the  purification  of  peptides  expressed  with  the  designed  ubiquitin 
expression tag was successfully achieved. This method for the production of pure peptides needs 
a lot of steps causing the loss of a lot of materials during these procedures. To overcome the 
peptide  lost  issue,  the  expression  and  the  purification  of  peptide  fused  to  ubiquitin  and  not 
cleaved from it was done. 
  The expression and the purification protocols were the same as the one previously described 
providing  the  same  amount  of  ubiquitin-fused  protein/peptide.  In  some  cases,  the  Ni-NTA 
elution  fraction  was  quite  pure  and  buffer  exchange  was  sufficient  to  have  enough  of  pure 
materials  to  perform  further  experiments.  To  increase  the  sample  purity,  size-exclusion 
chromatography  was  used  in  addition.  The  Ub-fused  peptide  eluted  monodispersly  at  the 
expected  volume,  no  cleaved  ubiquitin  was  detected  and  no  precipitations  were  observable 
during concentration (Figure 48). A final average amount of 100 to 150 mg of ubiquitin-fused 
protein/peptide per liter of expression was obtained for the different constructs used.  
 
Figure 48: Purification of Ub_NBR1-LIR. The  purification  was 
performed  on  a  NiNTA  column.  CL  represesents  the  cell  lysate,  FT  the 
flow-through, wash the washing step and El the elution fraction. The smear 
observed in the elution fraction is due to the presence of imidazole in the 
sample. 
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  Ub_NBR1-LIR and Ub_NBR1-LIR_Y732W were produced under these conditions and used 
for NMR and ITC experiments. These protocols were also effective for the expression and the 
purification of bigger proteins fused to ubiquitin, like GABARAPL-1 with a molecular size of 15 
kDa. 
 
6.3.4.  Use of ubiquitin-fused proteins for CD spectroscopy  
  To verify if the presence of ubiquitin interferes with the structure of the protein of interest, 
CD spectroscopy was used to provide structural information about the Ub-fused protein, the 
ubiquitin moiety and the target protein. 
 
Figure 49: CD spectroscopy with Ub-fused proteins. The intact Ub_GABARAPL-1 is represented in 
red, ubiquitin in green and GABARAPL-1 in blue. The curve resulting from the subtraction of the values obtained 
from ubiquitin alone to the ones of uncleaved Ub_GABARAPL-1 is in purple. This curve overlays with the curve of 
GABARAPL-1 alone. 
 
  CD spectra were recorded for Ub_GABARAPL-1 as well as for ubiquitin and GABARAPL-1 
alone. The CD spectrum of Ub_GABARAPL-1 fits with the CD spectrum resulting from the 
addition of ubiquitin and GABARAPL-1 spectra. By subtracting the data obtained during the CD 
spectrum of ubiquitin from the one of Ub_GABARAPL-1, a similar CD spectrum than the one 
issued from GABARAPL-1 alone was observed. No structural elements appeared or disappeared 
due to the fusion of ubiquitin to GABARAPL-1 (Figure 49). 
 
6.3.5.  Use of ubiquitin-fused peptides for ITC 
  In  the  “autophagy  project”,  the  binding  affinity  of  LC3B  to  p62-LIR  using  a  chemically 
synthesized  peptide  was  well  studied  by  ITC.  To  prove  that  the  ubiquitin  moiety  does  not 
interfere with the interaction and in consequence that a Ub-fused peptide could be used instead 
of a peptide alone, the ITC titration of p62-LIR against LC3B was reperformed in the same           Results 
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buffer conditions as with the free peptide but using p62-LIR fused to ubiquitin this time. The  
dissociation constants obtained for both titration experiments were almost identical with a Kd of 
1.5  µM  and  1.4  µM  for  LC3B/p62-LIR  and  LC3B/Ub_p62-LIR  interactions,  respectively. 
Looking to the thermodynamical data, the binding enthalpy and entropy obtained for LC3B 
interaction with Ub_p62-LIR (ΔH = -10.4 kcal mol
-1 and ΔS = -8.3 cal mol
-1 K
-1) were very 
similar than those obtained with the synthesized p62-LIR (ΔH = -10.5 kcal mol
-1 and ΔS = - 8.7 
cal mol
-1 K
-1) (Figure 50). Regarding to these data, ubiquitin did not interfere in the interaction 
of LC3B with p62-LIR and Ub_p62-LIR could be used for interaction studies by ITC instead of 
synthetic p62-LIR peptide. 
 
Figure 50: Effect of the ubiquitin moeity on the interaction of Ub-p62 with LC3B. The raw 
data and the thermodynamc values of the titration of p62-LIR against LC3B (left) and of Ub_p62-LIR against LC3B 
are shown. All experiments were performed at 25°C in the same conditions as  the GABARAPL-1 interaction 
studies with NBR1-LIR wild type and mutants. 
 
  To confirm the non-influence of ubiquitin in the ITC data obtained with Ub-fused proteins, a 
control titration experiment of ubiquitin against GABARAPL-1 was done (Figure 51). In this 
case, some unspecific binding effects were observed with a dissociation constant in the hundred 
micromolar range with a number of binding site fixed to one and a dissociation constant in the 
millimolar range without a fixed number of binding sites. These dissociation constant values are 
insiginificant  regarding  to  the  strong  binding  of  GABARAPL-1  with  Ub_NBR1-LIR  and 
Ub_NBR1-LIR_Y732W. Indeed, Ub-fused NBR1-LIR constructs were used in chapter 6.2.3.3.2 
to  study  the  interaction  of  GABARAPL-1  with  NBR1-LIR  and  NBR1-LIR_Y732W.  The Results   
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dissociation constants as well as the thermodynamic data were different between NBR1-LIR 
wild type and the mutant form. The only difference between both constructs is the substitution of 
the tyrosine by a tryptophan. This effect on the interaction by this single mutation was measured 
with the peptide linked to the ubiquitin leading sequence. The data obtained during ubiquitin 
titration were also used as a baseline for GABARAPL-1/Ub_NBR1-LIR interaction to subtract 
the unspecific interaction from the total interaction. 
 
Figure  51:  Effect  of  the  ubiquitin  moeity  on  the  interaction  of  Ub-fused  peptides  with 
protein. The raw data and the thermodynamic values for the ubiquitin control experiment are shown. The titration 
of ubiquitin against buffer (dilution heat) on the left side and of ubiquitin against GABARAPL-1 on the right side 
are represented. 
 
6.3.6.  Use of ubiquitin-fused proteins/peptides for NMR 
6.3.6.1.  Characterization of ubiquitin-fused proteins/peptides 
  To  prove  the  benefit  of  Ub-fused  constructs  for  NMR,  the  small  hydrophobic  peptides 
corresponding to the LIR domains of p62, NBR1, Nix-LIR_W140/144 and of a new autophagy 
receptor, optineurin,
105 were first used. [
15N, 
1H] TROSY-HSQC spectra were recorded for each 
of the precited peptides fused to ubiquitin. A number of extra resonances corresponding to the 
number  of  amino  acids  present  in  the  peptidic  sequence  were  observed  in  the  [
15N, 
1H] 
TROSY-HSQC spectra in addition to the resonances corresponding to ubiquitin (Figure 52). 
Thus for each peptide fused to ubiquitin, a singular NMR pattern was present as it will have been 
without  the  presence  of  ubiquitin.  It  should  also  be  mentionned  that  because  of  its  high 
flexibility/mobility, the resonances of the residues in the linker region containing the His6-tag           Results 
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between  ubiquitin  and  the  protein  of  interest  are  not  seen  in  the  [
15N, 
1H]  TROSY-HSQC 
spectra.  
 
Figure  52:  NMR  spectra  of  LIR  domains  fused  to  ubiquitin.  The  overlay  of  [
15N, 
1H] 
TROSY-HSQC  spectra  of  Ub_p62-LIR  (blue),  Ub_NBR1-LIR  (green),  Ub_Nix-LIR_W140/144  (magenta)  and 
Ub_optineurin  (cyan)  with  ubiquitin  (red)  is  represented.  The  resulting  extra  peaks  observed  in  each  spectrum 
reflect the specificity of each LIR motif. 
 
  What was true for small peptides was also applicable for proteins. LC3A was used as an 
initial example. First, a [
15N, 
1H] TROSY-HSQC spectrum of a purified LC3A fused to ubiquitin 
was recorded. Compared to the spectra of previously purified LC3A samples expressed as a 
NusA fusion construct and of ubiquitin from a previous work, the spectra are similar: Ub_LC3A 
is the superposition of the previous [
15N, 
1H] TROSY-HSQC spectra of ubiquitin and LC3A. 
Except some overlays, the peaks belonging to ubiquitin or to LC3A were easily distinguished in 
the [
15N, 
1H] TROSY-HSQC spectrum of Ub_LC3A. The presence of ubiquitin in the sample did 
not  interfere  with  LC3A  because  no  chemical  shift  perturbations  appeared  regarding  to  the 
reference [
15N, 
1H] TROSY-HSQC spectra of ubiquitin and LC3A alone. The peaks had the 
same intensity and the same shape for the protein alone as well as for the Ub-fused LC3A. The 
size of the full construct was not an issue for this NMR experiment. Some slight differences 
were anyhow observed but only caused by the small differences in buffer compositions and pH. 
The  same  results  as  for  Ub_LC3A  were  observed  for  Ub-fused  constructs  used  with  other 
proteins like LC3B (although the purification protocol lead to a large amount of lost protein) or 
for TBK1_ULD. The [
15N, 
1H] TROSY-HSQC spectra of Ub-fused proteins showed the same Results   
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pattern  that  their  own  reference  [
15N, 
1H]  TROSY-HSQC  spectra  with  extra  resonances 
belonging to ubiquitin only (Figure 53). 
 
 
Figure 53: NMR spectra of Ub-fused proteins. The overlay of [
15N, 
1H] TROSY-HSQC spectra of 
Ub-fused protein with ubiquitin (left), with the pure protein (middle) and with both (right) is shown. In every 
spectrum, ubiquitin is represented in red. In (A), Ub_LC3A is in green and LC3A alone in orange. In (B) Ub_LC3B 
is in blue and LC3B alone in yellow. In (C), Ub_TBK1_ULD is in purple and TBK1_ULD alone in pink. Except 
some small CSP caused by the buffer conditions, the [
15N, 
1H] TROSY-HSQC spectra of the protein fused to 
ubiquitin is totally covered by the spectra of ubiquitin and of the concerned protein alone. 
 
6.3.6.2.  Use of ubiquitin-fused constructs from cell lysate 
  After the expression and the harvest of only 100 mL of growing cells containing the DNA 
encoding  for  Ub-fused  proteins,  a  [
15N, 
1H]  TROSY-HSQC  spectrum  was  recorded  for  the 
supernatant of the cell pellet resuspended in the NMR buffer after sonication and centrifugation. 
The [
15N, 
1H] TROSY-HSQC spectra obtained for the different Ub-constructs prepared in less 
than one hour showed a nice peak dispersion, which corresponds to the [
15N, 
1H] TROSY-HSQC 
spectra of the same proteins obtained after few days of purification. Naturally, some background 
was  observed  for  all  spectra  but,  in  most  of  the  cases,  with  less  intensity  than  the  peaks 
corresponding to the target proteins. The same results were also obtained by using only 3 mL of 
protein culture. Surprisingly, Ub_LC3B provided spectra with less peak intensity and with more 
background  than  for  Ub_LC3A  whereas  the  expression  yield  observed  by  SDS-PAGE  was 
similar (Figure 54).            Results 
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Figure 54: NMR spectra from the cell lysate of Ub-fused proteins.  The  overlay  of  [
15N, 
1H] 
TROSY-HSQC spectra of Ub-fused proteins from cell lysate (left) and of Ub-fused proteins after purification (right) 
is shown. LC3A, LC3B, TBK1_ULD and optineurin, all fused to ubiquitin, are represented in (A), (B), (C) and (D), 
respectively. A similar peak distribution between the cell lysate the purified Ub-fused proteins is observed but with 
less background and sharper peaks for the purified proteins (except for Ub_LC3B with the loss of material during 
the purification protocol).  
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  In the case of Ub_p62-LIR cell lysate, several short [
15N, 
1H] TROSY-HSQC spectra have 
been recorded over 48 hours to monitor the appearance of degradation over time. Only a few 
resonances  corresponding  to  degradation  products  were  present  after  this  time.  Most  of  the 
resonances were still present in the last [
15N, 
1H] TROSY-HSQC spectrum proving that the 
sample was stable in these conditions for more than 24 hours (results not shown). Adjustments of 
the buffer conditions with more protease inhibitor cocktail and more reducing agents were done 
on  the  sample  preparation  to  protect  it  from  degradation.  Thus  an  enhanced  stability  of  the 
protein was observable in the [
15N, 
1H] TROSY-HSQC spectra. 
 
6.3.6.3.  Interaction studies 
 
Figure 55: LC3B interaction with p62 and Ub_p62. The NMR titrations of p62 (left) and Ub_p62 
(right) against LC3B (protein alone in red and in presence of LIR in purple) show a similar pattern, reflecting that 
ubiquitin  does  not  interfere  in  the  interaction.  The  small  differences  observable  are  caused  by  slight  buffer 
differences. 
 
  Another possible NMR application for a protein fused to ubiquitin is to study protein-protein 
interactions. In chapter 6.2.3.1.1, the interaction of LC3B with chemically synthesized p62-LIR 
was characterized. This NMR titration experiment was repeated but with a Ub-fused peptide this 
time. The same titration pattern than previously was observed with the disappearance of the 
cross-peaks corresponding to the free state and the appearance of the cross-peaks corresponding 
to the bound state upon titration as a proof for a strong interaction in a slow exchange mode. By 
a closer look on the [
15N, 
1H] TROSY-HSQC spectra, some very small chemical shift differences 
could be noticed between both [
15N, 
1H] TROSY-HSQC spectra (Figure 55). A probable reason 
for these changes is the persisting presence of some chemical agents in the synthetic peptides, 
which could affect the general conditions of the sample.  
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Figure 56: Interaction studies of Ub_NBR1-LIR with MAP1LC3 proteins.  The overlay of [
15N, 
1H] TROSY-HSQC spectra of Ub-NBR1-LIR in presence of LC3B (left) or GABARAPL-1 (right) is represented. 
Contours in different colors correspond to individual titration points (red as reference, magenta in presence of 
MAP1LC3 proteins at molar ratio 1:1/8 (only for LC3B), orange at 1:1/4, yellow at 1:1/2, gray at 1:1, cyan at 1:2, 
purple at 1:4 (only for LC3B) and blue at 1:8 (only for LC3B).  
 
  With the idea of first monitoring the effect of the interaction of MAP1LC3 proteins with the 
LIR domains of autophagy receptors to be able to then structurally determine this interaction, 
NMR  interactions  studies  were  performed  by  titrating  unlabeled  LC3B  and  GABARAPL-1 
against labeled Ub_NBR1-LIR. The interest was to observe the interaction from the LIR domain 
side. Thus a labeled LIR peptide was needed and to overcome the cost of chemically synthesized 
labeled  peptide,  a  Ub-fused  NBR1-LIR  construct  was  used.  The  [
15N, 
1H]  TROSY-HSQC 
reference  spectrum  of  Ub_NBR1-LIR  corresponded  to  ubiquitin  and  18  extra  peaks  as  the 
number  of  NBR1-LIR  residues.  At  the  first  titration  steps,  resonances  corresponding  to  the 
residues from NBR1-LIR were shifted when the ones from ubiquitin were not. Pursuing the 
titration, most of the resonances corresponding to the NBR1-LIR moiety disappeared (Figure 
56) like the resonances of GABARAPL-1 disappeared during the NMR titration of unlabeled 
NBR1-LIR  peptide  against  labeled  GABARAPL-1.  Only  the  resonances  corresponding  to 
ubiquitin were then observed. What was first suspected to be a degradation of the peptide moiety 
was  finally  understood  as  the  effect  of  the  intermediate  (close  to  slow)  exchange  mode  of 
LC3B/NBR1-LIR as it was explained in more details in the chapters 6.2.3.1.3 and 6.2.3.3.1. 
Approaching the saturation of the interaction, some peaks reappeared partially but the sample 
was to unstable as revealed by the appearance of precipitation in the NMR tube and signals of 
degradation  products  in  the  [
15N, 
1H]  TROSY-HSQC  spectra.  Interestingly,  the  resonances 
corresponding  to  NBR1-LIR  disappeared  already  at  a  molar  ratio  of  1:1/2  in  presence  of 
GABARAPL-1 but only at 1:4 in presence of LC3B, indicating that GABARAPL-1 interacts Results   
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stronger than LC3B with NBR1-LIR. Because the same effect was observed for the interaction 
studies involving the LIR motif as peptide, these results corroborate the fact that ubiquitin does 
not interfere with the interaction in both cases. Here, performing a [
13C, 
1H] HSQC could not 
have helped because the CH signals from ubiquitin are too many to be distinguished from the 
CH signals specific of NBR1-LIR. 
  As it was described above with ITC, GABARAPL-1 interaction with NBR1-LIR wild type 
and the Y732W mutant was also studied by NMR using peptides fused to ubiquitin as already 
described in chapter 6.2.3.3.1. 
 
6.3.6.4.  Assignment of peptides using ubiquitin-fused constructs 
 
Figure 57: Assignment of Ub-fused peptides. The differents strips represent the HNCACB correlation 
peaks for the stretch between D58 and E64 in the ubiquitin portion (left) and for the stretch between E730 and L736 
in the NBR1-LIR portion (right) of Ub_NBR1-LIR. The large presence of artifacts in the background of the strips is 
explained by the use of NUS-NMR to assign NBR1-LIR. 
 
  In comparison to existing ubiquitin assignments, the majority of the ubiquitin resonances 
from the Ub-fused peptides could be assigned with good presumption. Using traditional NMR 
experiments  but  also  Non-Uninominal  Sampling  (NUS)  NMR,  the  backbone  resonances  of 
p62-LIR  as  well  as  of  NBR1-LIR  fused  to  ubiquitin  were  assigned  and  the  assignment  of           Results 
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ubiquitin was also confirmed. In both cases, the resonances corresponding to the residues present 
in the loop containing the His6-tag and the TEV cleavage site between ubiquitin and the peptide 
were not totally assigned due to the fast flexibility of this region (Figure 57). Assignment of 
peptide side chains was started but further NMR experiments are still needed to obtain a total 
assignment of p62-LIR and NBR1-LIR moieties. 
 
6.3.7.  Solubility enhancement 
 
Figure 58: Stability of Ub_TBK1_ULD. The overlay of [
15N, 
1H] TROSY-HSQC spectra of TBK1_ULD 
(top) and Ub-TBK1_ULD (bottom) NMR spectra is shown. The initial NMR spectra of the TBK1_ULD forms pure 
or fused to ubiquitin at ~300 µM protein concentration are represented in the left plots. The same samples were 
recorded after being stored 24 hours at 25°C and are shown in the right plots. The strong tendency of TBK1_ULD to 
aggregate is decreased under fusion to ubiquitin. 
 
  In a purified form, TBK1_ULD had shown a strong tendency to aggregate, already starting at 
a concentration of 200 µM. Moreover, TBK1_ULD samples degraded really fast and after few 
days several resonances had already disappeared in [
15N, 
1H] TROSY-HSQC spectra. Fused to 
ubiquitin, it was possible to concentrate the sample above 500 µM and the Ub_TBK1_ULD 
sample showed good stability after more than 24 hours at room temperature (Figure 58). No 
degradation products were observed in the different [
15N, 
1H] TROSY-HSQC spectra recorded 
and  no  precipitation  was  observed  in  the  NMR  tube  after  few  days  unlike  the  purified 
TBK1_ULD expressed with the GST expression vector. 
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7.  Discussion 
7.1. Expression and purification of proteins for biophysical studies 
  The function of a protein is, in most cases, directly related to its structure. It is commonly 
admitted that proteins sharing the same structure share also the same function and vice-versa. 
Protein interaction partners are very important in biological systems in order to activate or to 
inhibit the protein activity. Knowing the structure of a protein allows to assume structurally 
which molecules could be able to interact with this protein. Thus, the structure determination of 
proteins raises a high interest in the scientific community in order to get more fundamental 
knowledge about protein functions but also in the pharmaceutical industry, which is looking for 
the best interacting compounds as therapeutic products by structure-based drug design. 
  The  Protein  Data  Bank  (PDB:  www.pdb.org)  compiles  structures  of  proteins  and  nucleic 
acids. More than 85% of the submitted structures were determined by X-Ray crystallography. 
X-ray crystallography is a powerful tool for the determination of the three dimensional structure 
of proteins and protein complexes of a high molecular mass but not all proteins provide crystals 
and  not  all  crystals  are  well-resolved  by  X-Ray  crystallography.  Moreover,  because  the 
physiological conditions of the protein are sometimes not suitable to obtain a crystal, substitutive 
conditions are used and could lead to structural artifacts. Finally, the biggest limitation of X-Ray 
crystallography is the impossibility to study the dynamic of a protein alone or in a complex. 
  The remaining structures present in the PDB were determined by NMR. Compared to X-Ray 
crystallography, the big advantage of NMR is the possibility to study the motion of a whole 
protein or only its sub-domains. Moreover, different NMR experiments are available providing 
different  information  about  solvent  exchange,  kinetics  and  thermodynamics  of  protein 
interactions as well as 3D structure determination. The disadvantage of NMR is the necessity to 
work with a relatively low molecular mass (below 30 kDa) because of the complexity to analyze 
a such complex and because of the limitations of the technique concerning molecules presenting 
a low tumbling rate leading to broad overlapped peaks. Moreover, due to the poor sensitivity of 
the method, a high amount of material is necessary to perform NMR experiments. Expression, 
isolation and purification of peptides and proteins are the crucial initial steps to be able to further 
study their structural organization. 
 
7.1.1.  TBK1 and IRF3 proteins 
  For  the  “TBK1_ULD  project”,  the  presence  of  an  ULD  in  TBK1  had  to  be  structurally 
confirmed. Other research laboratories tried to solve the structure of TBK1_ULD using X-Ray Discussion 
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crystallography but the crystals they obtained did not diffract enough to be able to determine any 
structures. 
  Two  TBK1  constructs  containing  the  putative  ULD  were  cloned  into  the  pGEX-4T1 
expression vector provided by Dr Fumiyo Ikeda to check which one could be the most preferable 
for NMR experiments. The first sequence (residues 302 to 383) contains only the predicted ULD 
whereas the second sequence consists of the ULD and the C-terminus of TBK1 (residues 282 to 
403). The expression of the protein was observed in an analytical expression screening. The 
advantage of a longer sequence is its probable higher expression yield due to a better stability but 
no  expression  improvement  being  noticed,  the  shorter  sequence  was  preferentially  chosen 
because of the prevision of an easier NMR assignment by reducing the number of atoms to 
assign. The expression and the first purification steps on a preparative scale supplied only the 
minimal amount of material required for such an experiment. Removal of GST by thrombin 
protease was not always sufficient and more enzyme than expected were needed, rising up the 
experiments costs. Moreover, the solubility of TBK1_ULD released from GST moiety was low 
with some precipitation observed after overnight cleavage of the elution sample of TBK1_ULD. 
Nevertheless, pure TBK1_ULD sample concentrated up to 300 µM were produced and used for 
NMR studies. Increasing the solubility of the TBK1302-383 protein sample was still a need to 
complete the NMR structural studies. Several attempts were done to improve the solubility by 
substituting residues at the N- and C- termini of TBK1_ULD. Unfortunately, these different 
mutations did not help and had even sometimes a worse effect on the protein solubility. Other 
attempts to increase the expression yield were also performed but the substitution of the GST 
expression vector to the NusA expresion vector did not help neither. Even though the expression 
yield  was  similar  or  better  than  for  GST_TBK1_ULD,  most  of  the  protein  was  present  in 
inclusion bodies and resolubilization processes did not work out. The use of an other expression 
vector was more promising. Fused to ubiquitin, the expression yield of TBK1_ULD was not 
significantly higher but the sample could be higher concentrated and was stable for a longer time 
without showing any precipitation. The same Ub_TBK1_ULD sample was thus used for several 
experiments when a new TBK1_ULD sample had to be prepared for each new NMR experiment. 
  Ikeda et al.
120 showed by GST pull-down assays that the IAD domain of IRF3, a binding 
partner  of  TBK1,  was  enough  to  bind  to  the  ULD  domain  of  TBK1.  Different  constructs 
corresponding to IRF3 full-length, the IAD domain alone and the IAD followed by the SRR 
domain were provided. Unfortunately, purification of IAD failed out, which could be explained 
by the structure of IRF3. The SRR domain folds over the IAD domain and probably stabilizes 
the whole protein (Figure 59).
150 The expression and the purification of IAD-SRR were more Discussion 
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successful and the protein was then used for preliminary interaction studies by NMR. Due to the 
beneficial effect of the ubiquitin expression tag, the expression of IAD-SRR fused to ubiquitin 
should be tried in the future and could probably lead to a better expression of the protein and 
further interactions studies could be performed. 
 
Figure 59: Crystal structure of IRF3_IAD-SRR. The structure of the IAD-SRR domain of IRF3 is 
presented as a ribbon diagram in two orientations (the view on the right corresponds to a 90° rotation). IAD and 
SRR domains are represented in magenta and cyan, respectively. The SRR domain interacts with the IAD domain to 
build a compact structure. (picture adapted from Qin et al.
150) 
 
 
7.1.2.  MAP1LC3 proteins and LIR domains 
  The different protein and peptide sequences provided by Dr. Vladimir Kirkin and Dr. David 
McEwan were cloned into pGEX-4T1 expression vectors. Although the constructs expressed 
well, DNA fragments coding for the different MAP1LC3 proteins and the LIR domains were 
cloned  into  the  expression  vector  pETM-60,  presenting  the  NusA  protein  to  enhance  the 
expression, a hexahistidine tag for purification and a TEV protease recognition sequence. The 
NusA expression tag had a great impact in the final expression yield of these proteins and the 
cleavage rate with the TEV protease was fast and efficient. Pure protein in large amount was 
more easily obtained than in the case of GST based constructs. As a matter of proof for the 
ubiquitin-tag project, these proteins were also expressed as ubiquitin-fused proteins and lead to 
an  even  larger  expression  yield  compared  to  the  same  proteins  fused  to  GST  and  NusA 
expression vectors. 
  To understand the role of the different residues present in the LIR domain of autophagy 
receptors,  the  production  of  small  peptides  up  to  20  amino  acid  length  was  needed.  First 
plasmids containing the coding sequence of the NBR1-LIR protein with different lengths (46 to Discussion 
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276 amino acids) expressed well as GST-fusion proteins but, after removal of the GST moiety, 
no protein was found in solution. Using the different techniques available in house (SDS-PAGE 
or size-exclusion chromatography), no protein was detected, probably due to protein degradation 
after cleavage of the expression tag. Ordering synthetic peptides was then the best option at this 
time. p62-LIR, Nix-LIR_W36, Nix-LIR_W140/144 as well as NBR1-LIR wild type and some 
mutants were thus used for ITC and NMR titration. Because the LIR peptides were also needed 
for structure determination by NMR, labeled peptides would have to be produced what would 
have been a huge cost if ordered as the non-labeled ones were. The use of peptides fused to 
ubiquitin appeared to be a great method to produce labeled peptide at a lower cost. 
  Unfortunately,  good  protein  concentration  does  not  necessarily  lead  to  a  good  NMR 
spectrum. A first set of experiments was often needed to optimize the buffer conditions in terms 
of buffer system, salt concentration and pH. The conditions were optimized until obtaining a 
[
15N, 
1H]  TROSY-HSQC  spectrum  presenting  nice  resolved,  globular  and  well-dispersed 
resonances. The chemical shift dispersion is indicative of a well-folded and of a globular domain 
but several centers and broad peaks are synonyms of dynamics, which could complicate the 
assignment of the protein. 
  Some peaks were sometimes not seen like the N-terminal part of the different MAP1LC3 
proteins because of conformational exchange. Generally, additives could increase the solubility 
of  the  protein  like  an  arginine/glutamic  acid  mixture  or  detergents  like  CHAPS  stabilize 
hydrophobic surface with reducing conformational exchange leading to sharper peaks with better 
shape and diminution of double peaks. Although the change of the conditions did not improve 
the behavior for MAP1LC3 proteins, addition of arginine/glutamic acid showed improvement in 
the NMR spectra of TBK1_ULD. 
  Thus, all the proteins required for the “TBK1_ULD” and the “Autophagy” projects were 
expressed and purified. Different expression vectors and different buffers had to be used to get to 
these results. Good NMR spectra were recorded for all these proteins, meaning that the proteins 
were well-folded under the purification conditions. This had made possible to study further these 
proteins with biophysical methods. NMR was successfully used during this thesis as technique to 
determine  the  secondary  structure  of  the  putative  ULD  domain  of  TBK1  when  X-Ray 
crystallography  failed.  NMR  was  also  used  to  structurally  characterize  the 
GABARAPL-1/NBR1-LIR complex. Finally, the description of the interaction of mammalian 
Atg8 proteins with different LIR domains was done by NMR and ITC. 
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7.1.3.  Ubiquitin as solubility tag suitable for biophysical methods 
  Most biophysical applications require to remove the expression tag and to operate with highly 
purified  proteins.  The  possibility  to  lose  the  benefits  of  a  high  yield  protein  within  fusion 
constructs  increases  with  each  purification  step  as  it  was  showed  for  TBK1_ULD,  which 
precipitated after the removal of the GST moiety. It was even worth concerning short peptides 
like for NBR1-LIR, which could not be easily treated with the most common methods provided 
in  biochemistry  laboratories.  Chemical  laboratories  could  easily  synthesize  peptides  for 
reasonable  price  but  it  becomes  very  expensive  if  they  are  labeled  (
15N, 
13C  or  both)  and 
companies even failed to synthesize some of the peptides. 
  Ubiquitin, presenting a fast and high expression yield as well as a high protein stability, 
possesses  the  ideal  qualities  to  be  used  as  an  expression  tag.  With  the  addition  of  slight 
modifications  within  ubiquitin,  the  internal  stability  and  solubility  of  the  expressed  fusion 
constructs was increased.
151 First experiments showed that proteins (LC3A and LC3B) as well as 
peptides (Nix-LIR_W36 and Nix-LIR_W140/144) are expressed in a very large amount (100 mg 
mL
-1) without any degradation products. Ubiquitin could be successfully removed from the fused 
constructs and, after few purification steps, pure proteins and peptides could be produced even 
with isotopic labeling. With the establishment and the optimization of purification protocols, the 
high expression yield obtained with Ub-fused peptides provided large amount of pure peptides 
useful for biophysical studies. Pure NBR1-LIR was produced this way in order to determine the 
structure of GABARAPL-1 in presence of NBR1-LIR by NMR. 
  The main idea behind ubiquitin behaving as an expression tag was to use the full construct 
without  any  cleavage  for  biophysical  methods  like  NMR,  ITC  or  CD  spectroscopy.  With 
ubiquitin being thermodynamically very stable, its effect during NMR, CD spectroscopy and 
ITC experiments should be always the same. Recording blank experiments with ubiquitin gave 
information  of  its  background  contribution  during  the  experiments  with  Ub-fused 
protein/peptide. Due to its small size (8 kDa against more than 50 kDa for the dimeric GST and 
the monomeric NusA) and its stable fold, ubiquitin should not affect NMR spectra like a bigger 
tag would do. Indeed, big proteins have a slow tumbling rate leading to fast relaxation and thus 
peak broadening. The presence of GST_IAD-SRR in the titration against TBK1_ULD lead to the 
disappearance of all resonances in the [
15N, 
1H] TROSY_HSQC spectra for example. To show 
that ubiquitin fulfills these conditions, the fact that the target protein possesses the same features 
within the fusion construct as well as being purified was proven. 
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7.1.3.1.  Ubiquitin-fused constructs for CD spectroscopy 
  CD  spectroscopy  was  performed  to  verify  if  the  structural  information  provided  for  the 
Ub-fused constructs was actually corresponding to the sum of the structural characteristics of 
ubiquitin and of the target protein alone. Using GABARAPL-1 as example for an ubiquitin-fused 
protein, the CD spectrum of Ub_GABARAPL-1 was perfectly the addition of ubiquitin and 
GABARAPL-1 spectra. No additional structural elements appeared or disappeared due to the 
fusion  of  GABARAPL-1  to  ubiquitin.  Another  application  possible  is  to  check  the  thermal 
stability  by  CD  spectroscopy.  Unfortunately  the  data  provided  by  the  melting  curves  of 
Ub_GABARAPL-1 were not useful for a clear statement but, in theory, the subtraction of the 
melting curve of ubiquitin from the one of the Ub-fused protein should give information on the 
thermal stability of the protein. Experiments done by Dr. Vladimir Rogov with Ub_ABIN1 were 
more positive concerning the possibility to study thermal stability of protein based on the results 
obtained  with  the  Ub-fused  protein ( Figure  60).
151  Point  mutations  on  a  protein  are  often 
performed to prove the functionnal importance of specific residues of a protein and can also be 
useful to enhance the expression and solubility of the protein for further structural studies. The 
Ub-fused construct could be also used as a fast method to determine by CD spectroscopy if the 
mutations have any effect on the protein folding after short protein expression and without big 
purification steps.  
 
Figure 60: Melting curves of ABIN1 fused to ubiquitin. The only observed thermal transition in the 
Ub_ABIN1 melting curve (red) is due to ABIN1. The small size of ubiquitin and its thermal stability (ubiquitin 
melting curve in blue) at biologically relevant conditions are crucial advantages of this system in comparison to the 
NusA- or GST-tags in CD studies.  
 
7.1.3.2.  Ubiquitin-fused constructs for ITC 
  ITC  furnishes  important  information  on  the  interaction  between  two  molecules  like  the 
dissociation constant and the thermodynamic values of the interaction. As it was previously 
explained,  production  of  sufficient  materials  to  perform  the  experiment  could  be  a  limiting Discussion 
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factor. If the protein/peptide is not an ubiquitin binding partner, an Ub-fused protein/peptide is 
totally suitable to study interactions using ITC. Dissociation constants, binding enthalpy and 
entropy obtained for LC3B interaction with Ub_p62-LIR and with synthesized p62-LIR in the 
same  experimental  conditions  were  very  similar,  proving  that  the  ubiquitin  moiety  did  not 
interfere in the interaction. The observed slight differences could be explained by an error due to 
the uncertainty in the sample concentration. Within their fusion to ubiquitin, the effect of single 
mutations in the interaction of NBR1-LIR with GABARAPL-1 was successfully studied.
152  
 
7.1.3.3.  Ubiquitin-fused constructs for NMR 
  Due to its stability and its small size, ubiquitin is well characterized by NMR and frequently 
used as a model for new NMR experiments.
153 The use of different MAP1LC3 proteins fused to 
ubiquitin  has  shown  that  the  peak  dispersion  in  NMR  experiments  was  good  enough  to 
distinguish  resonances  belonging  to  the  protein  target  from  the  ubiquitin  moiety  based  on 
published ubiquitin assignment (BMRB accession number 4768). To avoid the loss of protein 
through several purification steps, NMR experiments for proteins issued directly from the cell 
lysate  were  performed.  The  resulting  [
15N, 
1H]  TROSY_HSQC  spectra  were  very  similar 
compared to the ones obtained from pure proteins. Naturally, because of the absence purification 
steps,  more  background  was  present  in  the  [
15N, 
1H]  TROSY_HSQC  spectra.  Interestingly, 
LC3A and LC3B presented different behaviors in cell lysate when they were fused to ubiquitin. 
While LC3A had relatively no background, the [
15N, 
1H] TROSY_HSQC spectra of LC3B were 
more crowded. In the case of Ub_LC3B, the loss of quality resolution in the spectrum could be 
due to the formation of a large protein complex with remaining endogenous proteins, which is 
hardly observable in [
15N, 
1H] TROSY_HSQC spectra. Using protease inhibitors and sodium 
azide, Ub-fused proteins or peptides isolated from the cell lysate could be used for 24 hours 
measurements without any problems. For measurements needing longer time (approximately a 
week), further purification steps should be added to avoid any degradation.  
  Structure determination of proteins is often laborious and bioinformaticians try to automatize 
this  work.  First  tries  using  “traditional  assignment  methods”  with  Ub-fused  peptides 
(Ub_p62-LIR  and  Ub_NBR1-LIR)  were  already  performed  and  most  of  the  backbone 
resonances could be assigned. These constructs were in the meantime transferred to the group of 
Prof. Peter Güntert (Goethe University Frankfurt), which used computational methods to study 
biomolecular systems. Applying NUS-NMR methods, which only need 10 to 25% of the total 
spectroscopy  time  of  traditional  experiments,  in  combination  with  automated  assignment 
protocols (FLYA
154 and AUTOASSIGN
155), the resonances of Ub_p62-LIR and Ub_NBR1-LIR Discussion 
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backbone and side chains were assigned. Both methods provided the same results but the speed 
of execution plays in favor of NUS-NMR (Table 7).
156 Further experiments using Ub-fused 
proteins with higher molecular weight than p62-LIR and NBR1-LIR should be performed to 
confirm the beneficial effect of Ub-fusion coupled to automated NMR methods for assignment 
and structure determination. Thus, this approach allows using Ub-fused targets of any length 
independently from rates of resonance overlapping. 
 
Experiments  Time in hour  Gain of Time  
hncoca                    1.2  15 % 
ihnca                2.4  15 % 
hnco                 1.0  10 % 
hncaco               8.0  20 % 
hncocacb             7.5  20 % 
ihncacb              9.4  25 % 
hbhacbcaconh         11.9  20 % 
hbhacbcanh           11.9  20 % 
ihncaco              10.0  25 % 
ctocsynh             14.3  18 % 
htocsynh             14.3  18 % 
ihbhacbcanh          14.9  25 % 
ictocsynh            15.9  20 % 
ihtocsynh            15.9  20 % 
 
Table 7: NUS-NMR experiments for the assignment of Ub_NBR1-LIR. 
NUS-NMR was used to assign more than 80 % of the backbone and side chain resonances of Ub_NBR1-LIR. Only 
20 % of the total spectroscopy time needed with traditional NMR experiments was used. 
   
  With  Ub-fused  constructs,  titration  experiments  were  also  performed  showing  the  same 
pattern than using pure peptides cleaved from their expression tag. As it was shown for ITC 
experiments, interaction studies of LC3B with p62-LIR by NMR showed the same results using 
synthesized peptide and Ub-fused peptide with the resonances corresponding to LC3B affected 
in a similar manner. Some differences were also seen but most probably due to buffer effect like 
remaining of purification solvent for the synthesized peptide. To understand the effect of the 
aromatic residue in the LIR domain, unlabeled NBR1-LIR and NBR1-LIR_Y732W were used as 
ubiquitin fused peptides to titrate GABARAPL-1 by NMR. Titration of both Ub_NBR1-LIR and 
Ub_NBR1-LIR_Y732W against GABARAPL-1 showed different patterns with different binding 
modes. Because the titration of ubiquitin against GABARAPL-1 did not show any interaction, 
these differences were not caused by the ubiquitin part but by the only difference between the 
both sequences, the substitution of tyrosine to tryptophan. The result of the titration was in Discussion 
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adequation with the ITC results showing a stronger interaction for the tryptophan mutant form of 
NBR1-LIR. 
  Thus, labeled and unlabeled proteins or peptides fused to ubiquitin are suitable for NMR 
studies. Respecting the NMR limiting factor of an overall molecular mass lower than 30 kDa, a 
nice peak dispersion was seen and the extra resonances were easily recognizable as belonging to 
the  protein/peptide  moiety.  If  ubiquitin  is  not  interfering  in  the  interaction,  ubiquitin-fused 
constructs  could  be  used  as  well  for  interaction  studies,  especially  when  short  peptides  are 
needed. 
 
7.2. TBK1 
7.2.1.  TBK1_ULD structure 
  To confirm the presence of an ULD in TBK1 as predicted in silico by Dr. Kay Hofmann, the 
structural  characteristics  of  this  domain  were  studied  by  NMR.  NMR  spectroscopy  of 
TBK1_ULD was really challenging because the protein was poorly soluble and tended to form 
aggregates.  The  different  attempts  to  improve  the  quality  of  TBK1_ULD  samples  were 
unsuccessful  to  determine  the  three  dimensional  structure  of  the  protein.  Amino  acid 
mutagenesis or use of additives did not allow to reach higher protein concentrations needed to 
perform  3D  NOESY  experiments  with  a  good  quality  necessary  for  the  full  assignment  of 
TBK1_ULD,  prior  to  any  structure  calculation.  To  determine the  secondary  structure  of  the 
potential ULD domain of TBK1 under these conditions, calculations were only based on the 
assignment of the chemical shift values of TBK1302-385. Using selective labeling, the backbone of 
TBK1_ULD  was  assigned  and  the  secondary  structure  elements  were  identified  by  NMR 
spectroscopy.  The  secondary  structure  elements  of  TBK1_ULD  have  the  same  sequential 
arrangement (ββαββ) and the same length as the corresponding secondary structure elements in 
ubiquitin. TBK1 belongs thus to the UBL superfamily, especially the type II of ULD, defined by 
the presence of an ULD as an element of a bigger structure. Using the known ubiquitin hydrogen 
bonds and by transposing them onto the TBK1_ULD structure, first calculations for the three 
dimensional structure determination of TBK1_ULD confirmed also the Ub-fold. Nevertheless, 
the full backbone and side chain assignment of TBK1_ULD has still to be achieved to determine 
the real structure. Improvement in the quality of TBK1_ULD NMR sample is required first. 
Initial expression and purification assays with TBK1_ULD fused to ubiquitin were promising 
and further improvements in the method could help to provide enough pure TBK1_ULD for 
structural studies. Discussion 
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  Despite these structural similarities between the ULD of TBK1 and ubiquitin, differences 
exist in their dynamic behavior, reflected by broader signals for TBK1_ULD as for ubiquitin. 
This difference observed on the structured part of TBK1_ULD, especially on the β-sheet, could 
be important for the binding of the protein, which depends on the Ub-fold. This difference is 
enhanced by the presence of an enlarged hydrophobic surface of the ULD in TBK1, concentrated 
around  the  conserved  hydrophobic  patch  on  the  β-grasp  fold  (352-354  residues  LIY  in 
TBK1_ULD and 43-45 residues LIF in ubiquitin), while the rest of ubiquitin and TBK1_ULD 
amino acids have a low sequence similarity. This conserved motif is important because it is 
known to play a role in the interaction with binding partners for ubiquitin and other UBL. This 
bigger  hydrophobic  surface  could  be  one  of  the  reason  why  the  ULD  domain  of  TBK1 
precipitated quickly and was not easily purified as it could be for ubiquitin.  
 
7.2.2.  TBK1_ULD vs. IRF3_IAD-SRR 
  Ikeda et al.
120 showed that TBK1_ULD was interacting with the IAD domain of IRF3 using 
GST  pull-down  assays.  The  structure  determination  of  the  TBK1_ULD/IRF3_IAD  complex 
should  help  to  understand  how  TBK1  recruits  its  substrate  through  the  ULD  for  later 
phosphorylation via kinase domain of TBK1. ULD binds to IAD alone but the crystal structure 
of IRF3 showed that the core of the protein is a β-sandwich, which is covered up on one side by 
the  association  of  the  structural  elements  of  the  IAD  and  the  SRR  domains  stabilizing  the 
hydrophobic surface provided by α-helices of IAD.
122; 150; 157 That could explain why the IAD 
domain was predicted to be alone very unstable and why only IAD-SRR could be isolated. The 
difficulties  to  obtain  the  structure  of  TBK1_ULD  added  to  the  instability  of  IAD-SRR 
complicated  these  studies.  Nevertheless,  the  preliminary  interaction  studies  showed  that  the 
TBK1‐ULD/IRF3 interaction is a more complex process than a one to one binding mode with the 
whole TBK1_ULD molecule affected by the presence of IAD-SRR. 
  The main characteristic of TBK1_ULD is its direct function as a regulator of the kinase 
domain  of  TBK1  but  also  to  bind  to  other  IKK-related  kinases.  No  characterization  of 
TBK1_ULD  interaction  with  its  kinase  domain  has  been  determined  so  far.  However,  the 
presence  of  the  hydrophobic  patch  in  TBK1_ULD  seems  to  be  essential  for  IRF3  to  be 
phosphorylated.  Mutations  on  this  hydrophobic  motif  reduce  the  phosphorylation  activity  of 
TBK1. IRF3 does not dimerize, does not become active and does not transfer to the nucleus, as it 
appears with TBK1 wild type. In contrast, mutation of the hydrophobic patch does not affect the 
binding of TBK1_ULD to IRF3. TBK1_ULD plays a crucial role as a protein-protein interaction Discussion 
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domain in the regulation of the function of TBK1 by recruiting substrates to be phosphorylated 
in one hand and by controlling the activity of TBK1 kinase domain in the other hand.
120 This 
double function of TBK1_ULD by interacting with its kinase domain as well as with IRF3 could 
explain why TBK1_ULD seems to be affected on both sides in presence of IAD-SRR. Thus, a 
model  of  the  interaction  and  of  the  activity  regulation  between  TBK1  and  IRF3  could  be 
explained as follows: first IRF3 binds weakly to the ULD of TBK1 via its IAD domain; this 
fleeting binding brings the kinase domain of TBK1 close to the SRR domain of IRF3, which is 
then phosphorylated; finally this post-translational modification has for consequence that IRF3 
dimerizes via its IAD domain.
120 
  Complementary studies should be done for a better understanding of these interactions by 
characterizing the binding affinity and mapping the interaction on the surface of TBK1_ULD 
with IRF3 but also with its own kinase domain. 
  
7.2.3.  TBK1_ULD differs from most common ULDs 
  TBK1 belongs to the type II of UBL proteins where the ULD is “only” an ubiquitin-like 
region in the sequence of the protein. In contrast, type I UBL are post-translational modifiers 
conjugated in a similar way than ubiquitin. UBL are defined by their Ub-fold but some structural 
differences are still observed between them, which are categorized in three sub-families of ULD: 
RAD23 (and TBK1_ULD), very similar structurally to ubiquitin; ubiquitin-regulatory X domain 
(UBX) with an expanded surface loop; PB1, which is part of a higher order structure. Although 
TBK1_ULD structure is close to ubiquitin (RMSD over α-helix 1 and β-strands 1 to 4 is 1.5 Å 
and the global RMSD is 3 Å), their primary amino acid sequences differ a lot and TBK1_ULD 
presents a different function as well as other interaction partners. Other proteins presenting a 
β-grasp superfold have a broad range of functions, from a role in protein folding and degradation 
to  the  regulation  of  signal  transduction  and  enzymatic  activity.  For  proteins  presenting  an 
Ub-fold, it could be optimistic to think that the substitution of ULD by ubiquitin would have no 
effect on the protein function. It is not the case for TBK1 since ubiquitin does not bind to IRF3 
as TBK1_ULD. This is different for each ULD. While ubiquitin could substitute the function of 
RAD23_ULD,  the  function  of  IKKβ  is  abolished  in  the  presence  of  ubiquitin  instead  of 
IKKβ_ULD.  Interestingly,  proteins  possessing  an  ULD  bind  also  to  ubiquitin  via 
ubiquitin-binding domains (UBD) but not for TBK1. All together, the unique structural features 
of TBK1_ULD could explain the functional specificity of this ubiquitin homolog. 
 Discussion 
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7.3. Autophagy 
  The  aim  of  this  project  was  to  characterize  the  interactions  responsible  for  selective 
autophagy  between  the  LIR  domains  of  autophagy  receptors  with  different  mammalian 
homologs of the yeast autophagy effector Atg8.  
  The  three-dimensional  structure  determination  of  the  GABARAPL-1/NBR1-LIR  complex 
added insights of the interaction at a structural point of view. 
 
7.3.1.  MAP1LC3 proteins and LIR peptides 
  The first issue when studying proteins is of course to be able to have enough of pure protein. 
Even though the first plasmids provided could express nicely MAP1LC3 protein as GST fusions, 
the purification steps were challenging and did not offer enough materials. Replacement of GST 
as expression tag, first by NusA then by ubiquitin, could cover this problem and the obtained 
amount of MAP1LC3 proteins was sufficient for the studies. In parallel, peptides containing the 
LIR motifs of the different autophagy receptors had to be isolated. The first tries using different 
constructs of NBR1 as GST fusion produced some proteins but the purification was challenging 
or  even  unsuccessful.  In  a  first  time,  ordering  synthetic  peptides  was  a  solution  to  perform 
titration  experiments.  Nevertheless  this  solution  would  have  been  expensive  when  labeled 
peptides were needed for the structure determination studies. Expression of Ub-fused peptides 
and their use as free peptide or peptide still fused to ubiquitin was a successful solution to 
perform NMR and ITC studies.  
 
7.3.2.  Interaction studies 
  The  specificity  of  autophagy  effector/receptor  interactions  is  essential  for  selective 
degradation by autophagy. This interaction was shown to take place between the hydrophobic 
pockets  of  MAP1LC3  proteins  and  the  LIR  domain  of  autophagy  receptors.  The  constant 
discovery of new autophagy receptors brings along a diverse composition of LIR motifs, which 
could lead to a big difference in their binding to MAP1LC3 proteins. Based on their studies on 
the  structural  basis  of  LC3B/p62  and  Atg8/Atg19  interactions,  Noda  et  al.
87  determined  in 
autophagy receptor proteins a WxxL motif crucial for these interactions. The LIR motif consists 
of  the  following  sequence  xxΘxxΓ  where  Θ  and  Γ  are  aromatic  and  hydrophobic  residues, 
respectively, and x should represent at least one acidic residue. 
  Whereas ITC provided very interesting quantitative information about the thermodynamics of 
the interaction of MAP1LC3 proteins with the different LIR motifs, NMR brings the interaction 
studies at a structural level and shows the involvement of the residues in the interaction. Discussion 
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7.3.3.  Differences between LIR motifs 
7.3.3.1.  p62 
  Identified in parallel by different groups,
88 p62 is the prototypical LIR containing protein with 
three aspartates followed by a tryptophan as aromatic residue and a leucine as hydrophobic one. 
LC3B has been the most studied mammalian Atg8 family members and its structure in presence 
of p62 has been determined.
88; 89 Because the affinity of p62 to LC3B seems to be high enough 
to get the structure of complex by both X-ray crystallography and NMR methods, LC3B as 
mammalian Atg8 model and its interaction with p62 as LIR model were chosen as reference to 
be able to compare the binding of different LIR motifs to MAP1LC3 proteins. The NMR and 
ITC experiments confirmed the strong interaction of LC3B with p62 with a dissociation constant 
in the low micromolar range. The extremely negative value for the enthalpy plays in favor of the 
binding by increasing the binding surface. This effect is counterbalanced by a decrease of the 
mobility  of  both  protein  and  peptide  upon  binding  explained  by  the  negative  entropy  value 
reducing the overall binding affinity. 
  p62 was the first autophagy receptor discovered and its interaction with MAP1LC3 proteins is 
the strongest, regarding to the LIR motif of other autophagy receptors. Autophagy has a crucial 
role in cell surviving and lack of p62 lead to autophagy deficience. Thus, the tightly binding of 
p62 to MAP1LC3 proteins anchored into the autophagosome membran make of p62 the essential 
autophagy receptor needed for a good functioning of selective autophagy. 
 
7.3.3.2.  NBR1 
  For NBR1, it was shown that a YIII peptidic sequence was crucial for its interaction with all 
members of the MAP1LC3 protein family.
93 Interestingly in the LIR motif here, the aromatic 
residue  is  a  tyrosine,  the  hydrophobic  residue  an  isoleucine  and  only  two  acidic  residues, 
glutamate  and  aspartate,  are  present  before  the  aromatic  residue.  Finally,  the  presence  of 
isoleucines at position 2 and 3 as well as a leucine at 5, provides a strong hydrophobic patch at 
the C-terminus of NBR1-LIR. To establish the importance of the aromatic residue at position 1, 
the binding behavior of the non-tryptophan NBR1-LIR domain was compared with the LIR 
domains of p62 and Nix using NMR and ITC. 
  Compared to p62, the interaction of LC3B with NBR1 presented a less favorable binding 
enthalpy, which is partially compensated by a positive entropy contribution. These differences in 
binding between NBR1- and the p62- LIR domains are likely caused by the more favorable 
hydrophobic  character  of  the  tryptophan  present  in  p62-LIR  and  a  reduced  fitting  to  the 
hydrophobic pocket on LC3B due to the additional hydroxyl group of the tyrosine in NBR1-LIR. Discussion 
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The binding of the side chains of the NBR1-LIR domain to the surface and the hydrophobic 
pockets on LC3B is less optimal than for p62. To further study the specificity of the LIR motif of 
NBR1,  GABARAPL-1  was  choosen  as  MAP1LC3  protein.  Already  illustrated  by  a  lower 
dissociation constant than in case of LC3B/NBR1-LIR interaction, the entropy and enthalpy 
values of GABARAPL-1/NBR1-LIR interaction showed that less hydrophobic interactions are 
made and that the binding complex is not as tight. 
  To understand the influence of the tyrosine as aromatic residue in a LIR motif for the binding 
of NBR1 to MAP1LC3 proteins, two NBR1-LIR mutants were created: NBR1-LIR_Y732W and 
NBR1-LIR_Y732F  by  substituting  the  tyrosine  by  a  tryptophan  and  a  phenylalanine, 
respectively. GABARAPL-1 was chosen as representant of MAP1LC3 proteins in this study 
because it was in parallel the best candidate for NMR structural studies. Both NMR and ITC 
titration  experiments  indicated  that  the  presence  of  a  tyrosine  residue  in  position  1  in  the 
NBR1-LIR domain instead of a tryptophan residue in most LIR motifs results in an increased 
flexibility in the interaction with MAP1LC3 proteins. The less positive entropy in ITC for the 
tryptophan  mutant  suggests  that  this  residue  is  making  tighter  contacts  to  GABARAPL-1 
whereas there is more flexibility in the presence of the tyrosine. These data confirmed the NMR 
results suggesting a stronger interaction with NBR1-LIR_Y732W and a faster exchange mode 
for NBR1-LIR wild type. Phenylalanine instead of tyrosine lead also to a more negative binding 
enthalpy but at the same time to a less positive binding entropy. These two opposite effects lead 
to a similar dissociation constant for NBR1-LIR wild type and for the phenylalanine mutant. 
Nevertheless,  NBR1-LIR_Y732W  showed  a  stronger  interaction  to  GABARAPL-1  than 
NBR1-LIR_Y732W and NBR1-LIR wild type. By replacing the tyrosine with a phenylalanine, 
the binding surface in the hydrophobic pocket increased by the deletion of the hydroxyl group. 
At the same time, increasing the number of hydrophobic bonds did not help so much to get a 
stronger interaction because GABARAPL-1 could not adapt its hydrophobic pocket 1 for a better 
fitting for this aromatic residue like it is for the tyrosine residue. Presence of a tryptophan at 
position  1  of  the  LIR  domains  seems  therefore  to  be e ssential  for  a  strong  interaction  with 
MAP1LC3 proteins and its substitution by an other aromatic residue reduces equally the binding 
effect either with a tyrosine or a phenylalanine. 
  The structure of the GABARAPL-1/NBR1-LIR complex showed that the residues preceding 
the N-terminal part of the LIR motif were close to the two first α-helices of GABARAPL-1. 
Several positive charged residues being present in this region and negative charged residues 
being characteristic of the LIR motif, ionic bonds could stabilize the interaction. To investigate 
whether a higher number of negatively charged amino acids in the LIR motif could compensate Discussion 
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for the substitution of tryptophan with tyrosine, the stretch of negatively charged amino acids 
directly  N-terminal  to  Y732  in  NBR1  was  extended  by  mutating  two  serines  to  glutamates 
resulting to two other constructs, NBR1-LIR_S729E and NBR1-LIR_S728,729E. Introducing 
additional negatively charged amino acids also resulted in a more negative enthalpy but a less 
positive entropy relative to the wild type peptide. These opposite effects in the interaction are 
illustrated by a dissociation constant very similar to the one for NBR1-LIR wild type. Although 
an increase in the binding surface due to the addition of negative charged residue is noticed, 
these amino acids did not increase the binding affinity. 
  NBR1  and  p62  share  the  same  role  in  autophagy  with  the  selective  sequestration  of 
ubiquitinated  substrates  into  the  autophagosome.  Still,  p62  shows  a  stronger  interaction  to 
MAP1LC3  proteins  than  NBR1.  Moreover,  p62  seems,  for  the  moment,  to  bind  to  more 
ubiquitinated targets than NBR1 but only because these studies have not been performed for 
NBR1. Thus, even though NBR1 does bind to MAP1LC3 proteins as strong as p62, NBR1 is an 
essential  auxiliary  autophagy  receptor.  Both  autophagy  receptors  co-localize  in  ubiquitinated 
bodies and interact together to act as ubiquitin cargo receptors.  
 
7.3.3.3.  Nix 
  In the case of the Nix protein, the two identified LIR motifs have both a tryptophan residue at 
position 1 but the interaction with MAP1LC3 proteins is even weaker than for NBR1. Whereas 
Nix-LIR_W36 has also a leucine as hydrophobic residue at position 4, no second hydrophobic 
residue is present at the correct position after W140 nor W144 but an aspartate and an arginine, 
respectively. There is no N-terminal strong negatively charged block present before W36 and 
only one aspartate before each tryptophan in Nix-LIR_W140/144.
99  
  For Nix, a weaker interaction with MAP1LC3 proteins is illustrated by a dissociation constant 
in the hundred micromolar range and a less negative enthalpy as well as a low positive entropy 
compared to p62. The interaction between LC3B and Nix-LIR_W36 or Nix-LIR_W140/144 is 
less saturated with only a few residues in the peptides that could find correct partners on LC3B 
surface  to  form  proper  polar  and/or  nonpolar  contacts.  The  absence  of  negatively  charged 
residues N-terminally to the aromatic residue reduces the ionic interactions with the N-terminal 
residues  of  MAP1LC3  proteins.  While  Nix-LIR_W140/144  contains  one  acidic  residue  at 
position -1 (compared to three for p62 and two for NBR1), most importantly it does not have any 
hydrophobic  residues  at  position  4.  Consequently,  the  data  showed  the  weakest  binding  for 
Nix-LIR_W140/144. In the interaction with LC3B, ITC data showed that Nix-LIR_W140/144 
was  the  weakest  binder  followed  by  Nix-LIR_W36,  p62  being  the  strongest  one.  These Discussion 
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observations  were  confirmed  by  NMR  with  different  binding  patterns  for  each  interaction 
partner: slow exchange mode correlated to a strong interaction for p62 and fast exchange mode 
illustrating a weak interaction for Nix-LIR_W140/144. In between, an intermediate close to fast 
exchange mode was observed for Nix-LIR_W36. Using LC3A instead of LC3B as MAP1LC3 
protein, the CSP were more important in presence of Nix-LIR_W36 than of Nix-LIR_W140/144. 
While Nix-LIR_W140/144 titration against LC3A and LC3B showed a typical fast exchange 
mode, a fast (close to intermediate) exchange mode was observed in presence of Nix-LIR_W36. 
In parallel, Nix-LIR_W36 titration against GABARAPL-1 by NMR confirmed the tendency of 
Nix-LIR_W36 to interact in a fast-intermediate exchange mode with MAP1LC3 proteins. To 
reassign LC3B residues in presence of the LIR domains, no assignment using NMR experiments 
was done but only by following the chemical shift perturbations. So it is possible that some of 
the peaks corresponding to the bound form reappeared approaching to saturation but so far away 
from the free form that it could not be assign like this. Nevertheless, the number of new peaks 
appearing  being  lower  then  the  disappearing  one  for  Nix-LIR_W36,  it  confirmed  that  NH 
resonances are going into a intermediate (fast) kinetic exchange. 
  While the comparison of p62 and NBR1 interaction with MAP1LC3 proteins showed that the 
presence of a tryptophan as aromatic residue is more preferential, a tryptophan alone is not 
sufficient to assess a strong interaction profile to a LIR motif. Thus, in addition to the presence 
of the aromatic residue buried in hp1, the hydrophobic interactions of the LIR motif with hp2 are 
also  essential  and  have  to  be  complemented  with  electrostatic  interactions  mediated  by 
negatively charged amino acids. Nix binds less preferentially to MAP1LC3 proteins than NBR1 
and p62. While p62 and NBR1 have similarity in their domain organization, Nix differs from 
them. Especially, Nix presents a transmembran domain to be anchored in the outer mitochondrial 
membran and, most important, does not bind to ubiquitin. For the moment, no clear evidence of 
p62 or NBR1 binding to ubiquitin chains conjugated to the membran of mitochondria has been 
shown. Until data proving their role in the selective degradation of mitochondria by autophagy, 
Nix supplies this function as mitochondrial autophagy receptor.  
 
  Taken together, these results demonstrate the importance of the aromatic residue in the LIR 
motif  but  also  the  involvement  of  the  residues  in  the  neighborhood  for  the  interaction  with 
MAP1LC3 proteins. The replacement of tryptophan at position 1 with other aromatic residues 
leads to a weaker interaction. The presence of a tyrosine as aromatic residue reduces the overall 
binding affinity but due to its flexibility in the receiving hydrophobic pocket, the interaction 
surface  could  adapt  itself  to  still  allow  the  binding.  Other  substitutions  like  increasing  the Discussion 
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number of negatively charged residues at the N-terminus of the aromatic residue of the LIR 
domain,  however,  result  in  a  remarkable  enthalpy-entropy  compensation  allowing  different 
sequences to interact with an overall similar binding affinity. 
  The  characterization  of  a  new  autophagy  receptor,  optineurin,  showed  that  the 
phosphorylation of the serines preceding the LIR domain increases its interaction with LC3A 
and  LC3B.
105  The  substitution  of  serines  by  glutamates  is  often  seen  as  a  mimetic  of 
phosphorylation. In the case of NBR1, the phosphorylation of the LIR motif does not have such 
an obvious effect in the binding to MAP1LC3 proteins like for optineurin. Interestingly, instead 
of acidic residues, both Nix-LIR motifs present serines, which could be phosphorylated and then 
carry, a negative charge and finally could interact stronger to MAP1LC3 proteins. In vivo studies 
as well as the identification of kinases will be necessary for a clear statement if phosphorylation 
of NBR1 and/or Nix could increase their binding properties to MAP1LC3 proteins. 
  p62,  NBR1  and  Nix  have  a  similar  function  as  autophagy  receptors,  which  tether  entire 
organelles or individual proteins to the autophagosomal membrane.
82 Nevertheless, differences 
in their LIR motifs and in their binding affinity to MAP1LC3 proteins suggest some functional 
divergences. Further studies of the role of posttranslational modifications that might regulate the 
interaction between autophagy receptors and effectors will be of high interest. 
 
7.3.4.  Differences between MAP1LC3 proteins 
  The different MAP1LC3 proteins present different exchange mode of interactions with the 
different LIR motifs suggesting that differences in protein constitution have also to be taken in 
account to understand the specificity of the interaction. 
  In  yeast,  Atg8  is  the  only  protein  involved  in  autophagosome  formation  whereas  seven 
homologues  have  been  identified  so  far  in  mammalian  and  could  be  divided  into  two 
sub-families: LC3- (LC3A, LC3B and LC3C) and GABARAP- (GABARAP, GABARAPL-1, 
GABARAPL-2 and GABARAPL-3) proteins. 
 
7.3.4.1.  LC3B vs. LC3A 
  The interaction of LC3B with autophagy receptors being established as reference, the next 
interest was to compare their binding to other MAP1LC3 proteins. 
  Like for LC3B, NMR interaction studies of LC3A with Nix-LIRs showed that Nix-LIR_W36 
binds stronger than Nix-LIR_W140/144, confirming the GST pull-down assays performed by 
Novak et al.
99 For LC3A and LC3B, corresponding residues situated in the hydrophobic pockets 
1 and 2 or in the closest neighborhood, meaning in direct contact with the LIR motif, were the Discussion 
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most affected residues upon titration but the CSP were higher in presence of Nix-LIRs for LC3A 
than for LC3B. The ITC titration confirmed that LC3A was a better interaction partner to both 
Nix-LIRs  than  LC3B  and  that  Nix-LIR_W36  binds  stronger  to  LC3-  proteins  than 
Nix-LIR_W140/144. Interestingly,  the  free  energy  of  the  system  is  the  same  for  LC3A  and 
LC3B with both Nix-LIR_W36 and Nix-LIR_W140/144 (ΔG ≈ -6 kcal mol
-1) but, while the 
enthalpy and entropy have opposite effects in LC3B/Nix-LIRs interaction, LC3A/Nix-LIRs is 
entropy driven. The higher entropy values for LC3A interaction with Nix-LIRs could reflect the 
possibility for more hydrophobic bonds than for LC3B even though LC3A and LC3B have a 
very  similar  hydrophobic  pattern.  However,  NMR  studies  of  both  proteins  showed  already 
differences in their behavior, especially in the flexibility of the N-terminal part. Further studies 
focused on the structural insights of the interaction will be necessary to be able to explain the 
important difference between LC3A and LC3B in their interaction with Nix-LIRs. 
 
7.3.4.2.  LC3- vs. GABARAP- proteins 
  Although the high sequence and structure similarity between MAP1LC3 proteins, handling 
these proteins was challenging. For GABARAP- proteins, GABARAPL-1 and GABARAPL-2 
presented a different behavior in the first purification steps and GABARAPL-1 seemed to be 
more  preferential  for  further  studies  due  to  a  better  solubility  and  stability  of  the  protein. 
Concerning LC3- proteins, the NMR spectra of LC3A and LC3B fused to ubiquitin and isolated 
from the cell lysate showed different patterns. Whereas the [
15N, 
1H] TROSY_HSQC spectrum 
of LC3A was similar to the one of the purified protein, the [
15N, 
1H] TROSY_HSQC spectrum of 
LC3B  looked  like  one  of  a  bigger  protein  or  of  a  protein  involved  in  a  huge  complex. 
Intriguingly, during the different NMR experiments involving MAP1LC3 proteins, several broad 
or even double peaks were observed as well in [
15N, 
1H] TROSY_HSQC spectra as in HNCA, 
HNCACB or NOESY spectra. This fact can be interpreted as a certain degree of flexibility for 
these proteins. Moreover, during assignment attempts for GABARAPL-1 but also for LC3B or 
for  LC3A,  difficulties  were  encountered  concerning  the  N-terminal  part  of  these  proteins, 
especially around the two α-helices. Depending of the conditions, the [
15N, 
1H] TROSY_HSQC 
spectra  of  LC3A  presented  some  differences  that  could  be  interpreted  as  a  switch  between 
conformations. The presence of broad or double peaks as well as the disappearance of some 
peaks is probably provoked by proton amide exchange of these exposed residues with the buffer 
due to local dynamics created by the flexibility at the N-terminus of GABARAPL-1 like it was 
previously reported for GABARAP by Coyle et al.
74 Discussion 
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  The fact that MAP1LC3 proteins share a similar structure although they differ in their tissue 
localizations raises the question about different functions for LC3- and GABARAP- proteins in 
autophagy. Weidberg et al.
64 showed already that all MAP1LC3 proteins are indispensable for 
autophagosome formation but acting at different time points. Moreover, each MAP1LC3 protein 
does not bind identically to the different autophagy receptors. The main structural characteristic 
of MAP1LC3 proteins is the presence of two N-terminal α-helices. Interestingly, the amino acid 
composition of these helices differs between MAP1LC3 proteins. Whereas α-helix 1 and α-helix 
2 in LC3- proteins are basic and neutral, respectively, they present the opposite ionic character in 
GABARAP- proteins. Added to the knowledge earned by amino acid mutations in NBR1-LIR, it 
is  likely  that  the  initial  sequence  of  LIR  motif  in  autophagy  receptors  and  the  potential 
posttranslational modifications correlated to the electrostatic surface of the N-terminal α-helices 
of autophagy effectors could determine the specificity of the interaction and could explain their 
particular functions. Studies of the effects of mutagenesis of the N-terminal region of MAP1LC3 
proteins on the interaction with LIR motifs is still needed to be able to understand the importance 
of each residue and to explain the specificity of each autophagy effector and receptor on the 
interacting point of view. 
 
7.3.5.  Structure of GABARAPL-1/NBR1-LIR 
  One of the goals of this study was to further characterize the interaction of the NBR1-LIR 
domain with autophagy effector proteins by detailed NMR investigations on a structural point of 
view in order to better understand the involvement of the tyrosine residue in the LIR motif of 
NBR1 compared to the standard tryptophan in the majority of other LIR. 
  In  this  thesis,  the  first  NMR  complex  structure  of  a  mammalian  Atg8  homolog, 
GABARAPL-1, in presence of a non-tryptophan receptor LIR domain, NBR1 has been solved. 
Three dimensional structures (mainly solved by X-ray crystallography) of different MAP1LC3 
proteins  have  already  been  solved  and  show  a  high  structural  similarity  with  an  average 
backbone RMSD of 1.5 Å. In addition, the binding mode of peptides derived from different 
autophagy  receptors  is  also  very  similar  compared  to  the  structure  of  the 
GABARAPL-1/NBR1-LIR  complex  (RMSD  1.85  Å  with  the  NMR  resolved  structure  of 
LC3B/p62 (PDB: 2K6Q)
87 over analogous secondary structure elements; RMSD 1.59 Å with the 
X-Ray  crystallography  of  GABARAP/calreticulin  (PDB:  3DOW)
135  over  the  structured  part 
E12-V114).  The  structure  of  GABARAPL-1  in  presence  of  NBR1-LIR  presents  the  typical 
Ub-fold  preceded  by  two  N-terminal  α-helices,  forming  the  two  hydrophobic  pockets Discussion 
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characteristic for MAP1LC3 proteins. Nevertheless, some differences are still observable. Even 
though the LIRs of NBR1 and p62 share the same general motif, their amino acid composition 
differs, reflected especially by a different occupation of the hydrophobic pocket for the aromatic 
residue at position 1. The structure of the GABARAPL-1/NBR1-LIR complex shows that the 
side chain of NBR1-LIR Y732 is flexible and can adopt different positions in the hydrophobic 
pocket  1  of  GABARAPL-1  whereas  p62  shows  less  mobility  with  LC3B.  In  the  structure 
determination  of  GABARAP  by  Coyle  et  al.,
74  two  conformations  of  the  protein,  open  and 
closed, were identified. For all other structures of MAP1LC3 proteins, alone or in a complex, 
only the close conformation was observed. This is also the case for the GABARAPL-1/NBR1-
LIR  complex  but  the  difficulty  of  assignment  in  the  first  two  α-helices  provoked  by  some 
flexibility  in  the  N-terminal  region  could  be  engaged  due  to  this  conformational  exchange. 
Nevertheless, the presence of different resonances for Y732 of NBR1-LIR associated to the 
possibility for this same residue to take different positions in the hp1 of GABARAPL-1, all in 
accord with the NMR calculation of the structure of the GABARAPL-1/NBR1-LIR complex, 
plays also in favor of different possible conformations for the protein. Using different conditions 
in the analysis of GABARAPL-1 alone and in complex could maybe allow to better distinguish 
these two conformations for GABARAPL-1. The same studies on other MAP1LC3 proteins will 
be necessary to be able to structurally differentiate proteins from the same protein family. 
  It was already shown that the type of amino acid at position 4 does not dramatically affect the 
interaction as long as the residue at this position provides enough hydrophobic surface.
136 In the 
NBR1-LIR  domain  this  position  is  occupied  by  isoleucine  and  its  side  chain  in  the 
GABARAPL-1/NBR1-LIR complex structure is oriented in hp2 in the same manner as leucine 
in  the  LC3B/p62  complex.
87;  103  The  NBR1-LIR  domain  contains  also  more  hydrophobic 
residues  than  p62  at  positions  2,  3  and  5  (isoleucine,  isoleucine  and  leucine  for  threonine, 
histidine and serine). Such a hydrophobic track might lead to multiple binding modes or even 
competition  of  the  individual  amino  acids  for  the  hydrophobic  pockets.  The  broad  NMR 
resonances of amino acids in the core of the NBR1-LIR domain in complex with GABARAPL-1 
show  that  conformational  averaging  indeed  occurs,  but  at  the  same  time  did  not  allow  to 
characterize  the  different  potential  states  in  more  details.  While  the  reappearance  of  NBR1 
resonances  at  high  molar  ratios  argues  that  a  significant  contribution  to  the  observed  line 
broadening is due to intermediate exchange of the peptide between the bound and free state, the 
observation of multiple resonances for Y732 suggests that, at least for some residues, multiple 
conformations  in  the  bound  state  might  occur.  However,  no  multiple  resonances  or 
conformations during structure calculations have been observed for the isoleucine residues. The Discussion 
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increased  hydrophobic  interaction  throughout  the  entire  NBR1-LIR  domain  might,  however, 
compensate the tight interaction lost by the replacement of the typical tryptophan with a tyrosine. 
 
7.3.6.  MAP1LC3 proteins are not only involved in autophagy 
  The conserved amino acid sequences for each MAP1LC3 protein, from yeast to mammals, 
can be a sign of crucial function for this protein family. However, no special phenotype has been 
observed so far for GABARAP knockout mice. The high sequence and the structure homology 
between MAP1LC3 proteins could probably allow one protein to substitute the function of a 
homolog  if  necessary.  Nevertheless,  differences  in  the  binding  to  LIR  motifs  coupled  with 
differences in flexibility and in the potential oligomerization state lead to the hypothesis that 
each MAP1LC3 protein has more specific function in addition to selective autophagy. 
  Interestingly, none of the MAP1LC3 proteins was discovered from its role in autophagy but 
essentially in intracellular protein trafficking by enhancing vesicle fusion. 
  LC3-  proteins  were  first  identified  as  proteins  associated  to  microtubules.
57  Present  in 
neurons, these proteins bind to tubulin and regulate the microtubule binding activity of MAP1A 
and MAP1B. Whereas LC3B and LC3C were ubiquitously present in all tissues, LC3A is absent 
from peripherical blood leukocytes. Their expression level depend of their localization with a 
constant weaker expression for LC3C.
59 
  GABARAP- proteins were first denominated after the discovery of GABARAP, a protein 
associated  to  GABAA  receptors.  First  studies  showed  that  GABARAP  could  bind t o  the 
γ2-subunit of GABAA receptors as well as to tubulin at the same time, participating in targeting 
and  clustering  of  GABAA  receptors.
158  Vergnier-Magnin  et  al.
117  characterized  GEC1  as  a 
protein related to GABARAP due to their similarity with 87% of sequence identity and was 
consequently  renamed  GABARAPL-1.  Expressed  in  all  tissues  and  binding  to  tubulin, 
GABARAPL-1  acts  also  as  a  linker  between  membrane  receptors  and  microtubules. 
GABARAPL-2 also known as GATE-16 was described as a soluble transporter that could bind 
to NSF and Golgi membrane proteins leading to the modulation of intra-Golgi transport and 
being involved in membrane fusion.
67  
  Studies about the interaction partners of GABARAP are well characterized.
137 Although this 
work focused on the interaction of MAP1LC3 proteins with autophagy receptors, it should be 
noticed that mammalian Atg8 proteins also interact with modifying Atg8 protein enzymes but 
also with non-autophagy proteins, showing a wide role for MAP1LC3 proteins. 
  The structure of the GABARAPL-1/NBR1-LIR complex determined in this work is analog to 
the binding mode observed in the structure of GABARAP with calreticulin,
135 LC3 with p62,
87; Discussion 
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103 LC3 with Atg4B
104 or Atg8 with Atg19
87 and with Atg3
159 and suggested for the interaction 
of LC3 with Atg32,
89 of GABARAP with γ2 subunit of the GABAA receptor,
74 NSF,
138 clathrin 
Heavy Chain
80 or Nix
137 and of GABARAPL-1 with κ-opioid receptor.
160 The involvement of 
the two hydrophobic pockets of the mammalian Atg8 effector proteins binding to an aromatic 
residue  and  to  a  hydrophobic  residue  in  hp1  and  hp2,  respectively,  is  characteristic  of  the 
MAP1LC3 proteins. Additionnaly, the presence of an extended β conformation in the interaction 
partner resulting in an intermolecular parallel β-sheet with β-strand 2 of the Ub-fold is a known 
feature in protein-protein interaction involving ubiquitin-like proteins.
161; 162  
  Except tubulin using the N-terminal region,
163 most of the interaction partners of MAP1LC3 
proteins binds to the same surface including the Ub-fold and especially the two characteristic 
hydrophobic pockets. The same binding surface is involved even though the binding partners 
have a variety of functions from autophagy to the transport and clustering of diverse proteins and 
vesicles. Although these interaction partners have different functions, they all have the presence 
of an aromatic residue associated to a hydrophobic residue and negatively charged residues in 
the  binding  site  in  common.  Docking  experiments  demonstrated  that  the  indole  ring  of 
tryptophan is positionned between the side chains of K48 and L50 of GABARAP while the 
carboxyl group points out of the hydrophobic pocket.
80 Because of the high structure homology 
of GABARAP to other MAP1LC3 proteins and the conservation of the residues involved in hp1, 
it is extremely probable that the specificity of a ligand possessing an aromatic residue showed 
for GABARAP is also true for other LC3- and GABARAP- proteins. However, the discrepancy 
between different LIR motifs suggests that not a specific amino acid sequence is obligatory but 
hydrophobic interactions lead by aromatic residues are the main driving force in the binding 
mode of MAP1LC3 proteins with the interaction partners. 
  High conserved primary sequences, a wide tissue expression and a broad range of interaction 
partners  for  mammalian  Atg8  proteins  suggest  a  role  as  adaptor  proteins  that  bind 
simultaneously to multivalent receptor proteins on one hand and to membranes after association 
to  lipids  on  the  other.  In  a  general  and  synthetic  description,  MAP1LC3  proteins  are  thus 
involved  in  membrane  trafficking  events  but  some  questions  are  still  remaining.  Is  each 
MAP1LC3  protein  specifically  essential  for  selective  autophagy?  Does  the  role  of  each 
MAP1LC3 protein depend on different factors like the tissue localization or the cell conditions? 
Elazar and co-workers showed already functional differences between LC3- and GABARAP- 
proteins  in  the  autophagosome  formation.
64  Is  it  also  the  same  for  autophagy  receptor 
recognition?  Are  NBR1  and  p62  always  involved  in  parallel  to  recognize  ubiquitinated Discussion 
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substrates?  The  last  decade  has  seen  a  lot  of  research  performed,  which  led  to  a  better 
understanding of the autophagy pathway but some questions are still remaining for the next 
generations of PhD students. 
 
7.4. Conclusion and Outlook 
  Ubiquitin is a highly conserved protein. Considering the direct importance of ubiquitin in 
different cellular processes, the discovery of ubiquitin-like proteins involved in a great variety of 
biological pathways enhances the importance of their characteristic Ub-fold. Depending on the 
structure elements associated to the Ub-fold, interaction partners bind differently. Nevertheless, 
the same epitope on ubiquitin-like domains is used along one protein family to functionally 
differentiate proteins in between the ubiquitin-like superfamily. 
  In this work, two kind of ubiquitin-like proteins have been studied and both of them showed 
differences in their binding surface. Whereas the ubiquitin-like fold is preceded by two α-helices 
to  form  essential  hydrophobic  pockets  on  MAP1LC3  proteins  for  the  binding  of  autophagy 
receptors, these hydrophobic pockets are not present in TBK1_ULD. The surface of the Ub-fold 
on TBK1_ULD is differently used depending of binding to IRF3 or its own kinase domain. 
During this work, the structure of two proteins has been solved, the ULD domain of TBK1 and 
the  complex  issued  from  the  interaction  of  GABARAPL-1  with  NBR1-LIR.  Preliminary 
interaction studies of TBK1_ULD with IRF3_IAD-SRR have been started and the interaction of 
the  LIR  motif  of  autophagy  receptors  with  MAP1LC3  proteins  has  been  characterized. 
Concerning the “TBK1_ULD project”, in addition to a real characterization of the interaction 
with IAD-SRR, studies on the kinase domain of TBK1 will provide a better understanding of the 
immune  response  mechanism  involving  IKK  proteins.  For  the  “autophagy  project”, 
characterization of posttranslationnal modifications on autophagy receptors and effectors could 
explain the specifity of the different proteins. 
  Due to the solubility and stability provided by the structure of ubiquitin, the properties of the 
Ub-fold provide a great interest for protein engineering. Fused to proteins or peptides, ubiquitin 
was used as expression and solubility enhancer, which did not obligatory need to be removed for 
protein studies using biophysical methods. In this thesis, the use of Ub-fused constructs has been 
shown to be successful to produce pure labeled peptide for structure determination by NMR and 
to perform interaction studies by NMR and ITC. In order to answer to the remaining questions 
related to the two previous projects, a further use of Ub-fused constructs will be a method of 
proof for the benefits of ubiquitin in the expression of proteins and peptides but also for the use 
of biophysical methods without the constraints of difficult purification steps.  
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9.  Appendix 
9.1. Protein sequences 
>LC3A (after cleavage of NusA moeity) 
GAMGRPFKQRRSFADRCKEVQQIRDQHPSKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELVKIIRRRLQLNPTQ
AFFLLVNQHSMVSVSTPIADIYEQEKDEDGFLYMVYASQETF 
>LC3B (after cleavage of NusA moeity) 
GAMGKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQ
AFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF 
>GABARAPL-1 (after cleavage of Ub moeity) 
GAMFKFQYKEDHPFEYRKKEGEKIRKKYPDRVPVIVEKAPKARVPDLDKRKYLVPSDLTVGQFYFLIRKRIHLRPED
ALFFFVNNTIPPTSATMGQLYEDNHEEDYFLYVAYSDESVY 
>GABARAPL-2 (after cleavage of GST moeity) 
GSPEFKWMFKEDHSLEHRCVESAKIRAKYPDRVPVIVEKVSGSQIVDIDKRKYLVPSDITVAQFMWIIRKRIQLPSE
KAIFLFVDKTVPQSSLTMGQLYEKEKDEDGFLYVAYSGENTF 
>Ubiquitin (after cleavage of fused protein or peptide)  
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQELIFAGKQLEDGRTLSDYNIQKESTLHLVLQLESAS
GSGHHHHHHSAGENLYFQ 
>TBK1_ULD (after cleavage of GST moiety) 
GSPEFTSDVLHRMVIHVFSLQHMTAHKIYIHSYNTAAVFHELVYKQTKIVSSNQELIYEGRRLVLELGRLAQHFPKT
TEENPIFVTSLERPHRD 
NB: Amino acids from cloning artefacts and site-directed mutagenesis are underlined. 
 
9.2. Peptide sequences 
LIR motif  Synthesized peptides  Ub-fused peptides 
p62  RPEEQMESDNCSGGDDDWTHLS  GAMGDDDWTHLSS 
NBR1    GAMGSASSEDYIIILPES 
NBR1-LIR_Y732W    GAMGSASSEDWIIILPES 
NBR1-LIR_Y732F  GAMGSASSEDFIIILPES   
NBR1-LIR_S729E  GAMGSASEEDYIIILPES   
NBR1-
LIR_S728,729E 
GAMGSAEEEDYIIILPES   
Nix-W36  GLNSSWVELPMNSSN   
Nix-W140/144  SADWVSDWSSRPENIP   
Table 8: List of peptides used.  
The different LIR sequences used in this work are represented in bold characters with the aromatic residue at 
position 1 shown in red, the hydrophobic residue at position 4 in blue and the negatively charged residues in green. 
Any additional residues resulting from cloning artifacts are shown in italic characters. 
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9.3. ITC raw data 
 
 
Figure 61: ITC raw data of the interaction of MAP1LC3 proteins with LIR domains. All 
experiments were performed at 25°C in 50 mM sodium phosphate, 100 mM NaCl at pH 7.0.  
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9.4. GABARAPL-1/NBR1-LIR intermolecular NOEs 
 
 
 24 LYS  HB3   730 GLU  HB2   5.28 
 24 LYS  HB3   730 GLU  HB3   5.60 
 25 ILE  QG2   730 GLU  HN    7.10 
 25 ILE  QG2   730 GLU  QG    7.80 
 25 ILE  HG12  730 GLU  HB2   5.50 
 25 ILE  HG12  730 GLU  HB3   5.50 
 25 ILE  QD1   729 SER  HB2   4.82 
 25 ILE  QD1   729 SER  HB3   6.33 
 25 ILE  QD1   730 GLU  HN    6.30 
 25 ILE  QD1   730 GLU  HB2   6.60 
 25 ILE  QD1   730 GLU  HB3   6.60 
 25 ILE  QD1   730 GLU  QG    6.80 
 25 ILE  QD1   732 TYR  QD    7.65 
 28 LYS  HB2   729 SER  HB2   4.56 
 28 LYS  HB3   729 SER  HB2   4.63 
 28 LYS  HD2   729 SER  HN    5.60 
 29 TYR  QD    729 SER  HB2   6.93 
 29 TYR  QD    734 ILE  HG13  6.90 
 29 TYR  QE    729 SER  HB2   7.08 
 29 TYR  QE    734 ILE  HG13  6.60 
 29 TYR  QE    734 ILE  QD1   6.95 
 34 PRO  HB3   732 TYR  QE    6.76 
 36 ILE  QG1   732 TYR  QE    7.25 
 52 LYS  HB2   733 ILE  QD1   6.18 
 52 LYS  HB3   732 TYR  QD    7.06 
 52 LYS  HB3   732 TYR  QE    6.89 
 53 TYR  HN    732 TYR  QD    7.43 
 53 TYR  HA    733 ILE  QG2   6.47 
 53 TYR  HA    735 ILE  HB    5.80 
 53 TYR  HB3   733 ILE  QG2   6.59 
 53 TYR  HB3   735 ILE  QD1   6.90 
 53 TYR  QD    732 TYR  QE    8.90 
 53 TYR  QD    733 ILE  QG2   7.39 
 53 TYR  QD    733 ILE  QD1   8.80 
 53 TYR  QD    735 ILE  HB    7.09 
  
 53 TYR  QD    735 ILE  QG2   7.46 
 53 TYR  QD    735 ILE  QD1   7.70 
 53 TYR  QE    733 ILE  QG2   6.88 
 53 TYR  QE    733 ILE  QG1   8.60 
 53 TYR  QE    733 ILE  QD1   8.80 
 53 TYR  QE    735 ILE  QG2   7.25 
 53 TYR  QE    735 ILE  HG12  6.88 
 53 TYR  QE    735 ILE  HG13  7.70 
 53 TYR  QE    735 ILE  QD1   8.01 
 54 LEU  HN    734 ILE  HA    5.05 
 54 LEU  HN    734 ILE  QD1   6.60 
 54 LEU  HA    734 ILE  QD1   7.10 
 54 LEU  HB2   732 TYR  HB3   4.94 
 54 LEU  HB2   734 ILE  QG2   5.57 
 54 LEU  HB3   732 TYR  QD    6.89 
 54 LEU  HB3   734 ILE  HA    4.59 
 54 LEU  HB3   734 ILE  HG12  4.85 
 54 LEU  HB3   734 ILE  QD1   5.35 
 54 LEU  HG    732 TYR  QD    7.23 
 54 LEU  QD1   732 TYR  HB3   5.54 
 54 LEU  QD1   732 TYR  QD    8.57 
 54 LEU  QD1   732 TYR  QE    8.62 
 54 LEU  QD1   734 ILE  HG12  6.60 
 54 LEU  QD1   734 ILE  HG13  6.60 
 54 LEU  QD1   734 ILE  QD1   6.56 
 55 VAL  HN    736 LEU  QD2   7.10 
 55 VAL  QG1   736 LEU  QD2   7.60 
 56 PRO  HB2   736 LEU  QD2   6.60 
 56 PRO  HB3   736 LEU  HB2   5.50 
 56 PRO  HB3   736 LEU  HB3   5.43 
 56 PRO  HB3   736 LEU  QD2   5.80 
 56 PRO  QD    736 LEU  QD2   6.60 
 68 ILE  HG13  735 ILE  QD1   7.10 
 68 ILE  QD1   735 ILE  QD1   7.70 
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9.5. NMR structural statistics  
 
Table 9: Structural statistics of the 20 energy-minimized conformers of TBK1_ULD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Input restraint statistics 
 Total number of meaningful distance restraints 
 Intraresidual (i = j) 
 Sequential (|i – j|=1) 
 Medium range (1<|i – j|< 4) 
 Long range (|i – j| > 4) 
 Torsion angle restraints 
Restraint violations in final ensemble (20 conformers) 
 Distance restraint violations 
 Van der Waals restraints violations 
 Angle restraints violations 
 RMS deviations from experimental restraints 
  Distance restraints (Å) 
  Angle restraints (deg) 
RMS deviations from idealized covalent geometry 
 Bond lengths (Å) 
 Bond angles (deg) 
PROCHECK Ramachandran plot analysis (%) 
 Residues in most favoured regions 
 Residues in addionally allowed regions 
 Residues in generously allowed regions 
 Residues in disallowed regions 
Structural precision
c, RMSD (Å) to mean structure 
 Backbone atoms N, C
α, C’  
 All heavy atoms  
 
760 (58)
a 
136 
206 
203 (26) 
215 (32) 
91 
 
114 
47 
26 
 
n/a
b 
n/a
b 
 
0.014 
1.6 
 
60.8 
21.4 
13.0 
4.9 
 
0.65 ± 0.11 
1.44 ± 0.13 
a The number of included H-bond restraints is indicated in 
parentheses. 
b No energy minimization was performed 
c Values for the structured part (residues 14-88) 
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Table  10:  Structural  statistics  of  the  20  energy-minimized  conformers  of 
GABARAPL-1/NBR1-LIR 
 
Input restraint statistics 
 Total number of meaningful distance restraints 
 Intraresidual (i = j) 
 Sequential (|i – j|=1) 
 Medium range (1<|i – j|< 4) 
 Long range (|i – j| > 4) 
 Intermolecular 
 Torsion angle restraints 
Restraint violations in final ensemble (20 conformers) 
 Distance restraint violations 
  Number > 0.1 Å   
  Maximal violations (Å) 
 RMS deviations from experimental restraints 
  Distance restraints (Å) 
  Angle restraints (deg) 
RMS deviations from idealized covalent geometry 
 Bond lenghts (Å) 
 Bond angles (deg) 
PROCHECK Ramachandran plot analysis (%) 
 Residues in most favoured regions 
 Residues in addionally allowed regions 
 Residues in generously allowed regions 
 Residues in disallowed regions 
Structural precision
c, RMSD (Å) to mean structure 
 Backbone atoms N, C
α, C’  
 All heavy atoms  
 
1448 (84)
a 
207 
436 
295 (46)
a 
510 (38)
a 
69 (8)
b 
203 
 
 
0 
0.09 
 
0.0081 ±  0.0004 
0.55 ± 0.04 
 
0.0144 ± 0.0001 
1.730 ± 0.024 
 
85.3 
13.3 
1.1 
0.3 
 
0.65 ± 0.11 
1.21 ± 0.10 
a The number of included H-bond restraints is indicated in 
parentheses. 
b The number of unambiguously manually assigned 
intermolecular NOEs is indicated in parentheses. 
c Values for the structured part (GABARAPL-1 residues     
12-114, NBR1 residues 729-737). 
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